deaths,majorityOfAre,patientsWithHormoneReceptorPositive,Obj
deaths,majorityOfAre,patientsWithHormoneReceptor,Obj
objective,evaluate,timeToTreatmentFailure,Obj
degree,is,high,Obj
endocrineTherapy,backboneIn,cases,Obj
breastCancer,isSecond-leadingCauseOf,nervousSystemMetastasesAmongMalignancies,Obj
we,usingHybridizationOn,tissueSectionsFollowedByApproach,Obj
AC,decreasedLungMetastasis,demonstratedByUpregulationOfE-cadherinExpression,Obj
data,are,stillScarce,Obj
purpose,develop,realistic4dBreastPhantomIncludingContrastEnhancement,Obj
it,can,canTreatedWithHormonalReplacementTherapies,Obj
therapy,novelStrategyFor,breastCancerMetastasisPrevention,Obj
bcTissues,were,collectedFrom152BcPatients,Obj
problems,included,lubrication,Obj
model,showed,significantTumorGrowthReductionInMice,Obj
optimalPatientSelection,isCrucialGiven,effectsOfEndocrineTherapy,Obj
breastCancerCells,showedGrowthTo,irOverexpression,Obj
primaryDysfunctions,wereDueTo,penetrationPain,Obj
64-year-oldWoman'sHeadache,wasFound,result,Obj
AO,measuredWith,BCCT.core,Obj
Comparison,showed,matchingPatternsSeenOnHistology,Obj
doses,were,escalated,Obj
we,explored,significance,Obj
Comparison,showed,matchingPatternsSeen,Obj
partialBreastIrradiation,using,interstitialMulticatheterHigh-dose-rateBrachytherapy,Obj
tdo2Overexpression,was,associated,Obj
we,hereExplored,expressionOfTdo2InEscc,Obj
isolatedCompound,Using,13cResonance,Obj
information,isAvailableOn,alendronateRegardingAssociationWithBoneMetastases,Obj
therapy,mightBecome,novelStrategy,Obj
type,isWith,closedLoopStructure,Obj
purpose,develop,4dDigitalBreastPhantomIncludingTime-varyingContrastEnhancementForSimulationOfDedicatedBreastCtPerfusionImaging,Obj
Display,is,alsoConsideredAsNewCancerVaccineDeliveryStrategy,Obj
cellCycle,apoptosisOf,cancerCells,Obj
erαPolyubiquitinationInhibition,may,mayFactorInProgression,Obj
pi3k/akt/mtorPathway,be,growthPathwayInHrBreastCancer,Obj
64-year-oldWoman'sHeadache,resultFrom,diffuseAdenocarcinomaMetastasisFromUnknownSite,Obj
we,usingHybridizationOn,tissueSectionsFollowedByValidatedComputationalApproach,Obj
qpcrScreening,validatedSox4As,responsiveGene,Obj
purpose,develop,patient-based4dDigitalBreastPhantomIncludingContrastEnhancementForSimulation,Obj
samples,were,taken,Obj
we,haveRecentlyTested,fewPeptidesDerivedFromHer2/neuProto-oncogeneAsVaccineDeliveryModalities,Obj
virusTherapy,isStrategyFor,cancerTreatment,Obj
earlyDynamics,be,potentialPredictiveBiomarker,Obj
instruments,were,questionnaire,Obj
consecutivePatients,had,atLeast2YearFollow-up,Obj
qpcrScreening,validatedSox4As,highestResponsiveGene,Obj
ERI,ofDosesIs,level0,Obj
4dArray,finallyIsProduced,time-enhancementCurves,Obj
breastCancerXenografts,using,7TMri,Obj
64-year-oldWoman'sHeadache,resultFrom,diffuseAdenocarcinomaMetastasisInBoneMarrowFromUnknownPrimarySite,Obj
predictiveBiomarkers,optimize,clinicalOutcomeOfBreastCancerPatientsTreatedWithPalbociclib,Obj
anticancerActivities,free-radicalScavengingAgainst,breast-cancerCellLines,Obj
agents,remainsFor,idealStrategy,Obj
we,Using,hybridization,Obj
AC,decrease,observedWnt/β-cateninNuclearTranslocation,Obj
activities,excellentAntioxidantAgainst,cellLines,Obj
proliferation,isIn,breastTumourCells,Obj
adjuvantBreastIrradiation,using,multicatheterBrachytherapy,Obj
primaryObjective,evaluate,timeToTreatmentFailureInCombinationWithLetrozole,Obj
oralBisphosphonateTreatment,reducing,risk,Obj
extranuclearActivity,isRelatedTo,endocrineTherapyResistance,Obj
we,summarize,theirPotentialImplications,Obj
coefficient,rangedBefore,treatment,Obj
adjuvantPartialBreastIrradiation,using,fractionatedMulticatheterHigh-dose-rateBrachytherapy,Obj
targets,existingIn,loop,Obj
lowerOverallSurvival,isIn,firstYearsAfterDiagnosis,Obj
study,evaluateSatisfactionWith,surveillance,Obj
Patients,will,willAllocatedToOneOfThreeTreatmentArmsConsisting,Obj
extendedEndocrineTherapy,canReduce,recurrencesOccurring,Obj
goal-setting,isComponentOf,study,Obj
anticancerActivities,using,3,Obj
peptide,is,inPhageDisplayImmunotherapyPresentedByGeneticFusions,Obj
erαPolyubiquitinationInhibition,may,mayKeyFactorInProgressionOfBreastCancer,Obj
4dArray,finallyIsProduced,curves,Obj
treatment,canLose,effectiveness,Obj
cellAuthenticationTesting,confirmed,origin,Obj
recurrenceRisk,Extending,5YearsOfTamoxifenTherapyWith5YearsOfTamoxifen,Obj
cellProliferation,were,detectedBy3,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanGrowthFactorReceptor2-negativeBreastCancer,Obj
activities,antioxidantAgainst,cellLines,Obj
preoperativeMeasurements,leadTo,lowRateInImplant-basedImmediateBreastReconstruction,Obj
bilateralSalpingo-oophorectomy,mayImpactOn,qualityOfLife,Obj
egki-1Treatment,furthermoreArrested,cancerCellGrowth,Obj
preoperativeMeasurements,leadTo,rateOfComplicationsInImplant-basedBreastReconstruction,Obj
we,used,onlineKaplan-meierPlotterSurvivalAnalysisTool,Obj
targets,are,howeverRequired,Obj
phageConstructFormulation,actsAs,protectiveVaccineAgainstCancer,Obj
woman'sHeadache,wasFound,resultFromAdenocarcinomaMetastasisInBoneMarrowFromUnknownPrimarySite,Obj
we,explored,impactOfHeterogeneityOfErProteinExpression,Obj
macrophages,have,haveImplicatedInPromotionOfBreastCancerGrowth,Obj
3dPhantom,segmenting,fibroglandularTissue,Obj
co-treatment,regulating,expressionOfMitochondrialApoptoticProteins,Obj
phantom,can,canUsedDuringDevelopmentOfDedicatedBreastCtImagingForOptimizationOfImageAcquisition,Obj
stratification,isCrucialFor,development,Obj
differentPatterns,can,finallyCanAlsoSimulated,Obj
biomarkers,optimize,outcomeOfHr-positiveBreastCancerPatientsTreatedWithPalbociclib,Obj
expression,wasAssociatedWith,recurrenceRisk,Obj
doses,wereEscalatedTo,14Mg/m2,Obj
chemicalExchangeSaturationTransferMri,was,investigated,Obj
productivePrognosisDiscussions,be,canDeliveredByPractice-basedTeam,Obj
salpingo-oophorectomy,mayImpact,evenCanTreatedWithReplacementTherapies,Obj
breastCancer,leadingCauseOf,death,Obj
expression,performing,westernBlotAssay,Obj
erαPolyubiquitinationInhibition,may,mayKeyFactorInProgression,Obj
cells,had,karyotypeWithAberrations,Obj
we,analyzed,threeMicroarrayDatasetsDerivedFromGeneExpressionOmnibus,Obj
p,=,0.002,Obj
irMrnaExpressionLevels,wereDownregulatedIn,continuedPresence,Obj
purpose,develop,patient-based4dDigitalBreastPhantomIncludingContrastEnhancement,Obj
phageConstructFormulation,actsAs,protectiveVaccine,Obj
examinations,areConsidered,usefulForDiagnosisOfCancer,Obj
cells,grewTumorigenicityAs,monolayers,Obj
photograph,beforeWasTakenFor,patient,Obj
phantom,canModelBreastTissuePerfusionDuring,4dBreastCtImageAcquisition,Obj
sustainedResponse,suspiciousPrimaryLesionIn,rightBreasttreatment,Obj
Comparison,showed,matchingPatterns,Obj
EgKI-1,isHighlyExpressedBy,oncosphereOfTapewormEchinococcusGranulosus,Obj
3dPhantom,segmentingAdiposeTissueFrom,healthyPatient,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfGrowthFactorReceptorAdvancedBreastCancerInCombination,Obj
patients,received,acceleratedPartialBreastIrradiation,Obj
3dPhantom,segmentingAdiposeTissueFrom,patient,Obj
objective,evaluate,timeToTreatmentFailureOfPalbociclibAsSecond-lineOfTherapy,Obj
S961,inhibited,proliferation,Obj
biomarkers,optimize,clinicalOutcomeOfHr-positiveBreastCancerPatients,Obj
patterns,can,finallyCanSimulated,Obj
AC,decrease,observedWnt/β-cateninTranslocation,Obj
kinases,regulate,transition,Obj
3dStaticPhantom,segmentingAdiposeTissueFrom,patient,Obj
Results,show,enhancementOfTissuesConsistentWithGivenInputParameters,Obj
expression,regulates,aspectsOfMalignantPhenotypeIncludingCellProliferation,Obj
salpingo-oophorectomy,mayImpactBecauseOf,symptomsAssociatedWithEarlyMenopause,Obj
treatment,blocked,cellCycle,Obj
dynamics,bePotentialBiomarkerFor,cdk4/6Inhibitors,Obj
expression,isIn,humanTnbc,Obj
study,investigate,pivotalRoleOnIrSignallingInMcf-7,Obj
analysis,using,2231MrnaProfilesOfPatientsWithEr-positive/humanGrowthFactorReceptor2-negativeBreastCancer,Obj
interaction,wasAnalyzedBasedOn,searchTool,Obj
primaryObjective,evaluate,timeToTreatmentFailureAsSecond-line,Obj
compound,Using,¹H,Obj
problems,included,penetrationPain,Obj
It,is,vital,Obj
adjuvantBreastIrradiation,using,interstitialMulticatheterHigh-dose-rateBrachytherapy,Obj
extendedTherapy,canReduce,recurrences,Obj
Prognosis,isGenerallyPoorFor,marrowMetastasis,Obj
mechanisms,underlying,cognitiveDecline,Obj
information,isAvailableOn,agentForTreatment,Obj
activities,antioxidantScavengingAgainst,breast-cancerCellLines,Obj
evaluation,using,above-mentionedMethods,Obj
suspiciousPrimaryLesion,isWith,tamoxifenAlone,Obj
women,wereOlderThan,bp-naïveOnes,Obj
adjuvantAcceleratedPartialBreastIrradiation,using,multicatheterHigh-dose-rateBrachytherapy,Obj
expression,wasAssociatedWith,highRecurrenceRiskBeyond5YearsAfterDiagnosis,Obj
findings,showed,90PercecntAccuracyForMriPreoperativeEvaluation,Obj
bilateralSalpingo-oophorectomy,mayImpact,canTreatedWithReplacementTherapies,Obj
erαPolyubiquitinationSelectiveEstrogenReceptorDegraders,resultingVia,ubiquitinProteasomeSystem,Obj
recurrences,are,likelyEr-driven,Obj
Knockdown,alsoInduced,inactivationOfGrowthFactorReceptorSignalingPathway,Obj
3dStaticPhantom,segmentingVasculatureFrom,healthyPatient,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHormoneReceptor-positiveEpidermalGrowthFactorReceptor2-negativeBreastCancerInCombination,Obj
compound,inhibitsBreastCancerCellProliferationIn,manner,Obj
cosmeticOutcomes,wereAlsoAssessedAs,excellent/good,Obj
we,haveTested,fewPeptides,Obj
percentCytotoxicity,increaseWith,opaeConcentrationUpTo240G/ml,Obj
therapy,canReduce,recurrences,Obj
itsPotentialApplications,merit,investigationInFutureStudies,Obj
orthosiphonPallidus,has,excellentAntioxidant,Obj
peptide,is,inPhageDisplayImmunotherapyPresentedByGeneticFusionsToPhageCoatProteins,Obj
breastCancer,isSecond-leadingCauseOf,systemMetastasesAmongMalignancies,Obj
woman'sHeadache,wasFound,resultFromAdenocarcinomaMetastasisInBoneMarrow,Obj
isolatedCompound,Using,NMR,Obj
medianTime,was,forOutcome63Months,Obj
chemotherapy,Lacking,molecularTargets,Obj
measurements,thusLeadTo,rateOfComplicationsInImmediateBreastReconstruction,Obj
upregulatedExpression,regulates,aspects,Obj
tumors,were,associated,Obj
lateRecurrences,isWith,highExpressionOfEstrogen-responsiveGenes,Obj
woman'sHeadache,wasFound,resultFromDiffuseAdenocarcinomaMetastasisFromUnknownPrimarySite,Obj
We,performed,searchInFdaWebsite,Obj
breastCancer,leadingCauseOf,cancer-relatedDeath,Obj
co-exposure,inhibitedCellProliferationIn,additiveManner,Obj
787ConsecutivePatients,were,treated,Obj
adjuvantAcceleratedBreastIrradiation,using,multicatheterHigh-dose-rateBrachytherapy,Obj
photograph,record,changes,Obj
theirPotential,wasEvaluatedIn,nudeMouseXenograftModel,Obj
it,continue,combinationTherapyForPatientsWithAdvancedRecurrentBreastCancerDueToHematologicalToxicities,Obj
Display,is,alsoIncreasinglyConsideredAsCancerVaccineDeliveryStrategy,Obj
productivePrognosisDiscussions,be,canDeliveredEffectivelyByClinicalTeamWithinSemi-structuredPatientEducationAppointment,Obj
patients,receivedVmat-sibTechniqueFor,dose,Obj
retrospectiveStudy,included,womenWithBcsTreatedWithTrastuzumab,Obj
tam-secretedCytokines,associatingWith,clinicalOutcomes,Obj
adjuvantPartialBreastIrradiation,using,interstitialHigh-dose-rateBrachytherapy,Obj
purpose,was,determine,Obj
activities,free-radicalScavengingAgainst,humanCellLines,Obj
qpcrScreening,validatedSox4As,highestGene,Obj
diseaseNature,be,estrogenReceptor-positive/humanEpidermalGrowthFactorReceptor2-negativeBreastCancer,Obj
severalAspects,upregulatedExpressionOf,IRs,Obj
preoperativeMeasurements,thusLeadTo,lowRateOfComplicationsInBreastReconstruction,Obj
we,haveRecentlyTestedPeptidesIn,ourLaboratory,Obj
we,explored,expression,Obj
EgKI-1,givingRiseTo,hydatidCystLocalizedToLiver,Obj
compound,Using,13cMagneticResonance,Obj
goal-setting,is,whereMajorComponentOfStudy,Obj
association,isWith,boost,Obj
we,explore,potentialTargetsForTnbc,Obj
aim,assess,OBCS,Obj
pi3kInhibitors,have,haveDisappointingDueToModestEffectSizes,Obj
patients,diagnosedWith,advancedBreastCancer,Obj
measurements,leadTo,lowRateOfComplicationsInImmediateBreastReconstruction,Obj
we,investigated,combinatorialAnti-proliferativeEffectsOfTamoxifen,Obj
study,evaluate,satisfaction,Obj
limitedInformation,isAvailableOn,mostCommonAgent,Obj
we,explored,clinicalImpactOfIntratumorHeterogeneityOfErProteinExpression,Obj
phantom,can,canUsedDuringDevelopment,Obj
64-year-oldWoman'sHeadache,wasFound,resultFromDiffuseAdenocarcinomaMetastasisFromPrimarySite,Obj
adjuvantAcceleratedPartialBreastIrradiation,using,high-dose-rateBrachytherapy,Obj
we,investigated,combinatorialEffectsOfTamoxifenOnErCancer,Obj
breastIrradiation,using,interstitialFractionatedHigh-dose-rateBrachytherapy,Obj
Analysis,hasLedTo,development,Obj
We,performed,searchInFdaWebsiteInAscoProceedings,Obj
AC,decreased,lungMetastasis,Obj
woman'sHeadache,resultFrom,adenocarcinomaMetastasisInBoneMarrowFromPrimarySite,Obj
morphologicalChanges,concentrationsOf,20-60Μg/ml,Obj
primaryObjective,evaluate,timeToTreatmentFailureInCombinationWithLetrozoleAsSecond-lineOfTherapy,Obj
limitedInformation,isAvailableOn,oralAgentForTreatment,Obj
64-year-oldWoman'sHeadache,wasFound,resultFromDiffuseAdenocarcinomaMetastasisFromUnknownPrimarySite,Obj
kinases,beenIdentifiedAs,drivers,Obj
heterogeneousTumors,wereAssociatedWith,survival,Obj
skinToxicity,was,atEndOfRtTreatmentG1In511Percecnt,Obj
we,haveTested,fewPeptidesDerivedFromHer2/neuProto-oncogeneAsVaccineDeliveryModalities,Obj
preoperativeMeasurements,thusLeadTo,lowRateOfComplicationsInImplant-basedImmediateBreastReconstruction,Obj
breastCancerXenografts,were,scanned,Obj
upregulatedExpression,regulates,severalAspectsOfMalignantPhenotype,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfGrowthFactorReceptorBreastCancerInCombination,Obj
breastIrradiation,using,high-dose-rateBrachytherapy,Obj
bilateralSalpingo-oophorectomy,mayImpactBecauseOf,symptomsAssociated,Obj
evaluate,possibleInfluenceOn,PROs,Obj
TDO2,may,furthermoreMayPotentialTargetInEscc,Obj
Data,wereCollectedFrom,medicalFiles,Obj
endocrineTherapy,remains,backbone,Obj
primaryOutcome,is,numberOfSeromaAspirationsConsistOfNumber,Obj
preciseStratification,isCrucialFor,developmentOfTherapies,Obj
ourData,confirmed,resultsOfOtherStudies,Obj
mtorInhibitorEverolimus,improves,progressionSurvival,Obj
intraoperativeFindings,showed,81Percecnt,Obj
we,thereforePerformed,analysis,Obj
cancerDiagnosis,isIn,patientsWithEarlyBreastCancer,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanEpidermalGrowthFactorReceptorBreastCancerInCombination,Obj
AO,was,scored,Obj
3dStaticPhantom,segmentingVasculatureFrom,patient,Obj
information,isAvailableOn,mostCommonAgentForTreatmentOfPost-menopausalOsteoporosis,Obj
orthosiphonPallidus,has,excellentAntioxidantAgainstHumanBreast-cancerCellLines,Obj
activities,antioxidantFree-radicalScavengingAgainst,humanCellLines,Obj
History,isAssociatedWith,likelihoodOfBoneMetastasesInPostmenopausalWomen,Obj
treatment,isIn,combinationWithFulvestrant,Obj
patients,have,poorPrognosis,Obj
circRNAs,have,withDevelopmentOfHigh-throughputSequencingHaveDiscoveredInTumorousTissues,Obj
primaryOutcome,is,numberConsist,Obj
silencingLincrna-ror,increase,sensitivityOfBcMad-mb-231Cells,Obj
cyclin-dependentKinases,regulate,transitionFromG0/g1-phaseToS-phase,Obj
irMrnaExpressionLevels,were,significantlyDownregulated,Obj
breastCancer,remains,cause,Obj
We,searchedPubmedFor,eligibleStudies,Obj
kinases,been,identified,Obj
we,selectedMcf-7In,presentStudy,Obj
adjuvantPartialBreastIrradiation,using,fractionatedHigh-dose-rateBrachytherapy,Obj
Analysis,hasLedTo,developmentOfNewGenerationOfTherapiesForBreastCancer,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveHumanEpidermalGrowthFactorReceptorAdvancedBreastCancerInCombination,Obj
4dArray,isProduced,curves,Obj
polyubiquitination,isRelatedTo,erαTranscriptionCycle,Obj
use,was,inCox'sProportionalHazardsSurvivalModelAssociatedWithHazardRatioOf004,Obj
isolatedCompound,was,identified,Obj
expression,regulates,severalAspectsOfPhenotypeIncludingCellProliferation,Obj
Patients,will,willAllocatedToOneThreeTreatmentArms,Obj
heterogeneousTumors,wereAssociatedWith,significantlyShorterDisease-freeSurvival,Obj
tamoxifenResistance,noncodingRna-regulatorOf,lincRNA-ROR,Obj
combination,isWith,letrozole,Obj
bcTissues,presented,expression,Obj
letrozoleTherapy,is,viableEffectiveTreatmentOption,Obj
triple-negativeBreastCancer,is,subtypeOfBreastCancerWithPoorClinicalOutcome,Obj
clinicians,build,prognosisDiscussionCommunicationSkills,Obj
Patients,will,willAllocatedToOneOfThreeTreatmentArms,Obj
dynamics,be,potentialBiomarker,Obj
therapies,oftenDelay,termOverallSurvivalDataAreLacking,Obj
erαPolyubiquitinationEstrogenReceptorDegraders,resultingIn,erαDegradation,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveEpidermalGrowthFactorReceptorBreastCancer,Obj
acceleratedBreastIrradiation,using,interstitialFractionatedMulticatheterHigh-dose-rateBrachytherapy,Obj
work,shows,impactOfHeterogeneity,Obj
64-year-oldWoman'sHeadache,wasFound,resultFromAdenocarcinomaMetastasisInBoneMarrowFromUnknownSite,Obj
acceleratedPartialBreastIrradiation,using,brachytherapy,Obj
cosmeticOutcomes,wereAssessedAs,excellent/good,Obj
breastCancer,isSubtypeWith,clinicalOutcome,Obj
predictiveBiomarkers,optimize,clinicalOutcomeOfBreastCancerPatientsTreated,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHumanEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination,Obj
breastCancer,is,diseases,Obj
massiveCircrnas,have,withDevelopmentOfSequencingHaveDiscovered,Obj
EgKI-1,affecting,cellGrowth,Obj
oncolyticVirusTherapy,is,strategy,Obj
breastUltrasound,canEnhance,prediction,Obj
breastLesionModel,be,added,Obj
exclusionCriteria,comprehend,implicationsOfStudy,Obj
egki-1Treatment,arrested,cancerCellGrowth,Obj
tdo2ProteinExpression,was,evaluatedIn90EsccTissueSamplesByImmunohistochemistry,Obj
combinedTreatment,suppressing,transcription,Obj
aim,examine,evidenceOnGoal-settingAmongWomenWithBreastCancerDiagnosis,Obj
severalAspects,expressionIn,breastCancerPathogenesis,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfReceptor-positiveEpidermalGrowthFactorReceptorAdvancedBreastCancer,Obj
results,willChart,literature,Obj
largeRna-regulator,affects,tamoxifenResistanceOfBcCells,Obj
ZJU-0725,were,maintainedInVitro,Obj
majority,areIn,patients,Obj
receptorActivator,make,favorableBoneMarrowMicroenvironment,Obj
breastCancer,remains,causeOfDeath,Obj
doses,wereEscalatedTo,14Mg/m2ForEri,Obj
dynamics,bePotentialPredictiveBiomarkerFor,cdk4/6Inhibitors,Obj
G1,g2In,97Percecnt,Obj
phantom,can,canUsedDuringDevelopmentOfBreastCtImagingForOptimization,Obj
goal-setting,is,major,Obj
limitedInformation,isAvailableOn,mostCommonOralAgentForTreatmentOfPost-menopausalOsteoporosis,Obj
we,Using,inHybridization,Obj
S961,inhibited,proliferationInBreastTumourCells,Obj
triple-negativeBreastCancer,isSubtypeWith,outcome,Obj
64-year-oldWoman'sHeadache,resultFrom,adenocarcinomaMetastasisInBoneMarrow,Obj
Patients,will,willRandomlyAllocatedToOneThreeTreatmentArmsConsistingOfFlapFixation,Obj
therapy,backboneIn,cases,Obj
clinicalMeasurements,leadTo,lowRateInBreastReconstruction,Obj
chemotherapy,isTreatmentFor,tnbcPatients,Obj
women'sGoals,mayProvide,insight,Obj
productivePrognosisDiscussions,be,canDeliveredEffectivelyByPractice-basedTeamWithinSemi-structuredPatientEducationAppointment,Obj
tolerability,isWith,ERI,Obj
measurements,thusLeadTo,rateInImplant-basedImmediateBreastReconstruction,Obj
aim,examine,evidenceOnPersonalGoal-settingAmongWomenWithBreastCancerDiagnosis,Obj
we,hereExplored,expressionInEscc,Obj
breastCancer,is,subtypeOfBreastCancerWithPoorOutcome,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanEpidermalGrowthFactorReceptorBreastCancerInCombination,Obj
kinases,regulate,transitionFromG0/g1-phase,Obj
naringenin,inhibit,cellGrowthOfMcf-7CellsAtConcentrations,Obj
64-year-oldWoman'sHeadache,wasFound,resultFromDiffuseAdenocarcinomaMetastasisInBoneMarrowFromUnknownPrimarySite,Obj
3dStaticPhantom,segmentingBreastCtImageFrom,patient,Obj
we,thereforeAdditionallyPerformed,analysis,Obj
stratification,isThereforeCrucialFor,developmentOfTherapies,Obj
itsPotentialPracticalApplications,merit,investigationInFutureStudies,Obj
acTreatment,downregulating,mesenchymalMarkerProteinsLikeN-cadherin,Obj
purpose,develop,4dBreastPhantomIncludingTime-varyingContrastEnhancementForSimulationOfBreastCtPerfusionImaging,Obj
breastIrradiation,using,multicatheterBrachytherapy,Obj
History,isAssociatedWith,lowerLikelihoodOfBoneMetastasesInPostmenopausalWomenWithEarlyBreastCancer,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveEpidermalGrowthFactorReceptorAdvancedBreastCancerInCombination,Obj
purpose,develop,patient-based4dDigitalBreastPhantomIncludingTime-varyingContrastEnhancementForSimulationOfDedicatedBreastCtPerfusionImaging,Obj
partialBreastIrradiation,using,fractionatedHigh-dose-rateBrachytherapy,Obj
mainProblems,included,lubrication,Obj
preoperativeMeasurements,thusLeadTo,lowRateInImplant-basedImmediateBreastReconstruction,Obj
cellMigration,treatmentOf,tamoxifen,Obj
preoperativeMeasurements,thusLeadTo,lowRateOfComplicationsInImmediateBreastReconstruction,Obj
cells,had,near-tetraploidKaryotypeWithStructuralAberrations,Obj
kinases,regulate,transitionToS-phase,Obj
productivePrognosisDiscussions,be,canDeliveredByPractice-basedTeamWithinPatientEducationAppointment,Obj
cyclin-dependentKinases,beenIdentifiedAs,driversOfProliferationInHormoneReceptor,Obj
information,isAvailableOn,mostCommonAgentForTreatment,Obj
3dPhantom,segmentingBreastCtImageFrom,healthyPatientIntoSkin,Obj
we,summarize,theirPotentialImplicationsOnBreastCancer,Obj
historicalCohortStudy,wasConductedAt,oncologyDivisionAtTelAvivMedicalCenter,Obj
data,are,howeverStillScarce,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHumanEpidermalGrowthFactorReceptorAdvancedBreastCancer,Obj
purpose,develop,4dBreastPhantomIncludingTime-varyingContrastEnhancementForSimulation,Obj
clinicalMeasurements,leadTo,lowRate,Obj
activities,antioxidantScavengingAgainst,humanCellLines,Obj
theDelayed,was,higher,Obj
probability,evaluate,possibleInfluenceOnOutcomes,Obj
therapies,delay,termSurvivalDataAreLacking,Obj
anticancerActivities,excellentAntioxidantAgainst,humanCellLines,Obj
activities,scavengingAgainst,breast-cancerCellLines,Obj
we,usingImmunofluorescenceOn,tissueSectionsFollowedByValidatedApproach,Obj
silencingLincrna-ror,increase,sensitivityToTam,Obj
clinicalMeasurements,leadTo,lowRateOfComplicationsInImmediateBreastReconstruction,Obj
breastLesionModel,wasDevelopedFor,creation,Obj
seromaFormation,isComplicationAfter,mastectomy,Obj
study,included,womenWithBcsTreatedWithTrastuzumab,Obj
breastIrradiation,using,brachytherapy,Obj
immunohistochemistryStudy,confirmed,diseaseNature,Obj
prognosisDiscussions,be,canDeliveredEffectivelyByPractice-basedTeamWithinSemi-structuredPatientEducationAppointment,Obj
amedDatabases,will,willSearched,Obj
Patients,will,willRandomlyAllocatedToOneOfThreeTreatmentArmsConsistingOfFlapFixation,Obj
correspondingCurves,areComputedFor,voxelInPhantom,Obj
intraoperativeFindings,showed,accuracy,Obj
preoperativeMeasurements,thusLeadTo,lowRateInImmediateBreastReconstruction,Obj
investigated,effectsOf,tamoxifen,Obj
4dPhantom,has,dimensions,Obj
EgKI-1,givingRiseTo,cystLocalized,Obj
aim,compare,itsSequelae,Obj
aspects,upregulatedExpressionIn,breastCancerPathogenesis,Obj
skinToxicity,was,atEndOfRtTreatmentG1In511PercecntOfPatients,Obj
effect,Incorporating,goal-setting,Obj
limitedInformation,isAvailableOn,mostCommonOralAgent,Obj
lateRecurrenceRisk,Extending,5YearsOfTamoxifenTherapyWith5Years,Obj
retrospectiveStudy,included,womenWithHer2-positiveBcsTreatedWithTrastuzumabFrom2008To2017,Obj
retrospectiveStudy,included,womenWithHer2-positiveBcsTreatedWithTrastuzumab,Obj
anticancerActivities,antioxidantScavengingAgainst,humanBreast-cancerCellLines,Obj
we,haveRecentlyTested,peptides,Obj
we,performed,pooledAnalysis,Obj
study,investigate,roleOnIrSignallingInMcf-7,Obj
erαPolyubiquitinationEstrogenReceptorDegraders,resultingVia,ubiquitinProteasomeSystem,Obj
goal-setting,is,component,Obj
it,can,canTreatedWithReplacementTherapies,Obj
prognosisDiscussions,be,canDeliveredEffectivelyByClinicalTeamWithinSemi-structuredPatientEducationAppointment,Obj
cxcl1Expression,is,correlated,Obj
endocrineTherapy,backboneOf,treatment,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveEpidermalGrowthFactorReceptorAdvancedBreastCancerInCombination,Obj
heterogeneousTumors,were,associated,Obj
anticancerActivities,antioxidantScavengingAgainst,cellLines,Obj
sameTime,upregulating,epithelialMarkerProteins,Obj
itsPotentialApplications,merit,furtherInvestigationInFutureStudies,Obj
Two-thirds,wereSatisfiedWith,theirRelations,Obj
studyPopulation,included,post-menopausalWomenWithEarlyBreastCancer,Obj
chemotherapy,is,mainAdjuvantTreatment,Obj
it,owingTo,lowerDegreeOfConcernAboutCancerRisk,Obj
skinToxicity,was,atEndG1In511Percecnt,Obj
anticancerActivities,free-radicalScavengingAgainst,cellLines,Obj
cells,grewAs,monolayers,Obj
clinicalMeasurements,thusLeadTo,lowRateInImmediateBreastReconstruction,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHumanGrowthFactorReceptorAdvancedBreastCancer,Obj
recentStudies,haveImproved,care,Obj
tnbcPatients,betterResponseComparedTo,otherBreastCancerSubtypes,Obj
aim,compare,seromaFormation,Obj
naringenin,inhibit,cellGrowthAtConcentrations,Obj
We,generated,threeRepresentationsOfBreastCancerPatientCohorts,Obj
salpingo-oophorectomy,mayImpactOn,quality,Obj
women,wereOlderThan,ones,Obj
primaryObjective,evaluate,timeToTreatmentFailureOfPalbociclibInCombination,Obj
adjuvantAcceleratedBreastIrradiation,using,fractionatedMulticatheterHigh-dose-rateBrachytherapy,Obj
geneOntologyFunction,were,performed,Obj
theirTreatment-relatedCosmeticChanges,wereRecordedOn,nonstandardizedPhotographs,Obj
survival,was,64Months,Obj
mad-mb-231Cells,showed,decreasedProliferation,Obj
AC,substantiallySuppressed,breastCancerMetastasis,Obj
events,are,responsible,Obj
co-exposure,isWith,them,Obj
sameTime,upregulating,markerProteins,Obj
purpose,develop,realistic4dBreastPhantomIncludingTime-varyingContrastEnhancementForSimulationOfDedicatedBreastCtPerfusionImaging,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfEpidermalGrowthFactorReceptor2-negativeBreastCancerInCombination,Obj
we,haveRecentlyTested,peptidesDerivedFromHer2/neuProto-oncogeneAsVaccineDeliveryModalitiesForTreatmentOfTuboBreastCancerXenograftTumors,Obj
productivePrognosisDiscussions,be,canDeliveredByPractice-basedClinicalTeam,Obj
clinicalMeasurements,thusLeadTo,rate,Obj
use,was,inCox'sHazardsSurvivalModelAssociatedWithHazardRatioOf004ForBoneMetastasis,Obj
Meta-analysis,calculateHazardRatiosWith,95PercecntCisForProgression-freeSurvival,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfReceptor-positiveGrowthFactorReceptor2-negativeBreastCancerInCombination,Obj
curves,areCalculatedBy,convolutionBetweenInputFunction,Obj
4dArray,isProduced,time-enhancementCurvesAtSamplingRate,Obj
triple-negativeBreastCancer,is,subtypeOfBreastCancerWithClinicalOutcome,Obj
G2,isIn,97Percecnt,Obj
History,isAssociatedWith,likelihoodOfBoneMetastasesInWomenWithEarlyBreastCancer,Obj
purpose,develop,realisticPatient-based4dDigitalBreastPhantomIncludingContrastEnhancementForSimulationOfBreastCtPerfusionImaging,Obj
we,explored,clinicalImpact,Obj
biomarkers,optimize,outcome,Obj
Palbociclib,is,effective,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanEpidermalGrowthFactorReceptorBreastCancer,Obj
quilting,applicationOf,adhesiveTissueGlues,Obj
largeRna-regulator,regulating,pi3k/akt/mtorSignalingPathway,Obj
tdo2Overexpression,wasAssociatedWith,tumorStage,Obj
targets,areStillRequiredFor,investigation,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfReceptor-positiveHumanEpidermalGrowthFactorReceptorBreastCancerInCombination,Obj
massiveCircrnas,have,withDevelopmentOfHigh-throughputSequencingHaveDiscovered,Obj
proposedDigitalPhantom,canModel,breastTissuePerfusion,Obj
possibility,holds,greatPromiseInFuture,Obj
information,isAvailableOn,commonAgentForTreatmentOfPost-menopausalOsteoporosis,Obj
mastectomies,isWith,immediateBreastReconstruction,Obj
therapeuticTargets,are,howeverRequired,Obj
latestAdvancements,displaySystemsAs,modalities,Obj
preciseStratification,is,thereforeCrucial,Obj
productivePrognosisDiscussions,be,canDeliveredEffectively,Obj
predictiveBiomarkers,optimize,clinicalOutcomeOfHr-positiveBreastCancerPatientsTreatedWithPalbociclib,Obj
periodicExaminations,are,considered,Obj
measurements,thusLeadTo,rateOfComplications,Obj
cdk4/6InhibitorPalbociclib,has,hasApprovedForTreatmentOfBreastCancerPatients,Obj
percentCytotoxicity,increaseWith,opaeConcentration,Obj
estrogenReceptor,inDiagnosisIs,lateRecurrences,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfReceptor-positiveEpidermalGrowthFactorReceptorAdvancedBreastCancerInCombination,Obj
limitedInformation,isAvailableOn,mostCommonOralAgentForTreatmentOfOsteoporosis,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanGrowthFactorReceptorAdvancedBreastCancer,Obj
effect,wasDueTo,differencesBeforeBoostAdministration,Obj
it,continue,combinationTherapyForPatientsWithBreastCancer,Obj
adjuvantAcceleratedPartialBreastIrradiation,using,interstitialHigh-dose-rateBrachytherapy,Obj
measurements,leadTo,rateInImplant-basedImmediateBreastReconstruction,Obj
breastCancer,is,diagnosedDiseases,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfGrowthFactorReceptor2-negativeBreastCancer,Obj
oralBisphosphonateTreatment,reducing,riskOfBoneMetastases,Obj
patterns,can,finallyCanAlsoSimulatedForTumorModels,Obj
purpose,determine,efficacyOfPalbociclib,Obj
irMrnaExpressionLevels,wereDownregulatedIn,presenceOfS961,Obj
woman'sHeadache,wasFound,resultFromDiffuseAdenocarcinomaMetastasis,Obj
cells,showed,ultrastructure,Obj
digitalPhantom,canModel,breastTissuePerfusion,Obj
CXCL1,canPromote,epithelial-mesenchymalTransition,Obj
compound,Using,13cNuclearResonance,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancer,Obj
expression,regulates,severalAspectsOfMalignantPhenotype,Obj
acceleratedBreastIrradiation,using,fractionatedHigh-dose-rateBrachytherapy,Obj
S961,inhibited,colonyFormation,Obj
massiveCircrnas,have,withDevelopmentOfSequencingHaveDiscoveredInTissues,Obj
meanIncrease,isIn,cellDeathIndex,Obj
breastCancer,remains,causeOfDeathInWomenWorldwide,Obj
cellLines,were,associated,Obj
morePatients,drank,alcohol,Obj
significantTumorGrowthReduction,isIn,egki-1-treatedMice,Obj
Prognosis,is,generallyPoor,Obj
woman'sHeadache,resultFrom,diffuseAdenocarcinomaMetastasisFromPrimarySite,Obj
pi3k/akt/mtorPathway,be,importantGrowthPathwayInHrPositiveBreastCancer,Obj
purpose,develop,realistic4dDigitalBreastPhantomIncludingTime-varyingContrastEnhancement,Obj
we,selectedMcf-7As,inModel,Obj
woman'sHeadache,wasFound,resultFromAdenocarcinomaMetastasisFromUnknownSite,Obj
t-patParticipants,hold,beliefsAboutDiseaseCurability,Obj
We,performed,searchOfDataOnPalbociclibInPubmed,Obj
3dPhantom,segmentingAdiposeTissueFrom,healthyPatientIntoSkin,Obj
tissues,presented,expression,Obj
circumstances,functionOf,women,Obj
4dArray,finallyIsProduced,time-enhancementCurvesAtSamplingRate,Obj
theirAssociation,isWith,earlyRecurrenceRisk,Obj
clinicalMeasurements,thusLeadTo,rateOfComplicationsInImplant-basedBreastReconstruction,Obj
Agents,mightOf,mightTherapeuticEffectForPatients,Obj
protein-proteinInteraction,visualizedBy,cytoscapeSoftware,Obj
acceleratedBreastIrradiation,using,interstitialFractionatedMulticatheterBrachytherapy,Obj
severalParameters,are,prognostic,Obj
intraoperativeFindings,showed,87PercecntForUltrasound,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveEpidermalGrowthFactorReceptorBreastCancerInCombination,Obj
targets,howeverAreRequiredFor,investigation,Obj
data,remainsFor,sequencing,Obj
seromaFormation,is,associated,Obj
We,searchedPubmedFor,studies,Obj
adjuvantBreastIrradiation,using,interstitialFractionatedHigh-dose-rateBrachytherapy,Obj
woman'sHeadache,resultFrom,diffuseAdenocarcinomaMetastasisInBoneMarrowFromPrimarySite,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveEpidermalGrowthFactorReceptor2-negativeBreastCancerInCombination,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveGrowthFactorReceptorAdvancedBreastCancerInCombination,Obj
therapy,mightBecome,strategyForBreastCancerMetastasisPrevention,Obj
activities,antioxidantScavengingAgainst,cellLines,Obj
study,included,514WomenWithBreastCancer,Obj
theirAge,was,4226±856Years,Obj
long-termIntervention,mightReduce,lateRecurrences,Obj
Meta-analysis,calculateHazardRatiosWith,cisForProgression-freeSurvival,Obj
woman'sHeadache,resultFrom,adenocarcinomaMetastasisFromSite,Obj
orthosiphonPallidus,has,antioxidantAgainstCellLines,Obj
women'sGoals,mayProvideInsightIn,contextOfBreastCancer,Obj
cxcl1-basedTherapy,novelStrategyFor,breastCancerMetastasisPrevention,Obj
work,shows,impactOfIntratumorHeterogeneityInMolecularDiagnosticsForTreatmentSelectionInHer2CancerPatients,Obj
primaryOutcome,is,numberConsistOfNumberOfPatientClinicVisits,Obj
virusTherapy,isInterestingStrategyFor,cancerTreatment,Obj
isolatedCompound,Using,13cNuclearMagneticResonance,Obj
work,shows,impactOfHeterogeneityForTreatmentSelectionInHer2CancerPatients,Obj
woman'sHeadache,was,found,Obj
64-year-oldWoman'sHeadache,resultFrom,diffuseAdenocarcinomaMetastasisInBoneMarrowFromSite,Obj
Display,is,alsoConsidered,Obj
latestAdvancements,isIn,applicationsOfOvs,Obj
bilateralSalpingo-oophorectomy,mayImpact,canTreatedWithHormonalReplacementTherapies,Obj
conclusionsPalbociclib,is,treatmentOption,Obj
patients,received,acceleratedBreastIrradiation,Obj
role,prognosticSignificanceOf,plasmaEsr1MutationsInMbcPatientsWithExposure,Obj
benefits,were,seen,Obj
women,isWith,breastCancer,Obj
S961,downregulatedIrsWith,dose,Obj
AC,decreasedLungMetastasis,demonstratedByUpregulation,Obj
periodicExaminations,areConsidered,usefulForDiagnosisOfCancer,Obj
It,understand,molecularPathwaysInvolvedInPathogenesisOfProliferation,Obj
clinicalMeasurements,leadTo,rateOfComplicationsInImplant-basedImmediateBreastReconstruction,Obj
preciseStratification,is,crucial,Obj
S961,efficientlyBlockedExpressionIn,presenceOfInsulin,Obj
phantom,can,canUsedDuringDevelopmentOfContrast-enhancedDedicatedBreastCtImagingForOptimization,Obj
64-year-oldWoman'sHeadache,wasFound,resultFromAdenocarcinomaMetastasisFromPrimarySite,Obj
breastCancer,isSecond-leadingCauseOf,systemMetastases,Obj
purpose,develop,4dDigitalBreastPhantomIncludingTime-varyingContrastEnhancementForSimulationOfBreastCtPerfusionImaging,Obj
using,combinationOf,ovTherapy,Obj
prognosisDiscussions,be,canDeliveredByClinicalTeam,Obj
maximum,tolerated,MTD,Obj
EgKI-1,showsPromiseAs,therapeutic,Obj
compound,Using,13cNuclearMagneticResonance,Obj
publishedFemales,isWith,breastCancer,Obj
targets,areStillRequiredFor,furtherInvestigation,Obj
2MutationCarriers,follow,clinicalSurveillancePrograms,Obj
geo2rTool,screenOut,genesBetweenTnbc,Obj
we,additionallyPerformed,pooledAnalysis,Obj
chemotherapy,isMainTreatmentFor,tnbcPatients,Obj
outcomes,review,associationOfChemotherapyWithBoost,Obj
symptoms,associatedWith,menopause,Obj
adjuvantAcceleratedPartialBreastIrradiation,using,interstitialMulticatheterHigh-dose-rateBrachytherapy,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveHumanGrowthFactorReceptor2-negativeAdvancedBreastCancer,Obj
Results,show,expectedEnhancementOfTissuesConsistentWithInputParameters,Obj
objective,evaluate,timeToTreatmentFailureOfPalbociclibInCombinationWithLetrozole,Obj
endocrineTherapy,improving,quality,Obj
evaluation,startedWithout,breastReconstruction,Obj
we,furthermoreDiscovered,treatmentWithAc,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHumanEpidermalGrowthFactorReceptor2-negativeBreastCancer,Obj
targets,are,howeverStillRequired,Obj
Patients,were,followed-up,Obj
3dPhantom,segmentingVasculatureFrom,patient,Obj
predictiveBiomarkers,optimize,outcomeOfBreastCancerPatients,Obj
patientSelection,isCrucialGiven,sideEffectsOfTherapy,Obj
extendedEndocrineTherapy,canReduce,recurrences,Obj
greatPromise,isIn,futureOfCancerImmunotherapy,Obj
multipleCytokines,have,haveIdentified,Obj
suspiciousPrimaryLesion,achieved,sustainedResponse,Obj
adjuvantBreastIrradiation,using,fractionatedHigh-dose-rateBrachytherapy,Obj
therapies,oftenDelay,longTermOverallSurvivalDataAreLacking,Obj
ourReview,willSearchFor,publishedFemalesWithBreastCancer,Obj
We,predicting,benefit,Obj
doses,were,escalatedTo14Mg/m2ForEriForGem,Obj
it,can,evenCanTreated,Obj
expression,regulates,aspectsOfMalignantPhenotype,Obj
formation,isIn,variousMethodsOfFlapFixation,Obj
proposedPhantom,canModelBreastTissuePerfusionDuring,4dBreastCtImageAcquisition,Obj
cells,presented,higherExpression,Obj
We,searchedEmbaseFor,studies,Obj
mostPatients,found,t-patAppointment,Obj
salpingo-oophorectomy,mayImpactBecauseOf,symptoms,Obj
adjuvantAcceleratedBreastIrradiation,using,fractionatedMulticatheterBrachytherapy,Obj
erαPolyubiquitinationInhibition,may,thusMayFactorInProgression,Obj
circRNAs,have,withDevelopmentOfHigh-throughputSequencingHaveDiscovered,Obj
it,mainlyOwingTo,degreeOfConcern,Obj
co-exposure,significantlyInhibitedCellProliferationIn,manner,Obj
implication,remains,controversial,Obj
women,isWith,breastCancerDiagnosis,Obj
we,haveTested,peptidesDerivedAsVaccineDeliveryModalitiesForTreatmentOfTuboBreastCancerXenograftTumors,Obj
proposedDigitalPhantom,canModelBreastTissuePerfusionDuring,4dBreastCtImageAcquisition,Obj
cxcl1-basedTherapy,mightBecome,novelStrategy,Obj
treatment,suppressing,transcriptionOfCellCycleRegulationProteins,Obj
patientSelection,isCrucialGiven,effectsOfEndocrineTherapy,Obj
woman'sHeadache,wasFound,result,Obj
women,isWith,her2-positiveBcsTreatedFrom2008To2017,Obj
It,wasPerceivedBy,patientsAsValuable,Obj
percentCytotoxicity,wasFoundFor,cellLines,Obj
we,investigate,tolerabilityOfCombinationTherapyWithEri,Obj
we,summarizeKnowledgeIn,review,Obj
findings,showed,71PercecntForPinchTest,Obj
adjuvantAcceleratedBreastIrradiation,using,interstitialBrachytherapy,Obj
qpcrScreening,validatedSox4As,gene,Obj
visits,qualityOf,life,Obj
salpingo-oophorectomy,mayImpact,evenCanTreatedWithHormonalReplacementTherapies,Obj
severalClinicopathologicalParameters,arePrognosticFor,lateRecurrence,Obj
letrozoleTherapy,is,viableTreatmentOption,Obj
tdo2ProteinExpression,wasEvaluatedIn,90EsccTissueSamples,Obj
higherExpression,wasAssociatedWith,recurrenceRisk,Obj
purpose,develop,4dDigitalBreastPhantom,Obj
CXCL1,canPromote,breastCancerMigration,Obj
kinases,beenIdentifiedAs,keyDriversOfProliferation,Obj
we,explored,expressionOfTdo2,Obj
work,shows,impactOfIntratumorHeterogeneityForTreatmentSelection,Obj
prognosisDiscussions,be,canDeliveredByTeam,Obj
work,shows,impactOfIntratumorHeterogeneityInDiagnosticsForTreatmentSelectionInHer2CancerPatients,Obj
purpose,develop,4dBreastPhantom,Obj
outcomes,were,alsoAssessed,Obj
therapy,improving,survivalOfLife,Obj
preoperativeMeasurements,leadTo,rateInBreastReconstruction,Obj
expression,was,associated,Obj
mtrValues,wereEvaluatedAs,measureAt05ΜtSaturationAmplitude,Obj
measurements,leadTo,rateOfComplicationsInImplant-basedImmediateBreastReconstruction,Obj
it,owingTo,lowerDegree,Obj
ourData,confirmed,resultsOfOtherStudiesPublishedOnAssociation,Obj
cxcl1Silencing,resultsIn,reduction,Obj
using,differentModelsSuchAs,1,Obj
3dPhantom,segmenting,adiposeTissue,Obj
severalParameters,arePrognosticFor,recurrence,Obj
boneMetastases,isIn,postmenopausalWomenWithEarlyBreastCancer,Obj
therapeuticTargets,existingIn,loop,Obj
activities,scavengingAgainst,cellLines,Obj
chemicalExchangeSaturationTransferMri,was,investigatedInVivo,Obj
activities,excellentAntioxidantAgainst,breast-cancerCellLines,Obj
bcTissues,were,collected,Obj
research,evaluating,potentialBiomarkers,Obj
chemotherapy,is,treatment,Obj
itsPotentialPracticalApplications,merit,furtherInvestigationInFutureStudies,Obj
qpcrScreening,validated,SOX4,Obj
majority,areIn,patientsWithHormoneReceptorPositive,Obj
examinations,areConsidered,usefulForEarlyDiagnosisOfCancer,Obj
treatment,wasUsedIn,1984,Obj
qpcrScreening,furtherValidatedSox4Following,cxcl1Administration,Obj
kinases,regulate,transitionFromG0/g1-phaseToS-phase,Obj
investigated,effectsOn,erCancer,Obj
prognosisDiscussions,be,canDeliveredEffectivelyByPractice-basedTeam,Obj
adjuvantBreastIrradiation,using,multicatheterHigh-dose-rateBrachytherapy,Obj
64-year-oldWoman'sHeadache,resultFrom,adenocarcinomaMetastasisFromUnknownPrimarySite,Obj
50Patients,isWith,breastCancer,Obj
biomarkers,optimize,clinicalOutcomeOfBreastCancerPatientsTreated,Obj
sustainedResponse,suspiciousPrimaryLesionWith,tamoxifen,Obj
breastCancer,remains,leadingCause,Obj
biomarkers,are,urgentlyNeeded,Obj
orthosiphonPallidusExtract,showed,activity,Obj
adjuvantPartialBreastIrradiation,using,high-dose-rateBrachytherapy,Obj
findings,showed,accuracy,Obj
severalClinicopathologicalParameters,are,prognosticForLateRecurrence,Obj
mad-mb-231Cells,exhibited,highestLincrna-rorExpression,Obj
EgKI-1,shows,promiseForFutureDevelopment,Obj
severalTrials,are,ongoing,Obj
clinicalMeasurements,leadTo,rateOfComplicationsInBreastReconstruction,Obj
selectionTools,areSparse,prognostic,Obj
fractionation,ledTo,isolation,Obj
primaryObjective,evaluate,timeToTreatmentFailureInCombinationAsSecond-line,Obj
objective,evaluate,timeToTreatmentFailureInCombinationWithLetrozole,Obj
predictiveBiomarkers,optimize,clinicalOutcomeOfHr-positiveBreastCancerPatientsTreated,Obj
2MutationCarriers,areOffered,ovarianSurgery,Obj
upregulatedExpression,regulates,aspectsIncludingCellProliferation,Obj
typical4d,has,dimensionsOf,Obj
we,thereforeAdditionallyPerformed,pooledAnalysis,Obj
limitedInformation,isAvailableOn,agent,Obj
itsPotentialApplications,merit,investigation,Obj
seromaFormation,is,complication,Obj
sexualFunction,investigate,potentialRelationshipBetweenDysfunction,Obj
averageTime,was,405±523Years,Obj
purpose,develop,patient-based4dBreastPhantomIncludingTime-varyingContrastEnhancement,Obj
insulinResistance,have,haveIntricatelyLinkedToPathogenesisOfBreastCarcinoma,Obj
outcomes,review,associationOfChemotherapy,Obj
abundantChemokine,secretedBy,TAMs,Obj
work,shows,impactOfIntratumorHeterogeneityInDiagnosticsForTreatmentSelection,Obj
productivePrognosisDiscussions,be,canDeliveredEffectivelyByPractice-basedClinicalTeam,Obj
clinicalMeasurements,leadTo,lowRateOfComplicationsInImplant-basedImmediateBreastReconstruction,Obj
compound,Using,13c2-dimensionalNuclearMagneticResonance,Obj
History,isAssociatedWith,lowerLikelihoodOfBoneMetastasesInPostmenopausalWomen,Obj
circumstances,influenceFunctionWith,breastCancer,Obj
breastIrradiation,using,interstitialFractionatedMulticatheterHigh-dose-rateBrachytherapy,Obj
aqueousOrthosiphonPallidusExtract,showed,potentActivityInModels,Obj
suspiciousLesion,achieved,sustainedResponse,Obj
primaryDysfunctions,wereDueTo,506Percecnt,Obj
predictiveBiomarkers,optimize,outcomeOfHr-positiveBreastCancerPatients,Obj
changes,isIn,sexuality,Obj
effect,was,evaluated,Obj
21Skin-sparingMastectomies,were,consequentlyPerformed,Obj
evaluation,startedWithout,immediateBreastReconstruction,Obj
intervention,mightReduce,recurrencesInPatientsWithTumors,Obj
purpose,develop,patient-based4dDigitalBreastPhantomIncludingContrastEnhancementForSimulationOfBreastCtPerfusionImaging,Obj
cellLines,clusterOf,differentiation,Obj
64-year-oldWoman'sHeadache,resultFrom,adenocarcinomaMetastasisInBoneMarrowFromUnknownSite,Obj
inModel,showed,tumorGrowthReduction,Obj
measurements,leadTo,lowRateInImmediateBreastReconstruction,Obj
mayKeyFactor,isIn,progressionOfBreastCancer,Obj
typical4dPhantom,has,dimensionsOf,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfGrowthFactorReceptorAdvancedBreastCancerInCombination,Obj
64-year-oldWoman'sHeadache,resultFrom,adenocarcinomaMetastasisInBoneMarrowFromSite,Obj
perfusion,isIn,differentTypesOfBreastLesions,Obj
cells,had,karyotypeWithStructuralAberrations,Obj
therapeuticTargets,areRequiredFor,investigation,Obj
partialBreastIrradiation,using,interstitialMulticatheterBrachytherapy,Obj
purpose,develop,patient-based4dDigitalBreastPhantomIncludingTime-varyingContrastEnhancementForSimulation,Obj
studies,haveImproved,supportiveCare,Obj
geo2rTool,screenOut,expressedGenesBetweenTnbc,Obj
modality,resultingIn,detection,Obj
adjuvantAcceleratedPartialBreastIrradiation,using,fractionatedMulticatheterHigh-dose-rateBrachytherapy,Obj
possibility,holds,promise,Obj
objective,investigate,free-radicalScavenging,Obj
significantReduction,isIn,breastCancerGrowth,Obj
highCxcl1Expression,is,correlated,Obj
mbcPatients,isWith,priorExposureToAiTherapy,Obj
dose,wasFoundIn,only1Patient,Obj
Results,show,expectedEnhancement,Obj
Display,is,increasinglyConsideredAsCancerVaccineDeliveryStrategy,Obj
estrogenReceptorDegraders,haveLedIn,lineSettings,Obj
Agreement,wasHighBetween,trainees,Obj
information,is,available,Obj
analysis,using,2231MrnaProfilesOfPatientsWithEr-positive/humanEpidermalGrowthFactorReceptor2-negativeBreastCancer,Obj
predictiveRole,significanceOf,plasmaEsr1MutationsInMbcPatientsWithExposure,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHumanGrowthFactorReceptorAdvancedBreastCancerInCombination,Obj
Data,were,collected,Obj
audioAnalysis,assess,interventionFeasibility,Obj
salpingo-oophorectomy,mayImpact,canTreatedWithReplacementTherapies,Obj
64-year-oldWoman'sHeadache,resultFrom,diffuseAdenocarcinomaMetastasis,Obj
therapies,delay,longTermOverallSurvivalDataAreLacking,Obj
effect,wasEvaluatedBy,MTT,Obj
itsLigand,activate,osteoclasts,Obj
pi3k/akt/mtorPathway,isKnown,growthPathway,Obj
palbociclib,isIn,breastCancer,Obj
We,performed,search,Obj
analysis,using,2231MrnaProfilesOfPatientsWithEr-positive/humanGrowthFactorReceptorBreastCancer,Obj
t-patParticipants,hold,realisticBeliefs,Obj
primaryObjective,evaluate,timeToTreatmentFailureOfPalbociclibInCombinationWithLetrozoleAsSecond-line,Obj
personalGoal-setting,is,whereMajorComponent,Obj
multipleCytokines,associatingWith,outcomes,Obj
we,used,kaplan-meierPlotterSurvivalAnalysisTool,Obj
examinations,areConsidered,usefulForEarlyDiagnosisOfBreast/ovarianCancer,Obj
purpose,develop,realistic4dDigitalBreastPhantomIncludingContrastEnhancementForSimulation,Obj
aqueousOrthosiphonPallidusExtract,showed,potentActivity,Obj
changes,isIn,plasmaIl-6Levels,Obj
preoperativeMeasurements,leadTo,rateOfComplications,Obj
pik3caMutations,earlyDynamicsOfBe,potentialBiomarker,Obj
sensitivity,overcoming,mechanisms,Obj
irAntagonist,showed,antagonism,Obj
acTreatment,notablyInhibitedEmtAt,time,Obj
tnbcPatients,betterResponseComparedTo,breastCancerSubtypes,Obj
work,shows,impactInDiagnostics,Obj
measurements,leadTo,lowRateInImplant-basedImmediateBreastReconstruction,Obj
cxcl1-basedTherapy,strategyFor,breastCancerMetastasisPrevention,Obj
silencingLincrna-ror,suppressing,activationOfP13k/akt/mtorSignalingPathway,Obj
clinicalMeasurements,leadTo,rateInImplant-basedImmediateBreastReconstruction,Obj
breastCancer,isSubtypeOf,breastCancer,Obj
clinicalMeasurements,leadTo,rateOfComplicationsInImmediateBreastReconstruction,Obj
triple-negativeBreastCancer,isSubtypeWith,poorOutcome,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHumanEpidermalGrowthFactorReceptorBreastCancerInCombination,Obj
4dArray,finallyIsProduced,continuousTime-enhancementCurves,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveEpidermalGrowthFactorReceptorAdvancedBreastCancer,Obj
Display,is,increasinglyConsideredAsNewCancerVaccineDeliveryStrategy,Obj
acTreatment,notablyInhibited,EMT,Obj
co-treatment,isWith,them,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanGrowthFactorReceptorBreastCancer,Obj
multipleTam-secretedCytokines,associatingWith,poorClinicalOutcomes,Obj
Results,show,expectedEnhancementOfTissues,Obj
adjuvantPartialBreastIrradiation,using,brachytherapy,Obj
Interleukin-1,drives,breastCancerCellGrowth,Obj
patterns,can,canAlsoSimulated,Obj
polyubiquitination,is,related,Obj
predicting,benefitFrom,extendedEndocrineTherapy,Obj
geo2rTool,screenOut,DEGs,Obj
proposedPhantom,canModel,breastTissuePerfusion,Obj
tamoxifenResistance,largeIntergenicNoncodingRna-regulatorOf,reprogramming,Obj
multipleTam-secretedCytokines,associatingWith,clinicalOutcomes,Obj
symptoms,associatedWith,earlyMenopause,Obj
primaryObjective,evaluate,timeToTreatmentFailureOfPalbociclibInCombinationWithLetrozoleAsSecond-lineOfTherapy,Obj
hypofractionatedVmat-sib,wellToleratedIn,terms,Obj
Prognosis,isGenerallyPoorFor,marrowMetastasisFromSolidTumors,Obj
S961,alsoInhibited,proliferation,Obj
4dArray,isProduced,curvesAtSamplingRate,Obj
objective,evaluate,timeToTreatmentFailureInCombinationAsSecond-lineOfTherapy,Obj
Inhibition,reduced,sizeOfSpheroidColonies,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanGrowthFactorReceptor2-negativeBreastCancerInCombination,Obj
sexualDysfunctions,wereDueTo,506Percecnt,Obj
patientSelection,isCrucialGiven,effects,Obj
parameters,are,prognosticForLateRecurrence,Obj
therapeuticTargets,existingIn,loopTams,Obj
immediateVerbalMemoryIndex,wasSignificantlyHigherIn,study2,Obj
canineTapewormEchinococcusGranulosus,ofOncosphereIs,stage,Obj
preoperativeMeasurements,leadTo,rateInImmediateBreastReconstruction,Obj
massiveCircrnas,have,haveDiscoveredInTumorousTissues,Obj
response,suspiciousPrimaryLesionIn,breast.Treatment,Obj
predictiveBiomarkers,optimize,clinicalOutcomeOfBreastCancerPatients,Obj
objective,investigate,scavengingAgainstHumanCellLines,Obj
cestSignals,wereComparedTo,cell-deathHistopathology,Obj
effect,disappeared,yearsOfEndocrineTherapyReduced,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveHumanEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancer,Obj
we,investigated,effects,Obj
tam-secretedCytokines,have,haveIdentified,Obj
stratification,isThereforeCrucialFor,development,Obj
mean,followOf,56Years,Obj
purpose,develop,realisticPatient-based4dDigitalBreastPhantomIncludingTime-varyingContrastEnhancementForSimulationOfBreastCtPerfusionImaging,Obj
women,wereSignificantlyOlderThan,bp-naïveOnes,Obj
limitedInformation,isAvailableOn,mostCommonAgentForTreatment,Obj
we,hereExplored,biologicalSignificance,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanGrowthFactorReceptorBreastCancerInCombination,Obj
Overexpression,wasAssociatedWith,prognosisOfBreastCancerEspecially,Obj
antioxidantActivity,using,differentModels,Obj
Cox,has,proportionalHazardRegressionAnalysis,Obj
clinicalMeasurements,leadTo,lowRateInImmediateBreastReconstruction,Obj
inhibitors,combinationsWith,cyclinDependentKinase,Obj
outcome,is,numberOfSeromaAspirationsConsist,Obj
palbociclib,progression-freeSurvivalOfWas,64Months,Obj
671Percecnt,isIn,groupNab,Obj
preoperativeMeasurements,thusLeadTo,lowRateOfComplicationsInImplant-basedBreastReconstruction,Obj
cosmeticOutcomes,were,alsoAssessed,Obj
cellLines,were,characterized,Obj
massiveCircrnas,have,withDevelopmentOfHigh-throughputSequencingHaveDiscoveredInTumorousTissues,Obj
investigated,anti-proliferativeEffectsOf,tamoxifen,Obj
basal/humanEpidermalGrowthFactorReceptorBreastCancer,isResistantTo,monoclonalAntibody,Obj
search,isIn,ascoProceedings,Obj
response,suspiciousLesionIn,breast.Treatment,Obj
patients,received,partialBreastIrradiation,Obj
clinicalMeasurements,leadTo,lowRateInImplant-basedImmediateBreastReconstruction,Obj
mainProblems,included,penetrationPain,Obj
cellLines,wereCharacterizedIn,terms,Obj
Comparison,showed,significantDifferencesBetweenTumor,Obj
response,suspiciousLesionWith,tamoxifenAlone,Obj
role,significanceOf,plasmaEsr1MutationsInMbcPatientsWithExposureToAiTherapy,Obj
cases,were,gathered,Obj
theDelayed,wasSignificantlyHigherIn,study2,Obj
plasmaEsr1Mutations,isIn,mbcPatientsWithPriorExposureToAiTherapy,Obj
×,isWith,voxelSizeOf273Μm,Obj
irMrnaExpressionLevels,wereSignificantlyDownregulatedIn,continuedPresence,Obj
acceleratedPartialBreastIrradiation,using,multicatheterHigh-dose-rateBrachytherapy,Obj
selectiveEstrogenReceptorDegraders,haveLedIn,firstLineSettings,Obj
woman'sHeadache,resultFrom,diffuseAdenocarcinomaMetastasisFromUnknownSite,Obj
activities,scavengingAgainst,humanBreast-cancerCellLines,Obj
viruses,have,haveShown,Obj
tamoxifenResistance,largeIntergenicNoncodingRna-regulatorOf,lincRNA-ROR,Obj
purpose,determine,efficacyInPatientsPretreated,Obj
616Percecnt,isIn,groupAb,Obj
co-treatment,couldInhibitEffectively,cellProliferation,Obj
AC,decreaseWnt/β-cateninTranslocationThrough,pathway,Obj
we,usingHybridizationOn,tissueSections,Obj
ourData,confirmed,resultsOfStudiesPublishedOnAssociationOfHypofractionation,Obj
role,prognosticSignificanceOf,plasmaEsr1MutationsInMbcPatientsWithPriorExposureToAiTherapy,Obj
purpose,develop,realisticPatient-based4dBreastPhantomIncludingContrastEnhancementForSimulationOfBreastCtPerfusionImaging,Obj
We,summarized,knowledge,Obj
insulinResistance,have,haveIntricatelyLinkedToPathogenesis,Obj
advancements,displaySystemsAs,modalitiesInCancerTherapeutics,Obj
showing,expressionOf,estrogen-responsiveGenes,Obj
recapitulating,malignantCharacteristicsOf,ofParentTumor,Obj
therapeuticTargets,areRequiredFor,furtherInvestigation,Obj
measurements,leadTo,lowRateInBreastReconstruction,Obj
basal/humanEpidermalGrowthFactorReceptor2-positiveBreastCancer,isResistantTo,antibody,Obj
breastCancer,isSecond-leadingCauseOf,nervousSystemMetastases,Obj
64-year-oldWoman'sHeadache,wasFound,resultFromDiffuseAdenocarcinomaMetastasisInBoneMarrowFromPrimarySite,Obj
we,explored,potentialMechanismsInvolvedInDysfunctionMediatedBySeveralEstrogenReceptorSubtypes,Obj
periodicExaminations,areConsidered,usefulForEarlyDiagnosisOfBreast/ovarianCancer,Obj
polyubiquitination,moreoverIsRelatedTo,erαTranscriptionCycle,Obj
theirPotential,was,evaluated,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfReceptor-positiveEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination,Obj
bcTissues,presented,expressionOfLincrna-ror,Obj
use,was,associated,Obj
anticancerActivities,antioxidantFree-radicalScavengingAgainst,humanBreast-cancerCellLines,Obj
predictiveRole,prognosticSignificanceOf,plasmaEsr1MutationsInMbcPatientsWithPriorExposureToAiTherapy,Obj
evaluate,possibleInfluenceOn,patient-reportedOutcomes,Obj
cells,had,near-tetraploidKaryotype,Obj
response,suspiciousLesionIn,rightBreasttreatment,Obj
S961,efficientlyBlocked,expressionOfIrs,Obj
findings,indicate,utilizationOfAcid,Obj
information,isAvailableOn,commonAgentForTreatmentOfOsteoporosis,Obj
predictiveRole,prognosticSignificanceOf,plasmaEsr1MutationsInMbcPatientsWithExposure,Obj
tumor-associatedMacrophages,have,haveImplicatedInPromotionOfBreastCancerGrowth,Obj
time,sufferingFrom,cancer,Obj
compound,Using,13c2-dimensionalMagneticResonance,Obj
we,haveRecentlyTested,fewPeptidesDerivedFromHer2/neuProto-oncogene,Obj
studyPopulation,isFor,femalesWithBreastCancer,Obj
aromataseInhibitors,haveLedIn,lineSettings,Obj
it,mainlyOwingTo,degree,Obj
breastCancer,remains,causeOfDeathInWomen,Obj
expression,were,repressed,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentInCombinationWithFulvestrantInWomenWithDiseaseProgression,Obj
research,isAnticipated,continue,Obj
research,evaluating,mechanisms,Obj
receptorActivator,make,boneMarrowMicroenvironmentForTumorCells,Obj
had,karyotypeWith,structuralAberrations,Obj
we,investigated,combinatorialAnti-proliferativeEffectsOfTamoxifenOnErCancer,Obj
woman'sHeadache,resultFrom,adenocarcinomaMetastasisInBoneMarrow,Obj
differentPatterns,can,finallyCanAlsoSimulatedForTumorModels,Obj
pi3kInhibitors,have,haveDisappointingDueToEffectSizes,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfEpidermalGrowthFactorReceptor2-negativeBreastCancer,Obj
We,performed,searchOfDataOnPalbociclibInPubmedInFdaWebsiteInAscoProceedings,Obj
basal/humanGrowthFactorReceptorBreastCancer,isResistantTo,herceptin,Obj
morphologicalChanges,noncytotoxicConcentrationsOf,μg/ml,Obj
Patients,will,willRandomlyAllocatedToOneThreeTreatmentArmsConsisting,Obj
we,exploredImpactIn,study,Obj
3dPhantom,segmentingBreastCtImageFrom,patientIntoSkin,Obj
function,was,changed,Obj
partialBreastIrradiation,using,interstitialFractionatedBrachytherapy,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveGrowthFactorReceptorBreastCancer,Obj
outcomes,wereAlsoAssessedAs,excellent/good,Obj
brcaMutationalStatus,is,validatedBiomarker,Obj
woman'sHeadache,resultFrom,diffuseAdenocarcinomaMetastasisInBoneMarrowFromUnknownSite,Obj
anticancerActivities,free-radicalScavengingAgainst,humanCellLines,Obj
we,investigated,combinatorialAnti-proliferativeEffectsOnErCancer,Obj
preciseStratification,isThereforeCrucialFor,developmentOfTherapies,Obj
information,isAvailableOn,alendronate,Obj
Comparison,showed,differencesBetweenViableTumor,Obj
cells,showed,typicalMorphology,Obj
adjuvantBreastIrradiation,using,interstitialFractionatedMulticatheterHigh-dose-rateBrachytherapy,Obj
risk,isIn,osteoporoticWomenDiagnosedWithEarlyBreastCancer,Obj
We,performed,searchOfDataOnPalbociclibInFdaWebsiteInAscoProceedings,Obj
brcaStatus,is,validatedBiomarker,Obj
women'sPersonalGoals,mayProvide,insight,Obj
CXCL1,canPromote,epithelial-mesenchymalTransitionInMouse,Obj
intraoperativeFindings,showed,81PercecntForMammography,Obj
massiveCircrnas,have,haveDiscovered,Obj
sustainedResponse,suspiciousPrimaryLesionIn,breast.Treatment,Obj
purpose,develop,patient-based4dDigitalBreastPhantomIncludingContrastEnhancementForSimulationOfDedicatedBreastCtPerfusionImaging,Obj
photographs,measuring,distancesBetweenAnatomicFeatures,Obj
treatment,isWith,AC,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfReceptor-positiveGrowthFactorReceptorBreastCancer,Obj
Pearson,has,correlationCoefficient,Obj
Analysis,hasLedTo,developmentOfGenerationOfTherapies,Obj
preoperativeMeasurements,leadTo,rate,Obj
We,performed,searchOfDataOnPalbociclibInFdaWebsite,Obj
Display,is,alsoConsideredAsCancerVaccineDeliveryStrategy,Obj
basal/humanEpidermalGrowthFactorReceptorBreastCancer,is,resistant,Obj
clinicalMeasurements,leadTo,rateOfComplicationsInImplant-basedBreastReconstruction,Obj
orthosiphonPallidus,has,antioxidantAgainstHumanBreast-cancerCellLines,Obj
CXCL1,activates,itsTranscription,Obj
antioxidantActivity,using,models,Obj
905Percecnt,wouldChooseAgain,it,Obj
theirTreatment-relatedCosmeticChanges,were,recorded,Obj
patients,isWith,advancedBreastCancer,Obj
woman'sHeadache,resultFrom,adenocarcinomaMetastasisInBoneMarrowFromUnknownPrimarySite,Obj
preoperativeMeasurements,leadTo,lowRateInImmediateBreastReconstruction,Obj
Data,wereCollectedFrom,files,Obj
objective,investigate,free-radicalScavengingAgainstHumanBreast-cancerCellLines,Obj
women,were,significantlyOlder,Obj
outcome,is,numberConsistOfNumber,Obj
we,usingImmunofluorescenceOn,tissueSections,Obj
heterogeneousTumors,wereAssociatedWith,shorterSurvival,Obj
3dPhantom,segmentingVasculatureFrom,healthyPatient,Obj
peptide,is,presentedByFusions,Obj
breastCancer,causeAmong,womenWorldwide,Obj
mrnaExpression,using,quantitativePcr,Obj
bilateralSalpingo-oophorectomy,mayImpactBecauseOf,symptomsAssociatedWithEarlyMenopause,Obj
aldehydeDehydrogenase,expressing,expression,Obj
aim,examine,evidence,Obj
woman'sHeadache,wasFound,resultFromDiffuseAdenocarcinomaMetastasisInBoneMarrowFromSite,Obj
breastIrradiation,using,fractionatedHigh-dose-rateBrachytherapy,Obj
selectionTools,areSparse,prognosticForLateRecurrence,Obj
adjuvantAcceleratedBreastIrradiation,using,interstitialFractionatedMulticatheterBrachytherapy,Obj
4D,has,dimensionsOf,Obj
findings,showed,90PercecntAccuracy,Obj
DEGs,were,identified,Obj
doses,wereEscalatedFor,level1,Obj
selectionTools,areSparse,prognosticForRecurrence,Obj
prognosisDiscussions,be,canDeliveredByPractice-basedTeamWithinPatientEducationAppointment,Obj
woman'sHeadache,wasFound,resultFromAdenocarcinomaMetastasisFromUnknownPrimarySite,Obj
patients,havePrognosisWith,probabilityOfRelapse,Obj
phantom,can,canUsedDuringDevelopmentOfDynamicDedicatedBreastCtImagingForOptimizationOfImageAcquisition,Obj
woman'sHeadache,wasFound,resultFromDiffuseAdenocarcinomaMetastasisFromPrimarySite,Obj
plasmaEsr1MutationAssessment,have,significance,Obj
retrospectiveStudy,included,womenWithHer2-positiveBcsTreatedFrom2008To2017,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfEpidermalGrowthFactorReceptor2-negativeBreastCancer,Obj
336Patients,will,willRandomized,Obj
heterogeneousTumors,wereAssociatedWith,significantlyShorterSurvival,Obj
tumors,wereAssociatedWith,survival,Obj
sexualFunction,was,changed,Obj
use,was,inMultivariableCox'sHazardsSurvivalModelAssociatedWithHazardRatio,Obj
inModel,showed,significantTumorGrowthReductionInEgki-1-treatedMice,Obj
acTreatment,notablyConsistentlyInhibitedEmtAt,time,Obj
breastLesionModel,wasDevelopedFor,creationOfAbnormalCases,Obj
cells,hadRespectively,times,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination,Obj
predictiveBiomarkers,are,urgentlyNeeded,Obj
It,understand,pathwaysInvolvedInPathogenesisOfProliferation,Obj
21Skin-sparingMastectomies,were,performed,Obj
64-year-oldWoman'sHeadache,wasFound,resultFromAdenocarcinomaMetastasisFromSite,Obj
mtrValues,wereEvaluatedAs,measure,Obj
pi3k/akt/mtorPathway,isKnown,growthPathwayInHrBreastCancer,Obj
clinicalMeasurements,leadTo,lowRateInImplant-basedBreastReconstruction,Obj
intergenicNoncodingRna-regulator,regulating,pi3k/akt/mtorSignalingPathway,Obj
aqueousOrthosiphonPallidusExtract,showed,activityInIn-vitroModels,Obj
We,thereforeSummarized,knowledge,Obj
Comparison,showed,significantDifferences,Obj
acceleratedBreastIrradiation,using,fractionatedMulticatheterHigh-dose-rateBrachytherapy,Obj
breastCancer,isCauseOf,centralNervousSystemMetastasesAmongSevereMalignancies,Obj
primarySexualDysfunctions,were,due,Obj
TDO2,may,furthermoreMayPotentialTarget,Obj
4dArray,isProduced,continuousTime-enhancementCurvesAtDesiredSamplingRate,Obj
patients,received,adjuvantPartialBreastIrradiation,Obj
breastIrradiation,using,fractionatedBrachytherapy,Obj
Inhibition,reduced,cellProliferation,Obj
pathway,be,important,Obj
biomarkers,optimize,outcomeOfBreastCancerPatientsTreated,Obj
activities,antioxidantAgainst,humanBreast-cancerCellLines,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentInCombinationWithFulvestrant,Obj
aromataseInhibitors,haveLedInAdditionTo,anti-estrogenTherapy,Obj
ourScopingReview,willSearchFor,publishedFemalesWithBreastCancer,Obj
therapeuticTargets,are,stillRequired,Obj
problems,included,dysfunctionalExcitement,Obj
3dStaticPhantom,segmentingTissueFrom,healthyPatientIntoSkin,Obj
biomarkers,optimize,clinicalOutcomeOfHr-positiveBreastCancerPatientsTreated,Obj
purpose,determine,efficacyOfPalbociclibInPatients,Obj
anticancerActivities,free-radicalScavengingAgainst,humanBreast-cancerCellLines,Obj
Agents,mightOf,mightTherapeuticEffect,Obj
adjuvantAcceleratedPartialBreastIrradiation,using,interstitialFractionatedMulticatheterBrachytherapy,Obj
lateRecurrenceRisk,Extending,5YearsOfTamoxifenTherapyWith5YearsOfTamoxifen,Obj
activities,using,3,Obj
consecutivePatients,were,treated,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentInCombinationWithFulvestrantInPostmenopausalWomenWithDiseaseProgressionFollowingEndocrineTherapy,Obj
recombinantEgki-1,affecting,normalCellGrowth,Obj
intergenicRna-regulator,affects,tamoxifenResistanceOfBcCells,Obj
Prognosis,isVeryPoor,disease,Obj
cells,had,doublingTimes,Obj
its,ligand,RANKL,Obj
tumorModels,present,higherEnhancement,Obj
role,significanceOf,plasmaEsr1MutationsInMbcPatientsWithPriorExposureToAiTherapy,Obj
History,isAssociatedWith,likelihoodOfBoneMetastasesInWomenWithBreastCancer,Obj
retrospectiveStudy,included,womenWithBcsTreated,Obj
primaryOutcome,is,numberConsistOfNumber,Obj
acceleratedBreastIrradiation,using,high-dose-rateBrachytherapy,Obj
breastCancer,isSecond-leadingCauseOf,centralNervousSystemMetastases,Obj
purpose,determine,efficacyInPatients,Obj
studies,haveImproved,care,Obj
deaths,majorityOfAre,patients,Obj
Palbociclib,is,viable,Obj
treatment,howeverCanLose,effectiveness,Obj
partialBreastIrradiation,using,fractionatedMulticatheterHigh-dose-rateBrachytherapy,Obj
We,summarized,currentKnowledgeOfRecurrenceBiology,Obj
We,performed,wechslerMemoryScale-revisedTest,Obj
systems,advancementsIn,applicationsOfOvs,Obj
cyclin-dependentKinases,beenIdentifiedAs,drivers,Obj
work,shows,impactOfHeterogeneityForTreatmentSelection,Obj
adjuvantPartialBreastIrradiation,using,interstitialMulticatheterBrachytherapy,Obj
cells,presented,expression,Obj
erαPolyubiquitinationInhibition,may,thusMayKeyFactorInProgressionOfBreastCancer,Obj
clinicalMeasurements,leadTo,rateInImmediateBreastReconstruction,Obj
diagnosis,isIn,estrogenReceptor,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHumanGrowthFactorReceptorBreastCancer,Obj
prognosisDiscussions,be,canDeliveredEffectivelyByPractice-basedClinicalTeamWithinSemi-structuredPatientEducationAppointment,Obj
enrichmentAnalysis,wasAppliedOn,genes,Obj
expression,regulates,aspectsOfPhenotype,Obj
clinicalImplication,remains,controversial,Obj
recurrenceRisk,Extending,5YearsWith5YearsOfTamoxifen,Obj
clinicalMeasurements,thusLeadTo,rateInBreastReconstruction,Obj
changes,concentrationsOf,μg/ml,Obj
we,selectedMcf-7As,model,Obj
patients,received,adjuvantBreastIrradiation,Obj
inModel,showed,tumorGrowthReductionInEgki-1-treatedMice,Obj
work,shows,impact,Obj
findings,indicate,utilizationOfAcidForBreastCancerTherapy,Obj
preoperativeMeasurements,thusLeadTo,rateInImplant-basedBreastReconstruction,Obj
limitedInformation,isAvailableOn,oralAgent,Obj
work,shows,impactOfIntratumorHeterogeneity,Obj
clinicalMeasurements,thusLeadTo,rateInImplant-basedBreastReconstruction,Obj
breastCancer,leadingCauseAmong,women,Obj
lateRecurrences,isIn,patientsWithTumorsShowing,Obj
findings,showed,81PercecntForMammography,Obj
productivePrognosisDiscussions,be,canDeliveredEffectivelyByPractice-basedClinicalTeamWithinSemi-structuredPatientEducationAppointment,Obj
stratification,isThereforeCrucialFor,developmentOfPotentStandardizedTherapies,Obj
recentStudies,haveImproved,careAllowing,Obj
patients,hadUndergone,surgery,Obj
we,usedKaplan-meierPlotterSurvivalAnalysisToolIn,addition,Obj
isolatedCompound,Using,¹H,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfReceptor-positiveHumanEpidermalGrowthFactorReceptorAdvancedBreastCancerInCombination,Obj
objective,investigate,antioxidantFree-radicalScavengingAgainstHumanBreast-cancerCellLines,Obj
Prognosis,isGenerallyVeryPoorFor,marrowMetastasis,Obj
we,investigated,effectsOnErCancer,Obj
sustainedResponse,suspiciousLesionWith,tamoxifenAlone,Obj
ourScopingReview,willSearchFor,femalesWithBreastCancer,Obj
pooledAnalysis,using,2231MrnaProfilesOfPatientsWithEr-positive/humanEpidermalGrowthFactorReceptor2-negativeBreastCancer,Obj
aldehydeDehydrogenase,expressing,cellPopulation,Obj
ourData,confirmed,resultsOfOtherStudiesPublished,Obj
breastCancer,remainsDespite,yearsOfResearch,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfReceptor-positiveHumanEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancer,Obj
photograph,beforeAndAnotherWasTakenFor,patient,Obj
Expression,has,hasLinked,Obj
EgKI-1,affecting,normalCellGrowth,Obj
showing,highExpressionOf,estrogen-responsiveGenes,Obj
we,haveTested,peptidesDerivedAsVaccineDeliveryModalities,Obj
it,continue,combinationTherapyForPatientsWithAdvancedRecurrentBreastCancerDue,Obj
S961,efficientlyBlockedExpressionIn,presence,Obj
evaluate,possibleInfluenceOn,outcomes,Obj
objective,investigate,anticancerActivities,Obj
pooledAnalysis,using,2231MrnaProfilesOfPatientsWithEr-positive/humanEpidermalGrowthFactorReceptorBreastCancer,Obj
acceleratedPartialBreastIrradiation,using,interstitialMulticatheterHigh-dose-rateBrachytherapy,Obj
intratumorHeterogeneity,variedBetween,patientSamples,Obj
4dArray,isProduced,time-enhancementCurvesAtDesiredSamplingRate,Obj
Prognosis,isGenerallyVeryPoorFor,marrowMetastasisFromTumors,Obj
optimalPatientSelection,isCrucialGiven,sideEffectsOfEndocrineTherapy,Obj
4dArray,isProducedCurvesBy,sampling,Obj
Prognosis,isGenerallyVeryPoor,treatableDisease,Obj
we,investigated,anti-proliferativeEffectsOfTamoxifen,Obj
use,was,inMultivariableCox'sHazardsSurvivalModelAssociatedWithHazardRatioForBoneMetastasis,Obj
4D,has,dimensions,Obj
it,owingTo,degreeOfConcern,Obj
use,wasAssociatedIn,multivariableCox'sProportionalHazardsSurvivalModel,Obj
mammography,canEnhance,prediction,Obj
acceleratedBreastIrradiation,using,multicatheterBrachytherapy,Obj
bilateralSalpingo-oophorectomy,mayImpactBecauseOf,symptoms,Obj
tdo2ProteinExpression,wasEvaluatedBy,immunohistochemistry,Obj
noncytotoxicConcentrations,reversed,changes,Obj
we,provide,updateOfDataOnPharmacodynamics,Obj
phantom,can,canUsedDuringDevelopmentOfDynamicContrast-enhancedDedicatedBreastCtImaging,Obj
diseaseNature,be,estrogenReceptor-positive/humanEpidermalGrowthFactorReceptorBreastCancer,Obj
p,=,0.630,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveHumanEpidermalGrowthFactorReceptorBreastCancer,Obj
goal-setting,is,whereComponentOfStudy,Obj
periodicExaminations,areConsidered,usefulForDiagnosis,Obj
p,=,0.447,Obj
threeVisualRepresentations,using,threeDifferentMetrics,Obj
dose,was,found,Obj
clinicalMeasurements,leadTo,rate,Obj
Meta-analysis,calculateHazardRatiosWith,CIs,Obj
periodicExaminations,areConsidered,usefulForDiagnosisOfBreast/ovarianCancer,Obj
purpose,develop,patient-based4dBreastPhantomIncludingContrastEnhancementForSimulation,Obj
phantom,can,canUsed,Obj
information,isAvailableOn,mostCommonAgentForTreatmentOfOsteoporosis,Obj
pik3caMutations,dynamicsOfBe,potentialBiomarkerForCdk4/6Inhibitors,Obj
therapy,remains,backboneOfTreatment,Obj
invasiveness,isIn,mice,Obj
It,wasPerceivedBy,patientsWithAdvancedBreastCancerAsValuable,Obj
we,haveTested,peptidesDerivedFromHer2/neuProto-oncogeneAsVaccineDeliveryModalities,Obj
tdo2Overexpression,wasCorrelatedWith,poorOutcome,Obj
acceleratedPartialBreastIrradiation,using,fractionatedHigh-dose-rateBrachytherapy,Obj
aromataseInhibitors,haveLedInAdditionTo,anti-estrogenTherapyWithEstrogenReceptorModulators,Obj
degree,is,generallyHigh,Obj
Results,show,expectedEnhancementOfTissuesConsistent,Obj
patients,hadUndergone,breast-conservingSurgery,Obj
phantom,can,canUsedDuringDevelopmentOfDynamicContrast-enhancedBreastCtImagingForOptimization,Obj
correspondingTime-enhancementCurves,areComputedFor,voxelInPhantom,Obj
anticancerActivities,antioxidantFree-radicalScavengingAgainst,humanCellLines,Obj
role,prognosticSignificanceOf,plasmaEsr1MutationsInMbcPatientsWithPriorExposure,Obj
information,isAvailableOn,mostCommonOralAgent,Obj
candidates,isIn,2014,Obj
differentPatterns,can,canSimulated,Obj
adjuvantBreastIrradiation,using,fractionatedMulticatheterBrachytherapy,Obj
2MutationCarriers,follow,surveillancePrograms,Obj
estrogenReceptorDegraders,haveLedInAdditionTo,anti-estrogenTherapy,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancer,Obj
targets,areRequiredFor,investigation,Obj
it,continue,combinationTherapyForPatientsWithAdvancedBreastCancerDueToToxicities,Obj
prognosisDiscussions,be,canDeliveredByClinicalTeamWithinSemi-structuredPatientEducationAppointment,Obj
triple-negativeBreastCancer,is,subtypeOfBreastCancerWithPoorOutcome,Obj
characteristics,evaluate,perfusionInDifferentTypes,Obj
use,was,inCox'sHazardsSurvivalModelAssociatedWithHazardRatioOf004,Obj
predictiveRole,prognosticSignificanceOf,plasmaEsr1MutationsInMbcPatients,Obj
anti-epithelial-to-mesenchymalTransitionProperties,isIn,tnbcCells,Obj
maximum,thusTolerated,dose,Obj
patients,receivedVmat-sibTechniqueTo,breast,Obj
theirTumorigenicPotential,wasEvaluatedIn,athymicNudeMouseXenograftModel,Obj
trials,are,ongoing,Obj
recombinantEgki-1,affecting,cellGrowth,Obj
pi3k/akt/mtorPathway,be,importantGrowthPathway,Obj
mucin1,facilitates,potentialOfBreastCancerCells,Obj
cellProliferation,were,detected,Obj
purpose,develop,patient-based4dDigitalBreastPhantom,Obj
information,isAvailableOn,mostCommonOralAgentForTreatmentOfPost-menopausalOsteoporosis,Obj
audioAnalysis,was,conducted,Obj
role,significanceOf,plasmaEsr1MutationsInMbcPatientsWithPriorExposure,Obj
64-year-oldWoman'sHeadache,wasFound,resultFromDiffuseAdenocarcinomaMetastasisInBoneMarrowFromSite,Obj
outcome,isNumberOf,seromaAspirations,Obj
compound,Using,13cResonance,Obj
acceleratedBreastIrradiation,using,multicatheterHigh-dose-rateBrachytherapy,Obj
compound,reduces,cd44high/cd24lowSubpopulation,Obj
typical4d,has,dimensions,Obj
growth,isIn,boneMarrowAdiposeTissueNiche,Obj
targetingBreastCscs,is,paradigm,Obj
breastCancer,isCauseOf,systemMetastasesAmongMalignancies,Obj
information,isAvailableOn,agentForTreatmentOfPost-menopausalOsteoporosis,Obj
It,is,important,Obj
questionnaire,wasAdministeredTo,174Brca1-2MutationCarriers,Obj
we,Using,immunofluorescence,Obj
History,isAssociatedWith,likelihoodOfBoneMetastases,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanGrowthFactorReceptor2-negativeBreastCancerInCombination,Obj
lateRecurrenceRisk,Extending,5YearsWith5Years,Obj
patients,received,adjuvantAcceleratedPartialBreastIrradiation,Obj
objective,investigate,antioxidantScavengingAgainstBreast-cancerCellLines,Obj
measurements,thusLeadTo,lowRateOfComplicationsInBreastReconstruction,Obj
symptoms,associatedWith,surgicalMenopause,Obj
We,searchedCochraneLibraryDatabasesFor,eligibleStudies,Obj
64-year-oldWoman'sHeadache,resultFrom,diffuseAdenocarcinomaMetastasisFromSite,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination,Obj
it,mainlyOwingTo,lowerDegree,Obj
targets,howeverAreRequiredFor,furtherInvestigation,Obj
theDelayed,wasHigherIn,study2,Obj
511Percecnt,inG1Is,G2,Obj
EgKI-1,givingRiseTo,hydatidCystLocalized,Obj
Overexpression,wasAssociatedWith,unfavorablePrognosisOfBreastCancerEspecially,Obj
productivePrognosisDiscussions,be,canDelivered,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfReceptor-positiveHumanGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination,Obj
examinations,areConsidered,usefulForDiagnosis,Obj
We,summarized,currentKnowledgeOfLateRecurrenceBiology,Obj
acceleratedPartialBreastIrradiation,using,fractionatedMulticatheterHigh-dose-rateBrachytherapy,Obj
partialBreastIrradiation,using,multicatheterHigh-dose-rateBrachytherapy,Obj
we,thereforePerformed,pooledAnalysis,Obj
preoperativeMeasurements,leadTo,rateInImplant-basedImmediateBreastReconstruction,Obj
breastCancer,isCauseOf,centralNervousSystemMetastasesAmongMalignancies,Obj
information,will,willReported,Obj
measurements,thusLeadTo,rateInImplant-basedBreastReconstruction,Obj
threeVisualRepresentations,using,threeMetricsOfMortality,Obj
aqueousOrthosiphonPallidusExtract,showed,activityInModels,Obj
limitedInformation,isAvailableOn,alendronateRegardingAssociationWithBoneMetastases,Obj
threeRepresentations,using,threeDifferentMetricsOfMortality,Obj
treatment,howeverCanLoseDue,effectiveness,Obj
repeatedChromatographicPreparations,using,aroniaExtracts,Obj
goal-setting,is,majorComponent,Obj
breastCancer,causeAmong,women,Obj
nineteenFemalePatients,wereEnrolledIn,twoRadiationOncologyCenters,Obj
History,isAssociatedWith,likelihoodOfBoneMetastasesInPostmenopausalWomenWithBreastCancer,Obj
recentStudies,haveImproved,supportiveCare,Obj
preoperativeMeasurements,leadTo,rateOfComplicationsInImplant-basedImmediateBreastReconstruction,Obj
possibility,holds,greatPromiseInFutureOfCancerImmunotherapy,Obj
response,suspiciousLesionWith,tamoxifen,Obj
predictiveBiomarkers,allowing,patientSelection,Obj
we,haveRecentlyTested,fewPeptidesDerived,Obj
tdo2Function,were,evaluated,Obj
purpose,develop,realisticPatient-based4dBreastPhantomIncludingContrastEnhancementForSimulationOfDedicatedBreastCtPerfusionImaging,Obj
productivePrognosisDiscussions,be,canDeliveredByClinicalTeam,Obj
breastCancer,is,second-leadingCause,Obj
use,wasAssociatedWith,hazardRatioOf004,Obj
woman'sHeadache,wasFound,resultFromDiffuseAdenocarcinomaMetastasisInBoneMarrowFromPrimarySite,Obj
primaryObjective,evaluate,timeToTreatmentFailureInCombinationAsSecond-lineOfTherapy,Obj
use,was,inCox'sProportionalHazardsSurvivalModelAssociatedWithHazardRatioForBoneMetastasis,Obj
clinicalMeasurements,thusLeadTo,rateOfComplicationsInBreastReconstruction,Obj
combinations,isWith,cyclinDependentKinase,Obj
EgKI-1,isExpressedBy,oncosphere,Obj
woman'sHeadache,resultFrom,diffuseAdenocarcinomaMetastasisInBoneMarrowFromSite,Obj
cyclin-dependentKinases,regulate,transition,Obj
intraclassCorrelationCoefficient,rangedBefore,treatment,Obj
analysis,using,2231MrnaProfilesOfPatients,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanEpidermalGrowthFactorReceptorAdvancedBreastCancerInCombination,Obj
study,included,women,Obj
we,explored,impactOfIntratumorHeterogeneity,Obj
Analysis,hasLedTo,developmentOfGenerationOfTargetedTherapies,Obj
analysis,assess,interventionFeasibility,Obj
patients,have,prognosis,Obj
acceleratedPartialBreastIrradiation,using,interstitialFractionatedMulticatheterBrachytherapy,Obj
breastLesionModel,was,developed,Obj
multivariableCox,In,proportionalHazardsSurvivalModel,Obj
compound,inhibitsBreastCancerCellProliferationIn,dose-dependentManner,Obj
breastCancer,remainsDespite,years,Obj
adjuvantAcceleratedPartialBreastIrradiation,using,interstitialBrachytherapy,Obj
we,investigated,combinatorialEffects,Obj
methods,reduceSpaceAfter,mastectomy,Obj
anticancerActivities,scavengingAgainst,breast-cancerCellLines,Obj
measurements,thusLeadTo,lowRateInBreastReconstruction,Obj
mucin1,facilitates,potential,Obj
Overexpression,wasAssociatedWith,prognosisOfBreastCancer,Obj
breastCancer,isCauseOf,systemMetastasesAmongSevereMalignancies,Obj
we,provide,updateOfData,Obj
4dArray,finallyIsProduced,continuousCurvesAtSamplingRate,Obj
it,continue,combinationTherapyForPatientsWithAdvancedBreastCancerDue,Obj
we,explored,potentialMechanismsInvolvedInDysfunctionMediatedByEstrogenReceptorSubtypes,Obj
patients,wereDividedInto,twoGroupsIncluding196PatientsInGroupAb,Obj
We,thereforeSummarized,currentKnowledge,Obj
symptoms,associatedWith,earlySurgicalMenopause,Obj
pi3kInhibitors,have,haveDisappointing,Obj
femalePatients,wereEnrolledIn,twoRadiationOncologyCenters,Obj
We,performed,searchOfDataInFdaWebsite,Obj
study,included,womenWithHer2-positiveBcsTreatedFrom2008To2017,Obj
adjuvantBreastRadiotherapy,isIn,breastConservationTherapy,Obj
study,investigate,roleOfIrAntagonistS961OnIrSignallingInMcf-7,Obj
limitedInformation,isAvailableOn,commonOralAgentForTreatment,Obj
qpcrScreening,furtherValidatedSox4As,gene,Obj
activity,isRelatedTo,therapyResistance,Obj
we,investigated,anti-proliferativeEffectsOnErCancer,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanGrowthFactorReceptorAdvancedBreastCancerInCombination,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHumanEpidermalGrowthFactorReceptor2-negativeBreastCancerInCombination,Obj
adjuvantAcceleratedBreastIrradiation,using,brachytherapy,Obj
bilateralSalpingo-oophorectomy,mayImpactBecauseOf,symptomsAssociatedWithMenopause,Obj
limitedInformation,is,available,Obj
model,showed,significantTumorGrowthReductionInEgki-1-treatedMice,Obj
4dArray,finallyIsProduced,time-enhancementCurvesAtDesiredSamplingRate,Obj
tumorModels,alsoPresent,enhancement,Obj
immediateBreastReconstruction,withMastectomiesIs,NSM,Obj
preoperativeMeasurements,leadTo,lowRate,Obj
decline,isIn,breastCancerPatients,Obj
cdk4/6InhibitorPalbociclib,isIn,combinationWithEndocrineTherapy,Obj
measurements,leadTo,lowRateOfComplicationsInImplant-basedImmediateBreastReconstruction,Obj
tamoxifenResistance,intergenicRna-regulatorOf,reprogramming,Obj
pooledAnalysis,using,2231MrnaProfilesOfPatientsWithEr-positive/humanGrowthFactorReceptorBreastCancer,Obj
information,isAvailableOn,mostCommonAgent,Obj
chromatographicPreparations,using,aroniaExtracts,Obj
aim,examine,existingEvidenceOnGoal-settingAmongWomen,Obj
outcomes,review,association,Obj
activities,free-radicalScavengingAgainst,breast-cancerCellLines,Obj
peptide,is,presentedByGeneticFusionsToPhageCoatProteins,Obj
cells,had,karyotype,Obj
We,predicting,recurrenceFromTreatmentExtension,Obj
cyclin-dependentKinases,been,identified,Obj
instruments,wereQuestionnaireOn,women'sSexualFunction,Obj
clinicopathologicalParameters,are,prognostic,Obj
orthosiphonPallidus,excellentAntioxidantAgainst,humanBreast-cancerCellLines,Obj
breastCancer,isSubtypeWith,poorClinicalOutcome,Obj
targetedAgents,isIn,differentSubtypesOfBreastCancer,Obj
isolatedCompound,Using,13cNuclearResonance,Obj
TDO2,may,furthermoreMayPotentialTherapeuticTargetInEscc,Obj
preoperativeMeasurements,thusLeadTo,rateInImmediateBreastReconstruction,Obj
EgKI-1,is,highlyExpressed,Obj
acceleratedBreastIrradiation,using,brachytherapy,Obj
phantom,can,canUsedDuringDevelopmentOfBreastCtImagingForOptimizationOfImageAcquisition,Obj
787ConsecutivePatients,wereTreatedBetween,august2010,Obj
TDO2,may,mayPotentialTargetInEscc,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveGrowthFactorReceptor2-negativeBreastCancerInCombination,Obj
variousMethods,have,haveDescribed,Obj
TNBC,has,6SubtypesWithSignaturesWithDifferentPrognoses,Obj
expression,isIn,ESCC,Obj
it,continue,combinationTherapyForPatientsWithAdvancedBreastCancerDueToHematologicalToxicities,Obj
effect,was,due,Obj
we,evaluate,prognosticValueOfHubGenes,Obj
theirTreatment-relatedCosmeticChanges,wereRecordedOn,photographs,Obj
purpose,determine,efficacy,Obj
erαPolyubiquitinationSelectiveEstrogenReceptorDegraders,resultingIn,erαDegradation,Obj
basal/humanGrowthFactorReceptorBreastCancer,isResistantTo,antibody,Obj
Patients,were,enrolled,Obj
It,wasPerceivedBy,patients,Obj
Agreement,was,high,Obj
findings,showed,81Percecnt,Obj
4dArray,isProduced,continuousCurvesAtDesiredSamplingRate,Obj
TDO2,play,importantRole,Obj
circRNAs,have,withDevelopmentOfSequencingHaveDiscoveredInTissues,Obj
The,was,significantlyHigher,Obj
limitedInformation,isAvailableOn,mostCommonOralAgentForTreatment,Obj
seriousDamage,selecting,nabRegimen,Obj
orthosiphonPallidus,has,excellentAntioxidantAgainstBreast-cancerCellLines,Obj
mayPotentialTherapeuticTarget,isIn,ESCC,Obj
breastCancerCells,showed,proliferationOwing,Obj
therapy,backboneOf,treatment,Obj
selectiveEstrogenReceptorDegraders,haveLedInAdditionTo,anti-estrogenTherapyWithEstrogenReceptorModulators,Obj
pi3k/akt/mtorPathway,isKnown,importantGrowthPathway,Obj
endocrineTherapy,remains,backboneOfTreatmentInCases,Obj
breastCancer,isCauseOf,nervousSystemMetastasesAmongMalignancies,Obj
prognosisDiscussions,be,canDeliveredEffectivelyByPractice-basedClinicalTeamWithinPatientEducationAppointment,Obj
Palbociclib,isInhibitorOf,kinases,Obj
typical4dPhantom,has,dimensions,Obj
outcome,is,numberOfSeromaAspirationsConsistOfNumberOfPatientClinicVisits,Obj
purpose,develop,4dDigitalBreastPhantomIncludingTime-varyingContrastEnhancement,Obj
circumstances,influence,sexualFunction,Obj
tumorModels,presentEnhancement,expected,Obj
largeIntergenicNoncodingRna-regulator,affects,tamoxifenResistance,Obj
findings,indicate,novelUtilization,Obj
measurements,leadTo,rate,Obj
activities,free-radicalScavengingAgainst,cellLines,Obj
basal/humanGrowthFactorReceptor2-positiveBreastCancer,isResistantTo,herceptin,Obj
breastCancer,isCauseOf,centralSystemMetastasesAmongSevereMalignancies,Obj
64-year-oldWoman'sHeadache,resultFrom,adenocarcinomaMetastasisInBoneMarrowFromUnknownPrimarySite,Obj
objective,investigate,scavengingAgainstBreast-cancerCellLines,Obj
participants,ageOfWas,4634±828Years,Obj
maximum,tolerated,dose,Obj
study,included,womenWithHer2-positiveBcsTreatedWithTrastuzumab,Obj
lateRecurrences,are,likelyEr-driven,Obj
it,can,evenCanTreatedWithReplacementTherapies,Obj
massiveCircrnas,have,withDevelopmentOfHigh-throughputSequencingHaveDiscoveredInTissues,Obj
productivePrognosisDiscussions,be,canDeliveredEffectivelyByClinicalTeam,Obj
t-patParticipants,hold,beliefs,Obj
prognosisDiscussions,be,canDeliveredEffectivelyByClinicalTeam,Obj
64-year-oldWoman'sHeadache,wasFound,resultFromAdenocarcinomaMetastasisInBoneMarrowFromSite,Obj
optimalPatientSelection,isCrucialGiven,sideEffectsOfTherapy,Obj
response,suspiciousPrimaryLesionIn,rightBreasttreatment,Obj
Comparison,showed,differencesBetweenTumor,Obj
personalGoal-setting,is,component,Obj
4Patients,received,level1Doses,Obj
mostPatients,found,appointment,Obj
circRNAs,have,withDevelopmentOfHigh-throughputSequencingHaveDiscoveredInTissues,Obj
upregulatedExpression,regulates,aspectsOfPhenotype,Obj
TNBC,has,6SubtypesWithMolecularSignatures,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveHumanGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination,Obj
breastCancer,is,cancer,Obj
we,hereExplored,expression,Obj
other4Patients,received,level1Doses,Obj
it,mainlyOwingTo,degreeOfConcernAboutOvarianCancerRisk,Obj
maximum,thusTolerated,MTD,Obj
erαPolyubiquitination,is,inhibited,Obj
EgKI-1,isExpressedBy,oncosphereOfTapewormEchinococcusGranulosus,Obj
intratumorHeterogeneity,playRoleIn,treatmentFailure,Obj
It,was,found,Obj
multigeneAssays,arePrognosticFor,lateRecurrence,Obj
naringenin,inhibit,cellGrowthOfMcf-7CellsAtHigherConcentrations,Obj
patientSelection,is,crucial,Obj
activities,antioxidantAgainst,breast-cancerCellLines,Obj
postmenopausalWomen,isWith,diseaseProgressionFollowingEndocrineTherapy,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHumanEpidermalGrowthFactorReceptorBreastCancerInCombination,Obj
onePhotograph,beforeWasTakenFor,patient,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveGrowthFactorReceptorAdvancedBreastCancerInCombination,Obj
endocrineTherapy,remains,backboneOfTreatment,Obj
characteristics,evaluate,perfusionInTypes,Obj
objective,evaluate,time,Obj
compound,wasIdentifiedAs,acid,Obj
Overexpression,wasAssociatedWith,prognosis,Obj
majority,areIn,patientsWithHormoneReceptor,Obj
we,haveRecentlyTested,fewPeptidesDerivedAsVaccineDeliveryModalitiesForTreatmentOfTuboBreastCancerXenograftTumorsOfBalb/cMice,Obj
co-treatment,regulating,expressionOfMitochondrialProteins,Obj
p,=,0.006,Obj
We,performed,searchOfDataOnPalbociclibInAscoProceedings,Obj
phantom,can,canUsedDuringDevelopmentOfDynamicBreastCtImaging,Obj
use,was,inCox'sHazardsSurvivalModelAssociatedWithHazardRatio,Obj
use,wasAssociatedIn,cox'sProportionalHazardsSurvivalModel,Obj
noncytotoxicConcentrations,reversed,phenotype,Obj
acceleratedPartialBreastIrradiation,using,interstitialFractionatedMulticatheterHigh-dose-rateBrachytherapy,Obj
PROs,wereMeasuredWith,eortcQlq-c30,Obj
it,continue,combinationTherapyForPatientsWithBreastCancerDueToToxicities,Obj
recommendations,impact,manyAspectsOfTheirLife,Obj
virusTherapy,is,strategy,Obj
mtorInhibitorEverolimus,improves,progressionFreeSurvival,Obj
TNBC,has,6SubtypesWithDistinctSignaturesWithPrognoses,Obj
probability,evaluate,possibleInfluenceOfBrachytherapyOnOutcomes,Obj
woman'sHeadache,wasFound,resultFromAdenocarcinomaMetastasisFromPrimarySite,Obj
adjuvantPartialBreastIrradiation,using,interstitialFractionatedMulticatheterBrachytherapy,Obj
compound,inhibits,breastCancerCellProliferation,Obj
S961,inhibited,cellularProliferation,Obj
cells,wereExposedTo,tamoxifen,Obj
preciseStratification,isCrucialFor,development,Obj
VMAT-SIB,toleratedIn,terms,Obj
preoperativeMeasurements,leadTo,lowRateInBreastReconstruction,Obj
HR,remainedAfter,furtherAdjustmentForTumorStage,Obj
alendronate,agentFor,treatmentOfPost-menopausalOsteoporosis,Obj
mastectomy,is,usuallyWell-accepted,Obj
basal/humanEpidermalGrowthFactorReceptorBreastCancer,isResistantTo,herceptin,Obj
tamoxifenResistance,intergenicRna-regulatorOf,lincRNA-ROR,Obj
3dPhantom,segmentingBreastCtImageFrom,healthyPatient,Obj
expression,regulates,aspectsOfPhenotypeIncludingCellProliferation,Obj
biomarkers,optimize,outcomeOfHr-positiveBreastCancerPatientsTreated,Obj
History,is,associated,Obj
bp-treatedWomen,were,older,Obj
treatmentRegimens,improve,clinicalOutcomes,Obj
we,explored,biologicalSignificance,Obj
inModel,showed,tumorGrowthReductionInMice,Obj
adjuvantAcceleratedPartialBreastIrradiation,using,interstitialFractionatedMulticatheterHigh-dose-rateBrachytherapy,Obj
objective,evaluate,timeToTreatmentFailureOfPalbociclib,Obj
treatmentFailure,isIn,combinationWithLetrozole,Obj
breastCancer,causeOf,death,Obj
Display,is,alsoIncreasinglyConsideredAsNewCancerVaccineDeliveryStrategy,Obj
acid,preferentiallyReduced,proteinLevels,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveGrowthFactorReceptorBreastCancerInCombination,Obj
we,discussIn,paper,Obj
we,investigated,effectsOfTamoxifenOnErCancer,Obj
support,isWith,breastCancer,Obj
study,investigate,pivotalRoleOfIrAntagonistS961OnIrSignallingInMcf-7,Obj
problems,included,desire,Obj
We,performed,searchOfDataOnPalbociclib,Obj
prognosisDiscussions,be,canDeliveredByPractice-basedTeam,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHumanGrowthFactorReceptorBreastCancer,Obj
patients,isWith,residualDisease,Obj
differentPatterns,can,finallyCanSimulated,Obj
tdo2Overexpression,was,correlated,Obj
sameTime,upregulating,epithelialMarkerProteinsLikeOccludin,Obj
intraoperativeFindings,showed,accuracyForMriPreoperativeEvaluation,Obj
pooledAnalysis,using,2231MrnaProfiles,Obj
orthosiphonPallidus,antioxidantAgainst,breast-cancerCellLines,Obj
we,summarize,knowledgeOnHumanCircrnas,Obj
Overexpression,wasAssociatedWith,unfavorablePrognosisOfBreastCancer,Obj
adjuvantPartialBreastIrradiation,using,fractionatedBrachytherapy,Obj
objective,investigate,antioxidantFree-radicalScavengingAgainstHumanCellLines,Obj
acTreatment,notablyConsistentlyInhibited,EMT,Obj
use,was,inMultivariableCox'sProportionalHazardsSurvivalModelAssociatedWithHazardRatioOf004ForBoneMetastasis,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfEpidermalGrowthFactorReceptorBreastCancer,Obj
treatment,blockedCellCycleIn,g2/mPhase,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfReceptor-positiveHumanGrowthFactorReceptor2-negativeBreastCancerInCombination,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfEpidermalGrowthFactorReceptorBreastCancer,Obj
silencingLincrna-ror,sensitivityOf,bcMad-mb-231Cells,Obj
aim,examine,existingEvidenceOnPersonalGoal-settingAmongWomenWithBreastCancerDiagnosis,Obj
objective,evaluate,timeToTreatmentFailureOfPalbociclibInCombinationWithLetrozoleAsSecond-line,Obj
kinases,beenIdentifiedAs,keyDriversOfProliferationInHormoneReceptor,Obj
investigated,combinatorialAnti-proliferativeEffectsOf,tamoxifen,Obj
breastCancer,isCauseOf,centralSystemMetastasesAmongMalignancies,Obj
endocrineTherapy,canReduce,recurrences,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHormoneReceptor-positiveGrowthFactorReceptor2-negativeBreastCancerInCombination,Obj
concentrations,reversed,morphologicalChanges,Obj
806Percecnt,isIn,groupNab,Obj
targets,howeverAreStillRequiredFor,investigation,Obj
higherExpression,wasAssociatedWith,highRecurrenceRiskBeyond5Years,Obj
women'sPersonalGoals,mayProvide,insightIntoTheirPriorities,Obj
backbone,isIn,cases,Obj
cosmeticOutcomes,review,associationOfChemotherapyWithBoost,Obj
we,explored,clinicalImpactOfIntratumorHeterogeneity,Obj
TDO2,may,furthermoreMayPotentialTherapeuticTarget,Obj
treatment,suppressed,cellMigration,Obj
purpose,develop,patient-based4dDigitalBreastPhantomIncludingTime-varyingContrastEnhancement,Obj
association,was,evaluated,Obj
clinicalTrials,are,ongoing,Obj
adjuvantPartialBreastIrradiation,using,multicatheterBrachytherapy,Obj
breastCancer,isCauseOf,centralNervousSystemMetastases,Obj
Meta-analysis,calculate,combinedHazardRatios,Obj
chemotherapy,Lacking,targets,Obj
polyubiquitination,is,moreoverRelated,Obj
mammography,were,used,Obj
S961,downregulatedIrsWith,nanomolarDose,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanGrowthFactorReceptor2-negativeBreastCancer,Obj
cohortStudy,isWith,follow-upViaCancerRegistries,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentInCombinationWithFulvestrantInWomen,Obj
use,was,inCox'sHazardsSurvivalModelAssociatedWithHazardRatioForBoneMetastasis,Obj
therapy,improving,quality,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfGrowthFactorReceptor2-negativeBreastCancerInCombination,Obj
cellProliferation,were,thenDetected,Obj
acTreatment,consistentlyInhibited,EMT,Obj
percecnt,wouldChooseAgain,it,Obj
role,significanceOf,plasmaEsr1Mutations,Obj
acceleratedPartialBreastIrradiation,using,fractionatedMulticatheterBrachytherapy,Obj
TDO2,playRoleIn,progressionOfEscc,Obj
patients,diagnosedWith,breastCancer,Obj
64-year-oldWoman'sHeadache,wasFound,resultFromDiffuseAdenocarcinomaMetastasisInBoneMarrow,Obj
This,is,controlled,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfGrowthFactorReceptor2-negativeAdvancedBreastCancer,Obj
we,investigate,tolerabilityOfCombinationTherapy,Obj
stratification,is,thereforeCrucial,Obj
oncolyticVirusTherapy,is,interestingStrategy,Obj
tdo2Overexpression,wasCorrelatedWith,poorOutcomeOfEsccPatients,Obj
recurrenceRisk,Extending,5YearsWith5Years,Obj
patientSelf-reports,wereComparedAcross,intervention,Obj
intervention,mightReduce,recurrences,Obj
patients,isWith,earlyBreastCancer,Obj
objective,investigate,activities,Obj
oncolyticViruses,have,haveShown,Obj
cxcl1Expression,is,significantlyCorrelated,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveEpidermalGrowthFactorReceptorBreastCancerInCombination,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHumanEpidermalGrowthFactorReceptorAdvancedBreastCancerInCombination,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHumanGrowthFactorReceptor2-negativeBreastCancerInCombination,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanGrowthFactorReceptor2-negativeAdvancedBreastCancer,Obj
preoperativeMeasurements,leadTo,lowRateOfComplicationsInImmediateBreastReconstruction,Obj
theirTumorigenicPotential,was,evaluated,Obj
combination,isWith,fulvestrantInPostmenopausalWomen,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanEpidermalGrowthFactorReceptor2-negativeBreastCancerInCombination,Obj
treatableDisease,isIn,evenDismalCondition,Obj
tamoxifenResistance,intergenicNoncodingRna-regulatorOf,reprogramming,Obj
pi3k/akt/mtorPathway,is,known,Obj
limitedInformation,isAvailableOn,commonOralAgentForTreatmentOfPost-menopausalOsteoporosis,Obj
optimalPatientSelection,isCrucialGiven,sideEffects,Obj
breastCancer,second-leadingCauseOf,death,Obj
cells,were,exposed,Obj
treatment,was,firstUsed,Obj
purpose,develop,patient-based4dBreastPhantomIncludingContrastEnhancementForSimulationOfDedicatedBreastCtPerfusionImaging,Obj
We,thereforeSummarized,currentKnowledgeOfRecurrenceBiology,Obj
optimalPatientSelection,isCrucialGiven,effects,Obj
pallidus,is,popular,Obj
sexualFunction,wasChangedIn,womenWithBreastCancer,Obj
acid,reduced,proteinLevels,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination,Obj
systems,latestAdvancementsIn,applications,Obj
Agents,mightOf,mightEffectForPatients,Obj
ourData,confirmed,resultsOfStudies,Obj
bilateralSalpingo-oophorectomy,mayImpactBecauseOf,symptomsAssociatedWithSurgicalMenopause,Obj
We,predicting,lateRecurrence,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfEpidermalGrowthFactorReceptor2-negativeBreastCancerInCombination,Obj
orthosiphonPallidus,excellentAntioxidantAgainst,breast-cancerCellLines,Obj
model,showed,tumorGrowthReductionInMice,Obj
tamoxifenResistance,largeRna-regulatorOf,reprogramming,Obj
S961,downregulated,IRs,Obj
cells,grew,showHighInvasivenessInMice,Obj
immediateVerbalMemoryIndex,was,higher,Obj
isolatedCompound,Using,13c2-dimensionalMagneticResonance,Obj
64-year-oldWoman'sHeadache,resultFrom,adenocarcinomaMetastasis,Obj
objective,evaluate,timeToTreatmentFailureAsSecond-lineOfTherapy,Obj
adjuvantAcceleratedPartialBreastIrradiation,using,fractionatedMulticatheterBrachytherapy,Obj
primarySexualDysfunctions,wereDueTo,penetrationPain,Obj
modality,couldProvide,information,Obj
Patients,will,willRandomlyAllocatedToOneThreeTreatmentArms,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfReceptor-positiveHumanGrowthFactorReceptorAdvancedBreastCancer,Obj
partialBreastIrradiation,using,fractionatedMulticatheterBrachytherapy,Obj
activities,scavengingAgainst,humanCellLines,Obj
prognosisDiscussions,be,canDelivered,Obj
adjuvantAcceleratedBreastIrradiation,using,fractionatedBrachytherapy,Obj
hormone,receptor-positive,humanEpidermalGrowthFactorReceptor2-negativeMetastaticBreastCancerPatients,Obj
qpcrScreening,furtherValidatedSox4As,highestResponsiveGene,Obj
limitedInformation,isAvailableOn,commonAgentForTreatmentOfOsteoporosis,Obj
latestAdvancements,displaySystemsAs,modalitiesInCancerImmuneTherapeutics,Obj
growthHormoneTreatment,increase,meningiomaRisk,Obj
cytokines,associatingWith,outcomes,Obj
4dArray,finallyIsProduced,continuousTime-enhancementCurvesAtSamplingRate,Obj
viruses,areUnder,presentlyLaboratoryAsOncolyticTherapeutics,Obj
treatment,was,used,Obj
findings,showed,accuracyForMriPreoperativeEvaluation,Obj
breastCancer,causeOf,death,Obj
peptide,is,inPhageDisplayImmunotherapyPresentedByFusions,Obj
patients,isWith,tumorsShowing,Obj
compound,was,identified,Obj
hypofractionatedVmat-sib,toleratedIn,termsOfAcute,Obj
EgKI-1,inhibits,growth,Obj
it,continue,combinationTherapyForPatientsWithAdvancedRecurrentBreastCancer,Obj
salpingo-oophorectomy,mayImpact,evenCanTreated,Obj
upregulatedExpression,regulates,severalAspectsOfPhenotype,Obj
Comparison,showed,differences,Obj
optimalPatientSelection,isCrucialGiven,effectsOfTherapy,Obj
anticancerActivities,antioxidantAgainst,humanCellLines,Obj
cytokines,associatingWith,clinicalOutcomes,Obj
cells,grew,showInvasiveness,Obj
objective,investigate,antioxidantScavengingAgainstHumanBreast-cancerCellLines,Obj
We,performed,2×2Mixed,Obj
patients,received,level0Doses,Obj
it,may,mayManaged,Obj
purpose,develop,realistic4dBreastPhantomIncludingContrastEnhancementForSimulationOfDedicatedBreastCtPerfusionImaging,Obj
acTreatment,downregulating,markerProteinsLikeN-cadherin,Obj
studyPopulation,isFor,females,Obj
4dArray,finallyIsProduced,continuousCurves,Obj
AC,demonstratedBy,upregulationOfE-cadherinExpressionInBiopsiedLungTissue,Obj
work,shows,impactOfIntratumorHeterogeneityInMolecularDiagnosticsForTreatmentSelection,Obj
breastIrradiation,using,interstitialHigh-dose-rateBrachytherapy,Obj
64-year-oldWoman'sHeadache,wasFound,resultFromDiffuseAdenocarcinomaMetastasis,Obj
exclusionCriteria,consistOf,breastTherapy,Obj
study,investigate,roleOfIrAntagonistS961,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination,Obj
cyclin-dependentKinases,beenIdentifiedAs,keyDriversOfProliferation,Obj
purpose,develop,patient-based4dBreastPhantomIncludingTime-varyingContrastEnhancementForSimulation,Obj
plasmaEsr1MutationCarriers,had,significantlyWorsePfs,Obj
TNBC,differentResponsesTo,therapy,Obj
activities,excellentAntioxidantAgainst,humanCellLines,Obj
We,searched,Embase,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHumanGrowthFactorReceptor2-negativeBreastCancer,Obj
breastCancer,isSecond-leadingCauseOf,centralSystemMetastasesAmongMalignancies,Obj
risk-reducingMastectomy,is,well-accepted,Obj
outcomes,wereAssessedAs,excellent/good,Obj
we,treatmentWith,AC,Obj
AC,demonstratedBy,upregulationOfE-cadherinExpressionInLungTissue,Obj
phantom,can,canUsedForOptimizationOfImageAcquisition,Obj
extranuclearActivity,isRelatedTo,therapyResistance,Obj
TNBC,probablyDifferentResponsesTo,therapy,Obj
naringeninTreatmentGroup,expressionOf,ERα66,Obj
studies,haveImproved,careAllowing,Obj
recentStudies,haveImproved,supportiveCareAllowing,Obj
Prognosis,isVeryPoorFor,marrowMetastasis,Obj
2MutationCarriers,follow,intensiveSurveillancePrograms,Obj
intraoperativeFindings,showed,87Percecnt,Obj
stratification,isCrucialFor,developmentOfPotentTherapies,Obj
women'sGoals,mayProvideInsightIn,context,Obj
preoperativeClinicalMeasurements,canEnhance,prediction,Obj
enhancedUnderstanding,couldOptimizePatientSelectionIn,setting,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentInCombination,Obj
Meta-analysis,was,conducted,Obj
we,haveRecentlyTested,peptidesDerivedAsVaccineDeliveryModalitiesForTreatment,Obj
silencingLincrna-ror,increase,sensitivityOfBcMad-mb-231CellsToTam,Obj
productivePrognosisDiscussions,be,canDeliveredByClinicalTeamWithinSemi-structuredPatientEducationAppointment,Obj
measurements,leadTo,lowRateOfComplicationsInImplant-basedBreastReconstruction,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfGrowthFactorReceptor2-negativeBreastCancerInCombination,Obj
we,explored,potentialMechanismsInvolvedInMitochondrialDysfunctionMediatedByEstrogenReceptorSubtypes,Obj
stratification,isThereforeCrucialFor,developmentOfPotentTherapies,Obj
CXCL1,bindsTo,sox4Promoter,Obj
measurements,thusLeadTo,lowRate,Obj
tissues,presented,expressionOfLincrna-ror,Obj
theirAverageAge,was,4226±856Years,Obj
anticancerActivities,scavengingAgainst,humanBreast-cancerCellLines,Obj
largeIntergenicNoncodingRna-regulator,regulating,pi3k/akt/mtorSignalingPathway,Obj
We,performed,searchOfData,Obj
potentActivity,isIn,in-vitroModels,Obj
conclusionsPalbociclib,is,viableTreatmentOption,Obj
treatment,canLoseDue,effectiveness,Obj
tumor-associatedMacrophages,have,haveImplicatedInPromotion,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanEpidermalGrowthFactorReceptor2-negativeBreastCancer,Obj
woman'sHeadache,resultFrom,diffuseAdenocarcinomaMetastasisInBoneMarrowFromUnknownPrimarySite,Obj
TNBC,has,6SubtypesWithDistinctMolecularSignaturesWithPrognoses,Obj
cellLines,wereAssociatedWith,poorPrognosis,Obj
We,performed,searchOfDataOnPalbociclibInPubmedInFdaWebsite,Obj
preoperativeMeasurements,thusLeadTo,rateOfComplicationsInImmediateBreastReconstruction,Obj
we,explored,clinicalImpactOfHeterogeneityOfErProteinExpression,Obj
tissues,presented,higherExpression,Obj
tumors,wereAssociatedWith,shorterSurvival,Obj
sustainedResponse,suspiciousPrimaryLesionWith,tamoxifenAlone,Obj
targetingBreastCscs,isParadigmFor,cancerPrevention,Obj
heterogeneousTumors,wereAssociatedWith,disease-freeSurvival,Obj
activity,was,investigated,Obj
intervention,mightReduce,lateRecurrencesInPatients,Obj
anthracycline-basedAdjuvantTherapies,isIn,humanEpidermalGrowthFactorReceptor2,Obj
level1Group,ofPatientIs,grade3OralMucositis,Obj
bisphosphonateTreatment,reducing,riskOfBoneMetastases,Obj
stratification,isCrucialFor,developmentOfStandardizedTherapies,Obj
geo2rTool,was,used,Obj
tamoxifenResistance,noncodingRna-regulatorOf,reprogramming,Obj
cells,grew,showHighInvasiveness,Obj
cancer,is,treatable,Obj
pi3k/akt/mtorPathway,isKnown,importantGrowthPathwayInHrPositiveBreastCancer,Obj
pooledAnalysis,using,2231MrnaProfilesOfPatientsWithEr-positive/humanGrowthFactorReceptor2-negativeBreastCancer,Obj
limitedInformation,isAvailableOn,agentForTreatmentOfOsteoporosis,Obj
we,investigated,combinatorialEffectsOnErCancer,Obj
It,wasPerceivedBy,patientsWithBreastCancer,Obj
We,thereforeSummarized,knowledgeOfLateRecurrenceBiology,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanEpidermalGrowthFactorReceptorAdvancedBreastCancerInCombination,Obj
interaction,was,analyzed,Obj
plasmaEsr1MutationAssessment,have,clinicalValue,Obj
heterogeneity,variedBetween,patientSamples,Obj
Prognosis,isGenerallyPoor,disease,Obj
co-treatment,simultaneouslyAlsoInduced,cellApoptosis,Obj
orthosiphonPallidus,excellentAntioxidantAgainst,cellLines,Obj
3dPhantom,segmentingAdiposeTissueFrom,patientIntoSkin,Obj
cosmeticOutcome,was,excellent,Obj
threeRepresentations,using,threeMetricsOfMortality,Obj
measurements,leadTo,lowRate,Obj
acceleratedBreastIrradiation,using,interstitialMulticatheterBrachytherapy,Obj
patterns,can,finallyCanSimulatedForTumorModels,Obj
use,was,inCox'sProportionalHazardsSurvivalModelAssociatedWithHazardRatio,Obj
cd44CancerStemCellMarker,isIn,ESCC,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanEpidermalGrowthFactorReceptor2-negativeBreastCancer,Obj
plasmaEsr1MutationCarriers,had,osHr,Obj
targetingBreastCscs,isWith,phytochemicals,Obj
selectiveEstrogenReceptorDegraders,haveLedIn,lineSettings,Obj
Agents,mightOf,mightEffectForPatientsLikeOurs,Obj
History,isAssociatedWith,likelihoodOfBoneMetastasesInWomen,Obj
tamoxifenResistance,largeNoncodingRna-regulatorOf,lincRNA-ROR,Obj
partialBreastIrradiation,using,interstitialFractionatedHigh-dose-rateBrachytherapy,Obj
letrozoleTherapy,is,treatmentOption,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHormoneReceptor-positiveGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination,Obj
isolatedCompound,Using,13c2-dimensionalResonance,Obj
we,haveTested,fewPeptidesDerivedFromHer2/neuProto-oncogeneAsVaccineDeliveryModalitiesForTreatmentOfTuboBreastCancerXenograftTumorsOfBalb/cMice,Obj
it,continue,combinationTherapyForPatientsWithAdvancedBreastCancer,Obj
studyPopulation,isFor,publishedFemalesWithBreastCancer,Obj
typical4dPhantom,hasDimensionsAs,example,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHormoneReceptor-positiveEpidermalGrowthFactorReceptorBreastCancer,Obj
tdo2Overexpression,wasCorrelatedWith,outcomeOfEsccPatients,Obj
clinicalMeasurements,thusLeadTo,lowRateOfComplicationsInImmediateBreastReconstruction,Obj
percentCytotoxicity,increaseSteadilyWith,opaeConcentration,Obj
purpose,develop,realistic4dDigitalBreastPhantomIncludingContrastEnhancementForSimulationOfBreastCtPerfusionImaging,Obj
we,explore,potentialTherapeuticTargets,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination,Obj
morphologicalChanges,noncytotoxicConcentrationsOf,20-60Μg/ml,Obj
higherExpression,wasAssociatedWith,highRecurrenceRiskBeyond5YearsAfterDiagnosis,Obj
mad-mb-231Cells,exhibited,lincrna-rorExpression,Obj
prognosisDiscussions,be,canDeliveredEffectivelyByTeam,Obj
managementChallenges,isIn,treatmentOfAdvancedHrPositiveHighlighting,Obj
function,investigate,potentialRelationshipBetweenDysfunction,Obj
breastLesionModel,wasDevelopedFor,creationOfCases,Obj
isolatedCompound,Using,ionizationMassSpectrometry,Obj
death,isIn,womenWorldwide,Obj
orthosiphonPallidus,antioxidantAgainst,humanCellLines,Obj
qpcrScreening,furtherValidated,SOX4,Obj
objective,investigate,anticancerActivitiesOfOPallidus,Obj
Display,is,consideredAsCancerVaccineDeliveryStrategy,Obj
objective,evaluate,timeToTreatmentFailureAsSecond-line,Obj
measurements,thusLeadTo,lowRateInImplant-basedImmediateBreastReconstruction,Obj
kyotoEncyclopedia,using,databaseForAnnotation,Obj
studyPopulation,included,womenWithEarlyBreastCancer,Obj
we,explored,expressionOfTdo2InEscc,Obj
severalParameters,are,prognosticForRecurrence,Obj
intervention,mightReduce,lateRecurrences,Obj
lowRate,isIn,implant-basedImmediateBreastReconstruction,Obj
diffuseAdenocarcinomaMetastasis,isIn,boneMarrow,Obj
predictiveBiomarkers,optimize,outcomeOfBreastCancerPatientsTreated,Obj
We,alsoPerformed,2×2Mixed,Obj
ourReview,willSearchFor,females,Obj
3dStaticPhantom,segmentingVasculatureFrom,patientIntoSkin,Obj
aim,assess,objectiveBreastCosmesisScale,Obj
threeRepresentations,using,threeDifferentMetrics,Obj
limitedInformation,isAvailableOn,oralAgentForTreatmentOfPost-menopausalOsteoporosis,Obj
insulinResistance,have,haveIntricatelyLinked,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfReceptor-positiveHumanEpidermalGrowthFactorReceptorAdvancedBreastCancer,Obj
514Women,isWith,breastCancer,Obj
dose,wasFoundIn,only1PatientOfLevel1Group,Obj
aim,examine,existingEvidenceOnPersonalGoal-settingAmongWomen,Obj
methods,reduce,deadSpace,Obj
t-patParticipants,were,likely,Obj
Patients,presenting,early-stageBreastCancer,Obj
we,haveTested,fewPeptidesDerived,Obj
largeIntergenicRna-regulator,affects,tamoxifenResistanceOfBcCells,Obj
We,generated,threeRepresentationsOfSeer-basedBreastCancerPatientCohorts,Obj
purpose,develop,patient-based4dBreastPhantomIncludingTime-varyingContrastEnhancementForSimulationOfBreastCtPerfusionImaging,Obj
partialBreastIrradiation,using,multicatheterBrachytherapy,Obj
cellLines,expressedClusterOf,differentiation,Obj
had,near-tetraploidKaryotypeWith,structuralAberrations,Obj
primaryObjective,evaluate,timeToTreatmentFailureOfPalbociclibInCombinationAsSecond-line,Obj
clinicopathologicalParameters,arePrognosticFor,recurrence,Obj
bp-treatedWomen,wereOlderThan,ones,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApproved,Obj
3dStaticPhantom,segmentingTissueFrom,patient,Obj
acTreatment,inhibitedEmtAt,time,Obj
EgKI-1,inhibitsGrowthIn,manner,Obj
anticancerActivities,excellentAntioxidantAgainst,breast-cancerCellLines,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveGrowthFactorReceptorAdvancedBreastCancer,Obj
theirCosmeticChanges,wereRecordedOn,nonstandardizedPhotographs,Obj
primaryObjective,evaluate,timeToTreatmentFailureOfPalbociclibAsSecond-lineOfTherapy,Obj
S961,alsoInhibited,cellularProliferationInBreastTumourCells,Obj
therapies,delay,termOverallSurvivalDataAreLacking,Obj
patients,isWith,er-positive/humanEpidermalGrowthFactorReceptor2-negativeBreastCancer,Obj
Agents,mightOf,mightTherapeuticEffectForPatientsLikeOurs,Obj
palbociclib,isIn,PubMed,Obj
neutropenia,was,common,Obj
subgroupAnalyses,were,performed,Obj
upregulatedExpression,regulates,aspectsOfMalignantPhenotype,Obj
Inhibition,reduced,size,Obj
We,performed,searchOfDataOnPalbociclibInPubmedInAscoProceedings,Obj
cyclin-dependentKinases,regulate,transitionFromG0/g1-phase,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanGrowthFactorReceptorAdvancedBreastCancerInCombination,Obj
dose,wasFoundIn,grade3Mucositis,Obj
we,usingImmunofluorescenceOn,tissueSectionsFollowedByComputationalApproach,Obj
S961,efficientlyBlocked,expression,Obj
measurements,leadTo,rateOfComplications,Obj
contributing,supportWith,breastCancer,Obj
qpcrScreening,validatedSox4Following,cxcl1Administration,Obj
limitedInformation,isAvailableOn,commonOralAgentForTreatmentOfOsteoporosis,Obj
64-year-oldWoman'sHeadache,resultFrom,diffuseAdenocarcinomaMetastasisFromPrimarySite,Obj
cytokines,associatingWith,poorClinicalOutcomes,Obj
targets,areRequiredFor,furtherInvestigation,Obj
objective,evaluate,timeToTreatmentFailureOfPalbociclibAsSecond-line,Obj
long-termIntervention,isIn,pathway,Obj
diseaseNature,be,estrogenReceptor-positive/humanGrowthFactorReceptorBreastCancer,Obj
productivePrognosisDiscussions,be,canDeliveredByPractice-basedTeamWithinSemi-structuredPatientEducationAppointment,Obj
limitedInformation,isAvailableOn,mostCommonAgentForTreatmentOfOsteoporosis,Obj
data,are,howeverScarce,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatment,Obj
intratumorHeterogeneity,play,role,Obj
phantom,can,canUsedDuringDevelopmentForOptimizationOfImageAcquisition,Obj
maximumResponse,occurredAfter,chemotherapyInjectionInTumorModel,Obj
cxcl1Silencing,resultsIn,reductionInBreastCancerGrowth,Obj
we,haveTested,peptidesDerivedFromHer2/neuProto-oncogeneAsVaccineDeliveryModalitiesForTreatmentOfTuboBreastCancerXenograftTumors,Obj
ongoingResearch,evaluating,potentialBiomarkers,Obj
we,haveTested,fewPeptidesDerivedFromHer2/neuProto-oncogeneAsVaccineDeliveryModalitiesForTreatmentOfTuboBreastCancerXenograftTumors,Obj
we,willDiscuss,managementChallengesInTreatment,Obj
search,isIn,fdaWebsite,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfEpidermalGrowthFactorReceptorAdvancedBreastCancer,Obj
e3-ubiquitinLigases,alsoFunctionAs,coactivators,Obj
measurements,leadTo,lowRateOfComplicationsInBreastReconstruction,Obj
pik3caMutations,earlyDynamicsOfBe,potentialPredictiveBiomarker,Obj
adjuvantBreastIrradiation,using,interstitialMulticatheterBrachytherapy,Obj
productivePrognosisDiscussions,be,canDeliveredByPractice-basedClinicalTeamWithinPatientEducationAppointment,Obj
It,understand,molecularPathways,Obj
64-year-oldWoman'sHeadache,resultFrom,adenocarcinomaMetastasisFromSite,Obj
EgKI-1,givingRiseTo,hydatidCyst,Obj
bilateralSalpingo-oophorectomy,mayImpact,evenCanTreated,Obj
ourReview,willSearchFor,femalesWithBreastCancer,Obj
p,=,0.05,Obj
purpose,develop,realistic4dBreastPhantom,Obj
outcome,is,numberConsistOfNumberOfPatientClinicVisits,Obj
invasionAbility,transitionIn,mouse,Obj
cyclin-dependentKinases,beenIdentifiedAs,keyDrivers,Obj
cohortStudy,was,conducted,Obj
TNBC,has,6SubtypesWithDistinctSignaturesWithDifferentPrognoses,Obj
patients,isWith,hrPositiveMetastaticBreastCancer,Obj
cosmeticOutcomes,review,associationWithBoost,Obj
retrospectiveStudy,included,womenWithHer2-positiveBcsTreated,Obj
expression,wasAssociatedWith,recurrenceRiskBeyond5Years,Obj
outcomes,review,associationWithBoost,Obj
egki-1Treatment,disrupting,cellCycle,Obj
We,performed,wechslerMemoryTest,Obj
S961,alsoInhibited,proliferationInBreastTumourCells,Obj
breastCancer,is,subtypeOfBreastCancerWithOutcome,Obj
TDO2,may,mayPotentialTarget,Obj
S961,efficientlyBlockedExpressionIn,evenPresenceOfInsulin,Obj
goal-setting,is,whereMajorComponent,Obj
purpose,develop,4dBreastPhantomIncludingContrastEnhancementForSimulation,Obj
sexualFunction,wasChangedIn,women,Obj
breastCancer,isCauseOf,centralSystemMetastases,Obj
work,shows,impactOfHeterogeneityInDiagnosticsForTreatmentSelection,Obj
purpose,develop,realistic4dBreastPhantomIncludingTime-varyingContrastEnhancementForSimulationOfBreastCtPerfusionImaging,Obj
patients,received,adjuvantAcceleratedBreastIrradiation,Obj
cells,showed,morphology,Obj
highCxcl1Expression,isCorrelatedWith,breastCancerLymphNodeMetastasis,Obj
phantom,can,canUsedDuringDevelopmentOfContrast-enhancedDedicatedBreastCtImaging,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveGrowthFactorReceptorAdvancedBreastCancer,Obj
we,usingHybridizationOn,tissueSectionsFollowedByComputationalApproach,Obj
estrogenReceptorDegraders,haveLedIn,firstLineSettings,Obj
tamoxifenResistance,largeRna-regulatorOf,lincRNA-ROR,Obj
advancements,displaySystemsAs,newModalitiesInCancerTherapeutics,Obj
agents,remains,unclear,Obj
study,included,womenWithBcsTreatedWithTrastuzumabFrom2008To2017,Obj
Overexpression,wasAssociatedWith,unfavorablePrognosisEspecially,Obj
mucin1,facilitates,motilityPotential,Obj
clinicalMeasurements,thusLeadTo,lowRateInImplant-basedImmediateBreastReconstruction,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHumanGrowthFactorReceptorAdvancedBreastCancer,Obj
Meta-analysis,calculateHazardRatiosWith,95PercecntCis,Obj
breastCancer,causeOf,cancer-relatedDeath,Obj
evaluate,possibleInfluenceOf,BT,Obj
We,searchedEmbaseFor,eligibleStudies,Obj
196Patients,isIn,groupAb,Obj
immediateBreastReconstruction,isWith,implants,Obj
massiveCircrnas,have,haveDiscoveredInTissues,Obj
We,searchedCochraneLibraryDatabasesFor,studies,Obj
brcaStatus,is,biomarker,Obj
intergenicRna-regulator,affects,tamoxifenResistance,Obj
receptorActivator,make,favorableBoneMarrowMicroenvironmentForTumorCells,Obj
data,remainsFor,strategy,Obj
largeNoncodingRna-regulator,affects,tamoxifenResistanceOfBcCells,Obj
tumors,wereAssociatedWith,disease-freeSurvival,Obj
itsPotentialApplications,merit,furtherInvestigation,Obj
studyPopulation,included,womenWithBreastCancer,Obj
anticancerActivities,antioxidantAgainst,cellLines,Obj
pi3k/akt/mtorPathway,isKnown,growthPathwayInHrPositiveBreastCancer,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHumanEpidermalGrowthFactorReceptorBreastCancer,Obj
breastCancer,causeOf,deathInWomen,Obj
findings,showed,90PercecntAccuracyForMriEvaluation,Obj
purpose,develop,patient-based4dBreastPhantomIncludingTime-varyingContrastEnhancementForSimulationOfDedicatedBreastCtPerfusionImaging,Obj
objective,investigate,antioxidantFree-radicalScavengingAgainstBreast-cancerCellLines,Obj
information,isAvailableOn,commonOralAgentForTreatment,Obj
intensiveImmunohistochemistryStudy,confirmed,diseaseNature,Obj
study,included,womenWithBcsTreatedFrom2008To2017,Obj
The,wasHigherIn,study2,Obj
limitedInformation,isAvailableOn,commonAgent,Obj
intratumorHeterogeneity,play,keyRole,Obj
acceleratedBreastIrradiation,using,fractionatedMulticatheterBrachytherapy,Obj
acceleratedPartialBreastIrradiation,using,multicatheterBrachytherapy,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinases,Obj
acceleratedPartialBreastIrradiation,using,interstitialHigh-dose-rateBrachytherapy,Obj
patientSelection,isCrucialGiven,sideEffects,Obj
we,explored,expressionInEscc,Obj
adjuvantAcceleratedBreastIrradiation,using,interstitialHigh-dose-rateBrachytherapy,Obj
woman'sHeadache,resultFrom,adenocarcinomaMetastasisInBoneMarrowFromUnknownSite,Obj
we,haveTested,fewPeptidesDerivedAsVaccineDeliveryModalitiesForTreatment,Obj
woman'sHeadache,resultFrom,diffuseAdenocarcinomaMetastasisFromSite,Obj
effect,disappearedAfter,treatmentCessation,Obj
phantom,canModel,breastTissuePerfusion,Obj
benefits,wereSeenWithout,toxicity,Obj
earlyDynamics,be,potentialBiomarker,Obj
we,usedIn,addition,Obj
analysis,using,2231MrnaProfiles,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfReceptor-positiveHumanEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination,Obj
periodicExaminations,areConsidered,usefulForEarlyDiagnosis,Obj
upregulatedExpression,regulates,severalAspectsOfMalignantPhenotypeIncludingCellProliferation,Obj
interactions,isWith,coregulators,Obj
3dStaticPhantom,segmenting,tissue,Obj
work,shows,impactInMolecularDiagnosticsForTreatmentSelectionInHer2CancerPatients,Obj
patientSelection,isCrucialGiven,sideEffectsOfEndocrineTherapy,Obj
tam-secretedCytokines,associatingWith,outcomes,Obj
expression,were,repressedByTam,Obj
limitedInformation,isAvailableOn,mostCommonAgentForTreatmentOfPost-menopausalOsteoporosis,Obj
anti-estrogenTherapy,isWith,selectiveEstrogenReceptorModulators,Obj
it,owingTo,degreeOfConcernAboutCancerRisk,Obj
cellLines,wereCharacterizedIn,termsOfHistology,Obj
multipleCytokines,associatingWith,poorOutcomes,Obj
3dStaticPhantom,segmenting,fibroglandularTissue,Obj
ourData,confirmed,resultsOfStudiesPublished,Obj
irMrnaExpressionLevels,were,downregulated,Obj
furtherPros,were,measured,Obj
Analysis,hasLedTo,developmentOfNewGenerationOfTargetedTherapies,Obj
tissues,were,collected,Obj
cellCycle,inducedApoptosisOf,cancerCells,Obj
breastCancerCells,showed,growth,Obj
limitedInformation,isAvailableOn,alendronate,Obj
clinicalMeasurements,canEnhance,prediction,Obj
partialBreastIrradiation,using,interstitialHigh-dose-rateBrachytherapy,Obj
erαPolyubiquitination,isInducedBy,estradiolHormone,Obj
The,wasSignificantlyHigherIn,study2,Obj
we,investigated,effectsOfTamoxifen,Obj
geo2rTool,screenOut,differentiallyExpressedGenes,Obj
erαPolyubiquitinationInhibition,may,thusMayKeyFactorInProgression,Obj
enhancedUnderstanding,couldOptimize,patientSelection,Obj
predictiveBiomarkers,optimize,outcomeOfHr-positiveBreastCancerPatientsTreatedWithPalbociclib,Obj
1,530Patients,isWith,Obj
AC,suppressed,breastCancerMetastasis,Obj
breastCancer,isSubtypeWith,poorOutcome,Obj
peptide,is,presentedByFusionsToPhageCoatProteins,Obj
clinicians,found,interventionEasy,Obj
objective,investigate,free-radicalScavengingAgainstHumanCellLines,Obj
time,upregulating,markerProteins,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanEpidermalGrowthFactorReceptorAdvancedBreastCancer,Obj
we,usingHybridizationOn,tissueSectionsFollowedByValidatedApproach,Obj
events,areResponsibleFor,increaseInErαProteinLevels,Obj
we,willDiscuss,managementChallengesInTreatmentOfAdvancedHrPositive,Obj
We,summarized,currentKnowledge,Obj
silencingLincrna-ror,increase,sensitivity,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHumanGrowthFactorReceptor2-negativeAdvancedBreastCancer,Obj
maximumResponse,occurredAt,8-12H,Obj
adjuvantPartialBreastIrradiation,using,multicatheterHigh-dose-rateBrachytherapy,Obj
3dPhantom,segmenting,tissue,Obj
basal/humanEpidermalGrowthFactorReceptor2-positiveBreastCancer,isResistantTo,herceptin,Obj
activities,antioxidantScavengingAgainst,humanBreast-cancerCellLines,Obj
Results,show,enhancementOfTissues,Obj
orthosiphonPallidus,has,activities,Obj
curves,are,calculated,Obj
massiveCircrnas,have,withDevelopmentHaveDiscoveredInTissues,Obj
isolatedCompound,Using,13cMagneticResonance,Obj
Two-thirds,wereSatisfiedWith,theirSexualRelations,Obj
Prognosis,isGenerallyPoorFor,marrowMetastasisFromTumors,Obj
severalAspects,upregulatedExpressionIn,breastCancerPathogenesis,Obj
e-cadherinExpression,isIn,biopsiedLungTissue,Obj
partialBreastIrradiation,using,interstitialFractionatedMulticatheterHigh-dose-rateBrachytherapy,Obj
breastIrradiation,using,interstitialFractionatedBrachytherapy,Obj
erαPolyubiquitinationInhibition,may,thusMayKeyFactor,Obj
percentCytotoxicity,increaseSteadilyWith,opaeConcentrationUpTo240G/ml,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHumanEpidermalGrowthFactorReceptorAdvancedBreastCancerInCombination,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHormoneReceptor-positiveEpidermalGrowthFactorReceptorBreastCancerInCombination,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancer,Obj
3dStaticPhantom,segmenting,adiposeTissue,Obj
we,explored,impactOfIntratumorHeterogeneityOfErProteinExpression,Obj
brcaStatus,is,onlyBiomarker,Obj
response,suspiciousPrimaryLesionWith,tamoxifenAlone,Obj
breastCancer,isSecond-leadingCauseOf,centralNervousSystemMetastasesAmongMalignancies,Obj
Patients,wereEnrolledIn,phaseIiTrial,Obj
prognosisDiscussions,be,canDeliveredByPractice-basedClinicalTeam,Obj
3dPhantom,is,created,Obj
inModel,showed,significantTumorGrowthReduction,Obj
it,wasDifficultIn,conclusion,Obj
phantom,can,canUsedDuringDevelopmentOfDedicatedBreastCtImaging,Obj
clinicalMeasurements,thusLeadTo,lowRateInBreastReconstruction,Obj
we,haveRecentlyTested,fewPeptidesDerivedAsVaccineDeliveryModalities,Obj
latestAdvancements,display,systems,Obj
we,investigated,anti-proliferativeEffects,Obj
patients,isWith,advancedRecurrentBreastCancer,Obj
purpose,develop,patient-based4dBreastPhantomIncludingContrastEnhancement,Obj
care,allowing,lessToxicity,Obj
prognosisDiscussions,be,canDeliveredByClinicalTeamWithinPatientEducationAppointment,Obj
boneLoss,isIn,breastCancerPatients,Obj
ovTherapy,isWith,immuneCheckpointInhibitors,Obj
we,haveRecentlyTested,fewPeptidesDerivedFromHer2/neuProto-oncogeneAsVaccineDeliveryModalitiesForTreatment,Obj
History,isAssociatedWith,lowerLikelihoodOfBoneMetastasesInWomen,Obj
e3-ubiquitinLigases,functionAs,coactivators,Obj
information,isAvailableOn,alendronateRegardingAssociation,Obj
purpose,develop,realisticPatient-based4dDigitalBreastPhantomIncludingContrastEnhancementForSimulationOfDedicatedBreastCtPerfusionImaging,Obj
assays,arePrognosticFor,recurrence,Obj
differentPatterns,can,canSimulatedForTumorModels,Obj
4dArray,finallyIsProduced,curvesAtSamplingRate,Obj
Prognosis,isGenerallyVeryPoorFor,marrowMetastasisFromSolidTumors,Obj
breastCancer,isCauseOf,systemMetastases,Obj
work,shows,impactOfHeterogeneityInDiagnostics,Obj
intraoperativeFindings,showed,accuracyForMriEvaluation,Obj
combinedTreatment,suppressing,transcriptionOfCellCycleRegulationProteins,Obj
co-exposure,inhibitedCellProliferationIn,manner,Obj
VMAT-SIB,was,safe,Obj
prognosisDiscussions,be,canDeliveredByTeamWithinSemi-structuredPatientEducationAppointment,Obj
dose,wasFoundIn,grade3OralMucositis,Obj
using,modelsSuchAs,1,Obj
woman'sHeadache,wasFound,resultFromDiffuseAdenocarcinomaMetastasisInBoneMarrowFromUnknownPrimarySite,Obj
understanding,couldOptimizePatientSelectionIn,setting,Obj
purpose,develop,realisticPatient-based4dDigitalBreastPhantomIncludingContrastEnhancement,Obj
naringenin,inhibit,cellGrowthOfMcf-7Cells,Obj
3dPhantom,segmentingTissueFrom,healthyPatient,Obj
we,explored,potentialMechanismsInvolvedInDysfunctionMediated,Obj
ongoingResearch,evaluating,mechanisms,Obj
work,shows,impactOfIntratumorHeterogeneityForTreatmentSelectionInHer2CancerPatients,Obj
severalClinicalTrials,are,ongoing,Obj
cases,wereGatheredBetween,june2016,Obj
we,haveTested,fewPeptidesDerivedFromHer2/neuProto-oncogeneAsVaccineDeliveryModalitiesForTreatment,Obj
assays,are,prognostic,Obj
We,summarized,knowledgeOfLateRecurrenceBiology,Obj
lincrna-rorExpression,were,detected,Obj
silencingLincrna-ror,suppressing,activation,Obj
Analysis,hasLedTo,developmentOfNewGenerationOfTargetedTherapiesForBreastCancer,Obj
long-termIntervention,mightReduce,recurrences,Obj
t-patParticipants,hold,realisticBeliefsAboutDiseaseCurability,Obj
we,furthermoreDiscovered,treatment,Obj
prognosisDiscussions,be,canDeliveredByPractice-basedTeamWithinSemi-structuredPatientEducationAppointment,Obj
primaryOutcome,isNumberOf,seromaAspirations,Obj
use,was,inCox'sProportionalHazardsSurvivalModelAssociatedWithHazardRatioOf004ForBoneMetastasis,Obj
theirCosmeticChanges,wereRecordedOn,photographs,Obj
examinations,are,considered,Obj
we,willDiscuss,managementChallengesInTreatmentOfHr,Obj
parameters,are,prognosticForRecurrence,Obj
pik3caMutations,earlyDynamicsOfBe,potentialBiomarkerForCdk4/6Inhibitors,Obj
activities,antioxidantAgainst,humanCellLines,Obj
threeBasal/her2,recapitulating,characteristicsOfParentTumor's,Obj
changes,noncytotoxicConcentrationsOf,20-60Μg/ml,Obj
furtherInvestigation,isIn,futureStudies,Obj
digitalPhantom,canModelBreastTissuePerfusionDuring,4dBreastCtImageAcquisition,Obj
adjuvantBreastIrradiation,using,interstitialHigh-dose-rateBrachytherapy,Obj
cxcl1Expression,isCorrelatedWith,breastCancerLymphNodeMetastasis,Obj
TDO2,play,role,Obj
function,investigate,potentialRelationshipBetweenSexualDysfunction,Obj
woman'sHeadache,wasFound,resultFromDiffuseAdenocarcinomaMetastasisFromSite,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveGrowthFactorReceptor2-negativeAdvancedBreastCancer,Obj
hypofractionatedVmat-sib,isIn,patients,Obj
limitedInformation,isAvailableOn,commonAgentForTreatment,Obj
brcaMutationalStatus,is,onlyBiomarker,Obj
rnaInterference,wasUsedTo,silenceLincrna-ror,Obj
p,=,0.009,Obj
erαPolyubiquitination,is,induced,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfReceptor-positiveHumanEpidermalGrowthFactorReceptor2-negativeBreastCancer,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination,Obj
treatment,wasFirstUsedIn,1984,Obj
work,shows,impactForTreatmentSelection,Obj
periodicExaminations,areConsideredBy,915Percecnt,Obj
biomarkers,optimize,clinicalOutcomeOfHr-positiveBreastCancerPatientsTreatedWithPalbociclib,Obj
tamoxifenResistance,intergenicNoncodingRna-regulatorOf,lincRNA-ROR,Obj
adjuvantAcceleratedBreastIrradiation,using,interstitialMulticatheterHigh-dose-rateBrachytherapy,Obj
formation,interactionsWith,coregulators,Obj
it,mainlyOwingTo,lowerDegreeOfConcernAboutCancerRisk,Obj
probability,evaluate,possibleInfluenceOnPatient-reportedOutcomes,Obj
History,isAssociatedWith,lowerLikelihoodOfBoneMetastasesInPostmenopausalWomenWithBreastCancer,Obj
data,remains,unclear,Obj
measurements,leadTo,rateInImmediateBreastReconstruction,Obj
anticancerActivities,scavengingAgainst,humanCellLines,Obj
use,was,inMultivariableCox'sProportionalHazardsSurvivalModelAssociatedWithHazardRatioOf004,Obj
acceleratedPartialBreastIrradiation,using,interstitialBrachytherapy,Obj
Expression,has,hasLinkedWithTumorSurvival,Obj
It,understand,pathwaysInvolved,Obj
TNBC,has,6SubtypesWithDistinctSignatures,Obj
acceleratedPartialBreastIrradiation,using,fractionatedBrachytherapy,Obj
4dArray,finallyIsProduced,curvesAtDesiredSamplingRate,Obj
patients,receivedVmat-sibTechniqueIn,15Fractions,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfGrowthFactorReceptor2-negativeAdvancedBreastCancer,Obj
cdk4/6InhibitorPalbociclib,has,hasApprovedForTreatmentOfHr-positive/her2-negativeBreastCancerPatients,Obj
5Years,isWith,5YearsOfTamoxifen,Obj
cestSignals,wereComparedTo,cell-deathHistopathologyOfTumors,Obj
biomarkers,optimize,clinicalOutcomeOfBreastCancerPatientsTreatedWithPalbociclib,Obj
retrospectiveStudy,included,womenWithHer2-positiveBcs,Obj
aim,compare,seromaFormationInMethods,Obj
cells,were,whenExposed,Obj
viruses,areUnder,laboratoryAsOncolyticTherapeutics,Obj
orthosiphonPallidusExtract,showed,potentActivityInIn-vitroModels,Obj
multipleCytokines,associatingWith,poorClinicalOutcomes,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveGrowthFactorReceptorBreastCancer,Obj
mammography,were,usedForAssessment,Obj
intraoperativeFindings,showed,71Percecnt,Obj
clinicalMeasurements,thusLeadTo,rateInImmediateBreastReconstruction,Obj
earlyDynamics,bePotentialPredictiveBiomarkerFor,cdk4/6Inhibitors,Obj
meningiomaRisks,isIn,relationToGhTreatment,Obj
we,summarize,knowledge,Obj
time,upregulating,markerProteinsLikeOccludin,Obj
breastCancer,isSubtypeWith,outcome,Obj
exponential,dependsOn,perfusionParameters,Obj
research,is,anticipated,Obj
heterogeneity,variedSubstantiallyBetween,patientSamples,Obj
objective,evaluate,timeToTreatmentFailureOfPalbociclibInCombinationAsSecond-lineOfTherapy,Obj
S961,blocked,expressionOfIrs,Obj
averageTime,sufferingFrom,cancer,Obj
3dPhantom,segmentingVasculatureFrom,healthyPatientIntoSkin,Obj
limitedInformation,isAvailableOn,agentForTreatmentOfPost-menopausalOsteoporosis,Obj
upregulatedExpression,regulates,aspectsOfMalignantPhenotypeIncludingCellProliferation,Obj
The,was,higher,Obj
preoperativeMeasurements,thusLeadTo,rate,Obj
bp-treatedWomen,wereOlderThan,bp-naïveOnes,Obj
formation,is,common,Obj
co-treatment,couldInhibit,cellProliferation,Obj
mad-mb-231Cells,showed,proliferation,Obj
changes,isIn,wms-rIndicesBetweenTwoStudies,Obj
purpose,develop,realistic4dDigitalBreastPhantomIncludingTime-varyingContrastEnhancementForSimulation,Obj
4dArray,isProduced,continuousCurvesAtSamplingRate,Obj
evaluation,using,methods,Obj
Patients,will,willAllocated,Obj
expression,isIn,breastCancerPatients,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanEpidermalGrowthFactorReceptorBreastCancer,Obj
breastIrradiation,using,interstitialMulticatheterBrachytherapy,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfReceptor-positiveGrowthFactorReceptorAdvancedBreastCancerInCombination,Obj
therapy,mightBecome,novelStrategyForBreastCancerMetastasisPrevention,Obj
tumorModels,alsoPresent,higherEnhancement,Obj
extranuclearActivity,is,related,Obj
circRNAs,have,haveDiscovered,Obj
coefficient,rangedFrom,12Percecnt,Obj
partialBreastIrradiation,using,high-dose-rateBrachytherapy,Obj
objective,investigate,free-radicalScavengingAgainstCellLines,Obj
mechanisms,underlying,decline,Obj
History,isAssociatedWith,likelihood,Obj
bcTissues,presented,higherExpression,Obj
seromaFormation,isAssociatedWith,woundHealing,Obj
japanesePatients,isWith,metastaticBreastCancer,Obj
4dArray,isProduced,time-enhancementCurves,Obj
we,hereDiscussIn,paper,Obj
end,atG1Is,g2In97Percecnt,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveHumanEpidermalGrowthFactorReceptor2-negativeBreastCancerInCombination,Obj
otherPatients,received,level1Doses,Obj
purpose,develop,4dDigitalBreastPhantomIncludingContrastEnhancementForSimulationOfDedicatedBreastCtPerfusionImaging,Obj
breastCancer,remains,leadingCauseOfDeathInWomenWorldwide,Obj
anticancerActivities,scavengingAgainst,cellLines,Obj
pooledAnalysis,using,2231MrnaProfilesOfPatients,Obj
we,haveTested,peptidesDerivedFromHer2/neuProto-oncogene,Obj
prognosisDiscussions,be,canDeliveredEffectivelyByClinicalTeamWithinPatientEducationAppointment,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveEpidermalGrowthFactorReceptor2-negativeBreastCancerInCombination,Obj
it,continue,combinationTherapyForPatientsWithBreastCancerDue,Obj
objective,investigate,antioxidantScavengingAgainstCellLines,Obj
macrophages,have,haveImplicatedInPromotion,Obj
anticancerActivities,excellentAntioxidantAgainst,humanBreast-cancerCellLines,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveGrowthFactorReceptor2-negativeBreastCancer,Obj
we,haveTested,peptidesDerived,Obj
adjuvantPartialBreastIrradiation,using,fractionatedMulticatheterBrachytherapy,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanEpidermalGrowthFactorReceptorAdvancedBreastCancer,Obj
tumors,wereAssociatedWith,significantlyShorterDisease-freeSurvival,Obj
nineteenFemalePatients,were,enrolled,Obj
triple-negativeBreastCancer,is,subtype,Obj
This,is,multicenter,Obj
postmenopausalWomen,isWith,earlyBreastCancer,Obj
preoperativeMeasurements,leadTo,lowRateInImplant-basedBreastReconstruction,Obj
effect,Incorporating,personalGoal-setting,Obj
exclusionCriteria,consistOf,breastConservingTherapy,Obj
systems,latestAdvancementsIn,applicationsOfOvs,Obj
participants,averageAgeOfWas,4634±828Years,Obj
showing,highExpressionOf,genes,Obj
objective,investigate,antioxidantFree-radicalScavenging,Obj
model,showed,significantTumorGrowthReduction,Obj
therapy,is,viable,Obj
expression,regulates,aspects,Obj
activity,is,related,Obj
3-o-p-coumaroyltormenticAcid,reduced,proteinLevels,Obj
peptide,is,inPhageDisplayImmunotherapyPresented,Obj
4dPhantom,has,dimensionsOf,Obj
studies,haveImproved,supportiveCareAllowing,Obj
We,predicting,recurrence,Obj
woman'sHeadache,resultFrom,adenocarcinomaMetastasis,Obj
we,willDiscuss,managementChallenges,Obj
work,shows,impactOfIntratumorHeterogeneityInMolecularDiagnostics,Obj
effect,isIn,doubleBlindRandomizedControlledTrial,Obj
primaryOutcome,is,numberOfSeromaAspirationsConsistOfNumberOfPatientClinicVisits,Obj
64-year-oldWoman'sHeadache,resultFrom,diffuseAdenocarcinomaMetastasisInBoneMarrowFromPrimarySite,Obj
naringenin,inhibit,cellGrowthAtHigherConcentrations,Obj
oralBisphosphonateTreatment,could,couldSufficient,Obj
chemotherapy,isAdjuvantTreatmentFor,tnbcPatients,Obj
compound,Using,electrosprayIonizationMassSpectrometry,Obj
characteristics,can,canModified,Obj
sexualDysfunctions,were,due,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveHumanGrowthFactorReceptorAdvancedBreastCancer,Obj
therapeuticTargets,howeverAreRequiredFor,furtherInvestigation,Obj
TDO2,playRoleIn,progression,Obj
aim,examine,evidenceOnGoal-settingAmongWomen,Obj
threeNovelBasal/her2,recapitulating,characteristicsOfParentTumor's,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination,Obj
suspiciousPrimaryLesion,isIn,rightBreasttreatment,Obj
purpose,develop,realisticPatient-based4dDigitalBreastPhantomIncludingContrastEnhancementForSimulation,Obj
clinicalMeasurements,thusLeadTo,lowRateOfComplications,Obj
EgKI-1,givingRiseTo,cyst,Obj
purpose,develop,realistic4dDigitalBreastPhantomIncludingTime-varyingContrastEnhancementForSimulationOfDedicatedBreastCtPerfusionImaging,Obj
acTreatment,downregulating,mesenchymalMarkerProteins,Obj
expression,isIn,those,Obj
outcomes,were,assessed,Obj
objective,evaluate,timeToTreatmentFailureOfPalbociclibInCombinationWithLetrozoleAsSecond-lineOfTherapy,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfReceptor-positiveHumanGrowthFactorReceptor2-negativeAdvancedBreastCancer,Obj
formation,isWith,ERα,Obj
plasmaEsr1MutationCarriers,had,PFS,Obj
EgKI-1,inhibitsMigrationIn,dose-dependentManner,Obj
predictiveRole,prognosticSignificanceOf,plasmaEsr1Mutations,Obj
had,near-tetraploidOrAneuploidKaryotypeWith,structuralAberrations,Obj
acceleratedBreastIrradiation,using,fractionatedBrachytherapy,Obj
targets,are,required,Obj
pik3caMutations,dynamicsOfBe,potentialPredictiveBiomarkerForCdk4/6Inhibitors,Obj
we,analyzed,threeMicroarrayDatasets,Obj
largeIntergenicRna-regulator,affects,tamoxifenResistance,Obj
nature,be,2-negative,Obj
lateRecurrences,are,ER-driven,Obj
erαPolyubiquitinationInhibition,may,mayFactorInProgressionOfBreastCancer,Obj
intraoperativeFindings,showed,90PercecntAccuracy,Obj
subgroupAnalyses,were,alsoPerformed,Obj
64-year-oldWoman'sHeadache,wasFound,resultFromAdenocarcinomaMetastasis,Obj
stratification,is,crucial,Obj
preoperativeMeasurements,thusLeadTo,rateOfComplications,Obj
percecnt,wouldChoose,it,Obj
treatmentRegimens,improve,outcomes,Obj
patients,isWith,hormoneReceptorPositive,Obj
breastCancer,is,cause,Obj
it,continue,combinationTherapyForPatientsWithRecurrentBreastCancerDueToToxicities,Obj
preoperativeMeasurements,thusLeadTo,lowRateInBreastReconstruction,Obj
we,usingImmunofluorescenceOn,tissueSectionsFollowed,Obj
advancements,displaySystemsAs,modalities,Obj
cxcl1Silencing,isIn,TAMs,Obj
mainProblems,included,dysfunctionalExcitement,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHormoneReceptor-positiveEpidermalGrowthFactorReceptorAdvancedBreastCancer,Obj
measurements,leadTo,rateInImplant-basedBreastReconstruction,Obj
estrogenReceptorPatients,areCommonOf,cases,Obj
time,was,forPrimaryOutcome63Months,Obj
patients,were,divided,Obj
TNBC,has,6SubtypesWithMolecularSignaturesWithPrognoses,Obj
objective,investigate,scavengingAgainstCellLines,Obj
study,investigate,role,Obj
activities,antioxidantFree-radicalScavengingAgainst,cellLines,Obj
it,continue,combinationTherapyForPatientsWithRecurrentBreastCancerDue,Obj
we,usingHybridizationOn,tissueSectionsFollowed,Obj
patterns,can,canSimulatedForTumorModels,Obj
effects,feasibilityOf,prognosisDiscussion,Obj
Prognosis,isVeryPoor,treatableDisease,Obj
productivePrognosisDiscussions,be,canDeliveredByTeamWithinPatientEducationAppointment,Obj
phageConstructFormulation,actsAs,vaccineAgainstCancer,Obj
tissues,were,collectedFrom152BcPatients,Obj
breastCancer,isCauseOf,nervousSystemMetastases,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfReceptor-positiveHumanGrowthFactorReceptorBreastCancerInCombination,Obj
model,showed,tumorGrowthReductionInEgki-1-treatedMice,Obj
predictiveRole,significanceOf,plasmaEsr1MutationsInMbcPatients,Obj
patterns,can,finallyCanAlsoSimulated,Obj
it,continue,combinationTherapyDue,Obj
aspects,expressionOf,IRs,Obj
bp-treatedWomen,wereSignificantlyOlderThan,ones,Obj
dysfunctions,were,due,Obj
cells,grew,tumorigenicity,Obj
we,haveRecentlyTested,peptidesDerivedFromHer2/neuProto-oncogene,Obj
Patients,wereFollowed-upFor,2Years,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentInCombinationWithFulvestrantInPostmenopausalWomenWithDiseaseProgression,Obj
bilateralSalpingo-oophorectomy,mayImpact,evenCanTreatedWithHormonalReplacementTherapies,Obj
photograph,record,changesInBreastCosmesis,Obj
activity,using,differentModels,Obj
adjuvantAcceleratedPartialBreastIrradiation,using,fractionatedBrachytherapy,Obj
aldehydeDehydrogenase,expressing,expressionOfGenes,Obj
p,=Respectively,0.05,Obj
role,prognosticSignificanceOf,plasmaEsr1Mutations,Obj
AC,decreasedLungMetastasis,demonstratedByUpregulationOfE-cadherinExpressionInLungTissue,Obj
role,significanceOf,plasmaEsr1MutationsInMbcPatientsWithExposure,Obj
P,=,0.01,Obj
activities,were,determined,Obj
aspects,expressionIn,breastCancerPathogenesis,Obj
3dPhantom,is,firstCreated,Obj
multipleTam-secretedCytokines,have,haveIdentified,Obj
cosmeticOutcomes,were,assessed,Obj
medianTime,was,63Months,Obj
letrozoleTherapy,is,effectiveTreatmentOption,Obj
breastCancer,remainsDespite,yearsOfIntensiveResearch,Obj
We,searched,cochraneLibraryDatabases,Obj
post-menopausalWomen,isWith,earlyBreastCancer,Obj
measurements,thusLeadTo,rateOfComplicationsInImplant-basedBreastReconstruction,Obj
preoperativeMeasurements,leadTo,lowRateOfComplicationsInImplant-basedBreastReconstruction,Obj
64-year-oldWoman'sHeadache,was,found,Obj
viruses,areUnder,presentlyLaboratoryAsTherapeutics,Obj
we,selectedMcf-7In,study,Obj
Knockdown,alsoInduced,inactivation,Obj
Interleukin-1,drives,breastCancerCellGrowthInBoneMarrowAdiposeTissueNiche,Obj
phantom,can,canUsedDuringDevelopmentOfDynamicDedicatedBreastCtImagingForOptimization,Obj
aim,identify,evaluationMethodsForQuality,Obj
purpose,develop,realisticPatient-based4dBreastPhantomIncludingTime-varyingContrastEnhancement,Obj
association,using,pearson'sCorrelationCoefficient,Obj
studyPopulation,isFor,publishedFemales,Obj
3dStaticPhantom,segmentingAdiposeTissueFrom,healthyPatient,Obj
use,wasAssociatedIn,cox'sHazardsSurvivalModel,Obj
EgKI-1,showsPromiseAs,anti-cancerTherapeutic,Obj
purpose,develop,4dDigitalBreastPhantomIncludingContrastEnhancement,Obj
prognosisDiscussions,be,canDeliveredEffectivelyByTeamWithinPatientEducationAppointment,Obj
woman'sHeadache,resultFrom,diffuseAdenocarcinomaMetastasis,Obj
expression,regulates,severalAspectsOfMalignantPhenotypeIncludingCellProliferation,Obj
skinToxicities,were,recorded,Obj
photographs,measuring,distancesBetweenFeatures,Obj
3dPhantom,segmentingBreastCtImageFrom,patient,Obj
prognosisDiscussions,be,canDeliveredByTeamWithinPatientEducationAppointment,Obj
intervention,mightReduce,recurrencesInPatients,Obj
seromaFormation,isCommonComplicationAfter,mastectomy,Obj
breastCancer,isSecond-leadingCauseOf,centralSystemMetastases,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfReceptor-positiveEpidermalGrowthFactorReceptorBreastCancerInCombination,Obj
clinicalMeasurements,leadTo,lowRateOfComplicationsInBreastReconstruction,Obj
HR,remainedAfter,furtherAdjustment,Obj
plasmaEsr1MutationAssessment,guiding,endocrineTherapyChoice,Obj
personalGoal-setting,is,majorComponent,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHumanGrowthFactorReceptorAdvancedBreastCancerInCombination,Obj
geneSet,rankedAccordingTo,theirAssociationWithEarlyRecurrenceRisk,Obj
activity,using,models,Obj
pik3caMutations,dynamicsOfBe,potentialPredictiveBiomarker,Obj
expression,were,repressedAfterSilencingLincrna-ror,Obj
We,performed,searchOfDataInAscoProceedings,Obj
circRNAs,have,withDevelopmentOfSequencingHaveDiscovered,Obj
Prognosis,isPoorFor,marrowMetastasisFromTumors,Obj
aim,compare,seromaFormationInVariousMethodsOfFlapFixation,Obj
theirTumorigenicPotential,wasEvaluatedIn,nudeMouseXenograftModel,Obj
measurements,leadTo,lowRateInImplant-basedBreastReconstruction,Obj
primaryObjective,evaluate,timeToTreatmentFailureAsSecond-lineOfTherapy,Obj
purpose,develop,realisticPatient-based4dDigitalBreastPhantomIncludingTime-varyingContrastEnhancementForSimulationOfDedicatedBreastCtPerfusionImaging,Obj
preoperativeMeasurements,thusLeadTo,rateInBreastReconstruction,Obj
use,was,inMultivariableCox'sHazardsSurvivalModelAssociatedWithHazardRatioOf004,Obj
orthosiphonPallidus,has,antioxidantAgainstHumanCellLines,Obj
EgKI-1,inhibits,migration,Obj
triple-negativeBreastCancer,is,subtypeOfBreastCancerWithOutcome,Obj
theDelayed,was,significantlyHigher,Obj
advancements,display,systems,Obj
extendedTherapy,canReduce,recurrencesOccurring,Obj
we,haveRecentlyTested,peptidesDerivedFromHer2/neuProto-oncogeneAsVaccineDeliveryModalities,Obj
we,explore,potentialTargets,Obj
EgKI-1,isHighlyExpressedBy,oncosphere,Obj
work,shows,impactForTreatmentSelectionInHer2CancerPatients,Obj
we,haveTested,peptidesDerivedFromHer2/neuProto-oncogeneAsVaccineDeliveryModalitiesForTreatment,Obj
lateRecurrenceRisk,Extending,5YearsOfTamoxifenTherapy,Obj
predictiveBiomarkers,optimize,outcome,Obj
plasmaEsr1MutationAssessment,have,value,Obj
orthosiphonPallidus,has,excellentAntioxidantAgainstCellLines,Obj
treatment,markedlySuppressed,cellMigration,Obj
compound,Using,ionizationMassSpectrometry,Obj
association,regardingAlendronateIs,mostCommonOralAgentForTreatmentOfPost-menopausalOsteoporosis,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveHumanEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination,Obj
Analysis,hasLedTo,developmentOfNewGenerationOfTherapies,Obj
breastIrradiation,using,fractionatedMulticatheterBrachytherapy,Obj
woman'sHeadache,wasFound,resultFromAdenocarcinomaMetastasisFromSite,Obj
severalParameters,are,prognosticForLateRecurrence,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfReceptor-positiveGrowthFactorReceptor2-negativeBreastCancer,Obj
tdo2Function,wereEvaluatedBy,rnaInterference,Obj
Results,show,enhancementOfTissuesConsistentWithInputParameters,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHumanGrowthFactorReceptor2-negativeAdvancedBreastCancer,Obj
onePhotograph,record,changesInBreastCosmesis,Obj
personalGoal-setting,isMajorComponentOf,study,Obj
peptide,is,presented,Obj
outcome,is,numberOfSeromaAspirationsConsistOfNumber,Obj
study,investigate,roleOnIrSignalling,Obj
peptide,is,inPhageDisplayImmunotherapyPresentedByFusionsToPhageCoatProteins,Obj
cohortStudy,wasConductedAt,oncologyDivision,Obj
sameTime,upregulating,markerProteinsLikeOccludin,Obj
EgKI-1,inhibitsMigrationIn,manner,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfReceptor-positiveHumanGrowthFactorReceptorBreastCancer,Obj
concentrations,reversed,fibroblastic-to-epithelialPhenotype,Obj
historicalCohortStudy,wasConductedAt,oncologyDivision,Obj
immediateVerbalMemoryIndex,was,significantlyHigher,Obj
cellCycle,treatmentOf,tamoxifen,Obj
mtorInhibitorEverolimus,significantlyImproves,progressionFreeSurvival,Obj
TNBC,responsesTo,therapy,Obj
cells,were,whenExposedToSingleTamoxifen,Obj
work,shows,impactOfIntratumorHeterogeneityInDiagnostics,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveHumanEpidermalGrowthFactorReceptor2-negativeBreastCancer,Obj
purpose,develop,realisticPatient-based4dBreastPhantomIncludingTime-varyingContrastEnhancementForSimulationOfBreastCtPerfusionImaging,Obj
maximumResponse,occurredAfter,chemotherapyInjectionInInTumorModel,Obj
clinicopathologicalParameters,are,prognosticForLateRecurrence,Obj
4dArray,finallyIsProduced,continuousTime-enhancementCurvesAtDesiredSamplingRate,Obj
breastCancer,leadingCauseOf,deathInWomen,Obj
time,was,405±523Years,Obj
mad-mb-231Cells,sensitivityTo,TAM,Obj
pi3k/akt/mtorPathway,be,growthPathway,Obj
combination,isWith,endocrineTherapy,Obj
64-year-oldWoman'sHeadache,wasFound,resultFromAdenocarcinomaMetastasisFromUnknownSite,Obj
64-year-oldWoman'sHeadache,resultFrom,diffuseAdenocarcinomaMetastasisFromUnknownPrimarySite,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHormoneReceptor-positiveGrowthFactorReceptor2-negativeAdvancedBreastCancer,Obj
it,continue,combinationTherapyForPatientsDue,Obj
clinicalMeasurements,leadTo,rateInBreastReconstruction,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancer,Obj
long-termIntervention,mightReduce,recurrencesInPatients,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfReceptor-positiveGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination,Obj
clinicopathologicalParameters,are,prognosticForRecurrence,Obj
femalePatients,were,enrolled,Obj
it,may,mayManagedWithDoseReduction,Obj
clinicalMeasurements,thusLeadTo,rateOfComplicationsInImmediateBreastReconstruction,Obj
bilateralSalpingo-oophorectomy,mayImpact,evenCanTreatedWithReplacementTherapies,Obj
heterogeneousTumors,wereAssociatedWith,shorterDisease-freeSurvival,Obj
Prognosis,isVeryPoorFor,marrowMetastasisFromTumors,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentInCombinationWithFulvestrantInWomen,Obj
EgKI-1,givingRiseTo,cystLocalizedToLiver,Obj
productivePrognosisDiscussions,be,canDeliveredByTeam,Obj
therapies,delay,longTermSurvivalDataAreLacking,Obj
we,investigated,anti-proliferativeEffectsOfTamoxifenOnErCancer,Obj
descriptiveInformation,will,willReported,Obj
productivePrognosisDiscussions,be,canDeliveredByTeamWithinSemi-structuredPatientEducationAppointment,Obj
2MutationCarriers,areOffered,surgery,Obj
higherExpression,wasAssociatedWith,recurrenceRiskBeyond5Years,Obj
measurements,thusLeadTo,rateInBreastReconstruction,Obj
e3-ubiquitinLigases,functionAs,coactivatorsForErα,Obj
pi3kInhibitors,have,haveDisappointingDue,Obj
information,isAvailableOn,oralAgentForTreatmentOfPost-menopausalOsteoporosis,Obj
purpose,develop,patient-based4dBreastPhantomIncludingContrastEnhancementForSimulationOfBreastCtPerfusionImaging,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfReceptor-positiveEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancer,Obj
theirTumorigenicPotential,wasEvaluatedIn,mouseXenograftModel,Obj
We,generated,threeRepresentations,Obj
biomarkers,optimize,outcomeOfBreastCancerPatientsTreatedWithPalbociclib,Obj
purpose,develop,realistic4dDigitalBreastPhantomIncludingContrastEnhancementForSimulationOfDedicatedBreastCtPerfusionImaging,Obj
findings,showed,71Percecnt,Obj
64-year-oldWoman'sHeadache,wasFound,resultFromDiffuseAdenocarcinomaMetastasisFromUnknownSite,Obj
breastCancerXenografts,were,scannedChemotherapy,Obj
insulinResistance,have,haveLinkedToPathogenesisOfBreastCarcinoma,Obj
we,willDiscussManagementChallengesIn,review,Obj
recurrenceRisk,Extending,5Years,Obj
ongoingResearch,evaluating,potentialBiomarkersOfResistance,Obj
circRNAs,have,withDevelopmentHaveDiscoveredInTumorousTissues,Obj
silencingLincrna-ror,sensitivityTo,TAM,Obj
information,isAvailableOn,oralAgent,Obj
OBCS,is,easy,Obj
we,haveTested,fewPeptidesDerivedAsVaccineDeliveryModalities,Obj
compound,reduces,ALDH,Obj
it,continue,combinationTherapyForPatientsWithRecurrentBreastCancerDueToHematologicalToxicities,Obj
cyclin-dependentKinases,regulate,transitionToS-phase,Obj
risk-reducingMastectomy,is,usuallyWell-accepted,Obj
64-year-oldWoman'sHeadache,wasFound,resultFromAdenocarcinomaMetastasisInBoneMarrowFromPrimarySite,Obj
camphorata,exhibits,potential,Obj
modality,couldProvide,informationOfBreast,Obj
periodicExaminations,areConsidered,useful,Obj
correspondingCurves,defining,perfusionParametersForTissue,Obj
4dArray,finallyIsProducedCurvesBy,sampling,Obj
we,evaluate,value,Obj
pik3caMutations,dynamicsOfBe,potentialBiomarker,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentInCombinationWithFulvestrantInWomenWithDiseaseProgressionFollowingEndocrineTherapy,Obj
CXCL1,transitionIn,mouse,Obj
time,upregulating,epithelialMarkerProteins,Obj
4dArray,isProduced,continuousCurves,Obj
Patients,will,willRandomlyAllocatedToOneOfThreeTreatmentArms,Obj
personalGoal-setting,isComponentOf,study,Obj
S961,blockedExpressionIn,evenPresenceOfInsulin,Obj
G1,isIn,511PercecntOfPatients,Obj
acceleratedBreastIrradiation,using,interstitialBrachytherapy,Obj
it,owingTo,lowerDegreeOfConcern,Obj
cxcl1-basedTherapy,mightBecome,strategy,Obj
t-patClinicians,found,interventionEasy,Obj
expression,regulates,aspectsIncludingCellProliferation,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveGrowthFactorReceptor2-negativeAdvancedBreastCancer,Obj
preparations,using,aroniaExtracts,Obj
aim,examine,existingEvidence,Obj
co-treatment,simultaneouslyInduced,cellApoptosis,Obj
mad-mb-231Cells,showedProliferationAfter,lincrna-rorSilencing,Obj
noncodingRna-regulator,regulating,pi3k/akt/mtorSignalingPathway,Obj
sources,supplying,breast,Obj
predictiveRole,significanceOf,plasmaEsr1MutationsInMbcPatientsWithExposureToAiTherapy,Obj
information,isAvailableOn,oralAgentForTreatmentOfOsteoporosis,Obj
Tamoxifen,were,shown,Obj
quilting,applicationOf,tissueGlues,Obj
preciseStratification,isThereforeCrucialFor,developmentOfPotentStandardizedTherapies,Obj
severalClinicopathologicalParameters,arePrognosticFor,recurrence,Obj
tnbcPatients,responseComparedTo,breastCancerSubtypes,Obj
tumors,wereAssociatedWith,shorterDisease-freeSurvival,Obj
This,was,single-center,Obj
primaryObjective,evaluate,timeToTreatmentFailureOfPalbociclib,Obj
investigated,combinatorialAnti-proliferativeEffectsOn,erCancer,Obj
phantom,can,canUsedDuringDevelopmentOfContrast-enhancedBreastCtImagingForOptimizationOfImageAcquisition,Obj
anonymousQuestionnaire,was,administered,Obj
Prognosis,is,generallyVeryPoor,Obj
CXCL1,epithelial-mesenchymalTransitionIn,mouse,Obj
care,allowing,toxicity,Obj
cytokines,associatingWith,poorOutcomes,Obj
measurements,leadTo,rateOfComplicationsInBreastReconstruction,Obj
breastCancer,is,subtypeOfBreastCancerWithPoorClinicalOutcome,Obj
supportiveCare,allowing,toxicity,Obj
sexualDysfunctions,wereDueTo,penetrationPain,Obj
purpose,develop,4dBreastPhantomIncludingContrastEnhancementForSimulationOfBreastCtPerfusionImaging,Obj
It,wasPerceivedBy,patientsWithAdvancedBreastCancer,Obj
patients,isWith,HER2-positive,Obj
adjuvantAcceleratedBreastIrradiation,using,high-dose-rateBrachytherapy,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination,Obj
changes,noncytotoxicConcentrationsOf,μg/ml,Obj
we,willDiscuss,managementChallengesInTreatmentOfHrPositive,Obj
woman'sHeadache,resultFrom,adenocarcinomaMetastasisFromPrimarySite,Obj
theirPotential,wasEvaluatedIn,mouseXenograftModel,Obj
limitedInformation,isAvailableOn,oralAgentForTreatmentOfOsteoporosis,Obj
latestAdvancements,displaySystemsAs,newModalitiesInCancerImmuneTherapeutics,Obj
concentrations,reversed,phenotype,Obj
aim,examine,existingEvidenceOnGoal-setting,Obj
we,investigated,combinatorialEffectsOfTamoxifen,Obj
anticancerActivities,antioxidantAgainst,breast-cancerCellLines,Obj
onePhotograph,record,changes,Obj
patients,wereDividedInto,twoGroups,Obj
VMAT-SIB,wellToleratedIn,terms,Obj
64-year-oldWoman,has,headache,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfGrowthFactorReceptorAdvancedBreastCancer,Obj
mtorInhibitorEverolimus,addedTo,ET,Obj
Inhibition,reduced,number,Obj
largeIntergenicNoncodingRna-regulator,affects,tamoxifenResistanceOfBcCells,Obj
protein-proteinInteraction,wasAnalyzedBasedOn,searchToolForRetrieval,Obj
massiveCircrnas,have,withDevelopmentHaveDiscovered,Obj
primaryObjective,evaluate,timeToTreatmentFailureInCombination,Obj
We,performed,searchInAscoProceedings,Obj
co-exposure,inhibited,cellProliferation,Obj
receptorActivator,activate,osteoclasts,Obj
use,wasAssociatedIn,multivariableCox'sHazardsSurvivalModel,Obj
cells,grewShowInvasivenessAs,monolayers,Obj
sustainedResponse,suspiciousLesionIn,rightBreasttreatment,Obj
adjuvantBreastIrradiation,using,brachytherapy,Obj
questionnaire,was,administered,Obj
therapies,isIn,clinic,Obj
we,haveRecentlyTested,fewPeptidesDerivedAsVaccineDeliveryModalitiesForTreatment,Obj
work,shows,impactOfHeterogeneityInMolecularDiagnostics,Obj
objective,evaluate,timeToTreatmentFailureInCombinationAsSecond-line,Obj
cellLines,wereAssociatedWith,prognosis,Obj
cells,showed,epithelialMorphology,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveHumanGrowthFactorReceptorBreastCancer,Obj
measurements,leadTo,rateInBreastReconstruction,Obj
adjuvantAcceleratedPartialBreastIrradiation,using,fractionatedHigh-dose-rateBrachytherapy,Obj
study,investigate,pivotalRoleOfIrAntagonistS961,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveGrowthFactorReceptorBreastCancerInCombination,Obj
breastCancer,is,mostDiagnosedDiseases,Obj
tumorModels,evaluatedIn,work,Obj
studyPopulation,included,post-menopausalWomen,Obj
We,searched,PubMed,Obj
coefficient,rangedFrom,12PercecntTo265Percecnt,Obj
increase,isIn,erαProteinLevels,Obj
we,explore,potentialTherapeuticTargetsForTnbc,Obj
64-year-oldWoman'sHeadache,wasFound,resultFromDiffuseAdenocarcinomaMetastasisFromSite,Obj
primaryObjective,evaluate,time,Obj
importantGrowthPathway,isIn,hrPositiveBreastCancer,Obj
t-patParticipants,were,moreLikely,Obj
characteristics,evaluate,perfusionInDifferentTypesOfBreastLesions,Obj
we,haveRecentlyTested,peptidesDerivedFromHer2/neuProto-oncogeneAsVaccineDeliveryModalitiesForTreatmentOfTuboBreastCancerXenograftTumorsOfBalb/cMice,Obj
Results,show,enhancementOfTissuesConsistent,Obj
aspects,upregulatedExpressionOf,IRs,Obj
personalGoal-setting,is,whereComponentOfStudy,Obj
breastCancer,remains,leadingCauseOfDeath,Obj
consecutivePatients,wereTreatedBetween,august2010,Obj
biomarkers,optimize,outcomeOfHr-positiveBreastCancerPatients,Obj
ourScopingReview,willSearchFor,publishedFemales,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentInCombination,Obj
EgKI-1,is,expressed,Obj
intergenicRna-regulator,regulating,pi3k/akt/mtorSignalingPathway,Obj
Analysis,hasLedTo,developmentOfGeneration,Obj
Two-thirds,were,satisfied,Obj
outcome,is,number,Obj
S961,blockedExpressionIn,presence,Obj
aim,compare,seromaFormationInVariousMethods,Obj
purpose,develop,4dBreastPhantomIncludingTime-varyingContrastEnhancement,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHormoneReceptor-positiveEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination,Obj
breastCancer,leadingCauseOf,deathInWomenWorldwide,Obj
cells,presented,higherExpressionOfLincrna-ror,Obj
information,isAvailableOn,commonAgentForTreatment,Obj
basal/humanGrowthFactorReceptorBreastCancer,isResistantTo,monoclonalAntibody,Obj
lateRecurrenceRisk,Extending,5YearsWith5YearsOfTamoxifen,Obj
ZJU-0725,were,maintained,Obj
work,shows,impactOfHeterogeneityInMolecularDiagnosticsForTreatmentSelectionInHer2CancerPatients,Obj
women'sPersonalGoals,mayProvideInsightIn,context,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfReceptor-positiveHumanEpidermalGrowthFactorReceptorBreastCancer,Obj
activities,excellentAntioxidantAgainst,humanBreast-cancerCellLines,Obj
preciseStratification,isThereforeCrucialFor,development,Obj
anonymousQuestionnaire,wasAdministeredTo,174Brca1-2MutationCarriers,Obj
chemotherapy,isMainAdjuvantTreatmentFor,tnbcPatients,Obj
measurements,thusLeadTo,rateInImmediateBreastReconstruction,Obj
macrophages,have,haveImplicated,Obj
second-leadingCause,isIn,females,Obj
role,prognosticSignificanceOf,plasmaEsr1MutationsInMbcPatients,Obj
largeIntergenicRna-regulator,regulating,pi3k/akt/mtorSignalingPathway,Obj
breastIrradiation,using,interstitialMulticatheterHigh-dose-rateBrachytherapy,Obj
treatmentImprovements,isWith,breastCt,Obj
bp-treatedWomen,wereSignificantlyOlderThan,bp-naïveOnes,Obj
outcome,is,numberConsist,Obj
understanding,couldOptimize,patientSelection,Obj
mrnaExpression,using,PCR,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveEpidermalGrowthFactorReceptorBreastCancer,Obj
information,isAvailableOn,agentForTreatmentOfOsteoporosis,Obj
suspiciousLesion,achieved,response,Obj
bp-treatedPatients,amongOneIs,07Percecnt,Obj
mainProblems,included,excitement,Obj
rate,was,low,Obj
primaryObjective,evaluate,timeToTreatmentFailure,Obj
study,included,womenWithBcsTreated,Obj
Analysis,hasLedTo,developmentOfGenerationOfTargetedTherapiesForAdvancedBreastCancer,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHumanGrowthFactorReceptor2-negativeBreastCancerInCombination,Obj
prognosisDiscussions,be,canDeliveredEffectively,Obj
we,conducted,phase,Obj
therapy,canReduce,recurrencesOccurring,Obj
use,wasAssociatedWith,hazardRatioOf004ForBoneMetastasis,Obj
Inhibition,isIn,TE-10,Obj
tissues,presented,higherExpressionOfLincrna-ror,Obj
activities,antioxidantFree-radicalScavengingAgainst,humanBreast-cancerCellLines,Obj
we,additionallyPerformed,analysis,Obj
phantom,can,canUsedDuringDevelopmentOfDynamicBreastCtImagingForOptimizationOfImageAcquisition,Obj
anticancerActivities,antioxidantAgainst,humanBreast-cancerCellLines,Obj
exclusionCriteria,comprehend,extent,Obj
Patients,will,willRandomlyAllocated,Obj
clinicalMeasurements,thusLeadTo,lowRateOfComplicationsInImplant-basedImmediateBreastReconstruction,Obj
primaryObjective,evaluate,timeToTreatmentFailureOfPalbociclibAsSecond-line,Obj
we,summarize,currentKnowledgeOnHumanCircrnas,Obj
measurements,thusLeadTo,lowRateOfComplications,Obj
we,haveTested,peptidesDerivedFromHer2/neuProto-oncogeneAsVaccineDeliveryModalitiesForTreatmentOfTuboBreastCancerXenograftTumorsOfBalb/cMice,Obj
patients,received,level1Doses,Obj
breastCancerXenografts,were,scannedBeforeChemotherapy,Obj
function,investigate,potentialRelationship,Obj
distinctMolecularSignatures,isWith,differentPrognoses,Obj
dysfunctions,wereDueTo,penetrationPain,Obj
lincrna-rorExpression,using,reverseTranscriptionPolymeraseChainReaction,Obj
Meta-analysis,calculate,hazardRatios,Obj
tumorModels,moreoverShow,differentEnhancementDynamics,Obj
patientSelf-reports,were,compared,Obj
we,explored,potentialMechanismsInvolvedInMitochondrialDysfunctionMediated,Obj
biomarkers,optimize,outcomeOfBreastCancerPatients,Obj
targets,are,stillRequired,Obj
Patients,will,willAllocatedToOneThreeTreatmentArmsConsistingOfFlapFixation,Obj
measurements,thusLeadTo,rateOfComplicationsInBreastReconstruction,Obj
variousMethods,reduce,space,Obj
3dPhantom,segmentingTissueFrom,patient,Obj
cells,showed,typicalEpithelialMorphology,Obj
TAMs/CXCL1,promotes,breastCancerMetastasis,Obj
purpose,develop,realisticPatient-based4dDigitalBreastPhantomIncludingTime-varyingContrastEnhancementForSimulation,Obj
medianTime,was,forPrimaryOutcome63Months,Obj
mastectomy,is,well-accepted,Obj
protein-proteinInteraction,was,analyzed,Obj
correlation,isWith,intraoperativeFindings,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancer,Obj
breastCancer,is,mostFrequentlyOccurringCancer,Obj
effect,wasDueTo,differences,Obj
therapy,improving,survival,Obj
circRNAs,have,haveDiscoveredInTumorousTissues,Obj
expression,wasAssociatedWith,recurrenceRiskBeyond5YearsAfterDiagnosis,Obj
findings,showed,87PercecntForUltrasound,Obj
clinicalMeasurements,thusLeadTo,lowRateOfComplicationsInImplant-basedBreastReconstruction,Obj
salpingo-oophorectomy,mayImpactBecauseOf,symptomsAssociated,Obj
tamoxifenResistance,largeNoncodingRna-regulatorOf,reprogramming,Obj
primaryObjective,evaluate,timeToTreatmentFailureOfPalbociclibInCombinationAsSecond-lineOfTherapy,Obj
advancements,displaySystemsAs,newModalitiesInCancerImmuneTherapeutics,Obj
we,explored,potentialMechanismsInvolvedInDysfunction,Obj
cells,were,polyploid,Obj
investigated,combinatorialEffectsOf,tamoxifen,Obj
upregulatedExpression,regulates,aspectsOfPhenotypeIncludingCellProliferation,Obj
tam-secretedCytokines,associatingWith,poorClinicalOutcomes,Obj
kinases,beenIdentifiedAs,driversOfProliferation,Obj
women'sGoals,mayProvide,insightIntoTheirPriorities,Obj
Meta-analysis,calculateHazardRatiosWith,95PercecntCisForSurvival,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveHumanGrowthFactorReceptorBreastCancerInCombination,Obj
anticancerActivities,antioxidantFree-radicalScavengingAgainst,breast-cancerCellLines,Obj
ieSeromaAspirations,numberOf,visits,Obj
noncodingRna-regulator,affects,tamoxifenResistanceOfBcCells,Obj
phantom,can,canUsedDuringDevelopmentOfBreastCtImaging,Obj
We,thereforeSummarized,knowledgeOfRecurrenceBiology,Obj
preciseStratification,isCrucialFor,developmentOfPotentTherapies,Obj
findings,showed,87Percecnt,Obj
silenceLincrna-ror,isIn,mda-mb-231Cells,Obj
information,isAvailableOn,commonAgent,Obj
upregulatedExpression,regulates,severalAspectsIncludingCellProliferation,Obj
therapy,remains,backboneInCases,Obj
damage,selecting,nabRegimen,Obj
partialBreastIrradiation,using,interstitialBrachytherapy,Obj
History,isAssociatedWith,lowerLikelihoodOfBoneMetastases,Obj
breastCancer,leadingCauseOf,death,Obj
therapy,remains,backboneOfTreatmentInCases,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfReceptor-positiveGrowthFactorReceptor2-negativeAdvancedBreastCancer,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHormoneReceptor-positiveEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancer,Obj
we,summarize,currentKnowledge,Obj
predictiveBiomarkers,optimize,clinicalOutcome,Obj
We,suggested,that,Obj
quality,survivalOf,life,Obj
phantom,can,canUsedDuringDevelopmentOfDynamicContrast-enhancedBreastCtImaging,Obj
long-termIntervention,mightReduce,recurrencesInPatientsWithTumors,Obj
work,shows,impactOfHeterogeneityInMolecularDiagnosticsForTreatmentSelection,Obj
Results,show,enhancement,Obj
therapies,oftenDelay,longTermSurvivalDataAreLacking,Obj
TNBC,has,6SubtypesWithSignaturesWithPrognoses,Obj
phantom,can,canUsedDuringDevelopmentOfContrast-enhancedBreastCtImagingForOptimization,Obj
preoperativeMeasurements,thusLeadTo,lowRate,Obj
irMrnaExpressionLevels,wereSignificantlyDownregulatedIn,continuedPresenceOfS961,Obj
combinationTherapy,isWith,ERI,Obj
we,haveTested,fewPeptidesDerivedAsVaccineDeliveryModalitiesForTreatmentOfTuboBreastCancerXenograftTumorsOfBalb/cMice,Obj
highCxcl1Expression,is,significantlyCorrelated,Obj
we,haveRecentlyTested,peptidesDerived,Obj
dfsRate,was,616Percecnt,Obj
theirCosmeticChanges,were,recorded,Obj
severalClinicopathologicalParameters,are,prognostic,Obj
patients,havePrognosisWith,probability,Obj
EgKI-1,memberOf,kunitzTypeProteaseInhibitorFamily,Obj
Meta-analysis,calculateHazardRatiosWith,cisForSurvival,Obj
TNBC,has,6SubtypesWithDistinctMolecularSignatures,Obj
long-termIntervention,mightReduce,lateRecurrencesInPatients,Obj
787ConsecutivePatients,had,atLeast2YearFollow-up,Obj
percentCytotoxicity,increaseWith,increasingOpaeConcentration,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfReceptor-positiveHumanGrowthFactorReceptorAdvancedBreastCancerInCombination,Obj
3-o-p-coumaroyltormenticAcid,preferentiallyReduced,proteinLevels,Obj
prognosisDiscussions,be,canDeliveredEffectivelyByPractice-basedClinicalTeam,Obj
preoperativeMeasurements,canEnhance,prediction,Obj
sensitivity,overcoming,mechanismsOfResistance,Obj
Results,show,expectedEnhancementOfTissuesConsistentWithGivenInputParameters,Obj
endocrineTherapy,remains,backboneInCases,Obj
Analysis,hasLedTo,developmentOfNewGenerationOfTargetedTherapiesForAdvancedBreastCancer,Obj
mechanisms,remains,unclear,Obj
tumor-associatedMacrophages,have,haveImplicated,Obj
cosmeticOutcomes,review,association,Obj
upregulatedExpression,regulates,severalAspects,Obj
itsPotentialPracticalApplications,merit,investigation,Obj
theirPotential,wasEvaluatedIn,athymicNudeMouseXenograftModel,Obj
2MutationCarriers,areOffered,prophylacticBreast,Obj
ourData,confirmed,results,Obj
we,explored,potentialMechanismsInvolvedInMitochondrialDysfunctionMediatedBySeveralEstrogenReceptorSubtypes,Obj
circRNAs,have,withDevelopmentHaveDiscoveredInTissues,Obj
anticancerActivities,antioxidantScavengingAgainst,humanCellLines,Obj
It,wasPerceivedBy,patientsWithBreastCancerAsValuable,Obj
3dPhantom,segmenting,breastCtImage,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination,Obj
findings,indicate,novelUtilizationForBreastCancerTherapy,Obj
purpose,develop,realistic4dBreastPhantomIncludingTime-varyingContrastEnhancementForSimulation,Obj
advancements,displaySystemsAs,modalitiesInCancerImmuneTherapeutics,Obj
purpose,determine,efficacyOfPalbociclibInPatientsPretreated,Obj
highCxcl1Expression,isSignificantlyCorrelatedWith,breastCancerLymphNodeMetastasis,Obj
co-treatment,regulating,expressionOfApoptoticProteins,Obj
findings,indicate,utilization,Obj
benefits,wereSeenWithout,excessiveToxicity,Obj
orthosiphonPallidus,has,antioxidant,Obj
bilateralSalpingo-oophorectomy,mayImpactOn,quality,Obj
efficacy,isIn,patientsPretreatedWithOneLinesOfEndocrineTherapy,Obj
correlationCoefficient,rangedBefore,treatment,Obj
receptorActivator,make,boneMarrowMicroenvironment,Obj
3dStaticPhantom,segmentingAdiposeTissueFrom,healthyPatientIntoSkin,Obj
EgKI-1,promiseFor,futureDevelopment,Obj
clinicopathologicalParameters,arePrognosticFor,lateRecurrence,Obj
salpingo-oophorectomy,mayImpactBecauseOf,symptomsAssociatedWithSurgicalMenopause,Obj
preoperativeMeasurements,leadTo,rateInImplant-basedBreastReconstruction,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveGrowthFactorReceptor2-negativeBreastCancer,Obj
preoperativeMeasurements,leadTo,lowRateOfComplicationsInBreastReconstruction,Obj
primaryDysfunctions,were,due,Obj
Prognosis,isVeryPoorFor,marrowMetastasisFromSolidTumors,Obj
breastCancer,isSecond-leadingCauseOf,nervousSystemMetastasesAmongSevereMalignancies,Obj
evaluate,possibleInfluenceOf,brachytherapy,Obj
primaryObjective,evaluate,timeToTreatmentFailureOfPalbociclibInCombinationWithLetrozole,Obj
productivePrognosisDiscussions,be,canDeliveredEffectivelyByTeam,Obj
function,wasChangedIn,women,Obj
sexualFunction,investigate,potentialRelationship,Obj
productivePrognosisDiscussions,be,canDeliveredEffectivelyByPractice-basedTeamWithinPatientEducationAppointment,Obj
It,understand,molecularPathwaysInvolvedInPathogenesis,Obj
aqueousOrthosiphonPallidusExtract,showed,activity,Obj
cestSignals,were,compared,Obj
cyclin-dependentKinases,beenIdentifiedAs,driversOfProliferation,Obj
ourReview,willSearchFor,publishedFemales,Obj
S961,alsoInhibited,colonyFormation,Obj
64-year-oldWoman'sHeadache,wasFound,resultFromDiffuseAdenocarcinomaMetastasisInBoneMarrowFromUnknownSite,Obj
cells,presented,expressionOfLincrna-ror,Obj
patterns,can,canSimulated,Obj
mrnaExpression,was,measured,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanGrowthFactorReceptorBreastCancer,Obj
we,summarize,theirPotentialClinicalImplications,Obj
theirImportance,isIn,immediateImplant-basedBreastReconstruction,Obj
alendronate,isIn,90PercecntOfCases,Obj
investigated,anti-proliferativeEffectsOn,erCancer,Obj
threeVisualRepresentations,using,threeMetrics,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfEpidermalGrowthFactorReceptorAdvancedBreastCancer,Obj
anticancerActivities,were,determined,Obj
cohortStudy,wasConductedAt,oncologyDivisionAtTelAvivMedicalCenter,Obj
compound,Using,NMR,Obj
targetingBreastCscs,is,newParadigm,Obj
probability,evaluate,possibleInfluenceOfBrachytherapy,Obj
e3-ubiquitinLigases,alsoFunctionAs,coactivatorsForErα,Obj
pik3caMutations,isIn,circulatingTumorDna,Obj
preoperativeMeasurements,leadTo,rateOfComplicationsInImmediateBreastReconstruction,Obj
peptide,is,presentedByGeneticFusions,Obj
VMAT-SIB,wellToleratedIn,termsOfAcute,Obj
using,combinationOf,ovTherapyWithImmuneCheckpointInhibitors,Obj
basal/humanGrowthFactorReceptorBreastCancer,is,resistant,Obj
irMrnaExpressionLevels,wereDownregulatedIn,presence,Obj
intratumorHeterogeneity,variedSubstantiallyBetween,patientSamples,Obj
therapeuticTargets,are,required,Obj
cells,were,whenExposedToTamoxifen,Obj
breastCancerCells,showedProliferationOwingTo,irOverexpression,Obj
Patients,will,willAllocatedToOneThreeTreatmentArmsConsisting,Obj
mad-mb-231Cells,increasedSensitivityTo,TAM,Obj
oncolyticVirusTherapy,isStrategyFor,cancerTreatment,Obj
isolatedCompound,Using,13c2-dimensionalNuclearMagneticResonance,Obj
rnaInterference,was,used,Obj
objective,investigate,antioxidantFree-radicalScavengingAgainstCellLines,Obj
isolatedCompound,Using,electrosprayIonizationMassSpectrometry,Obj
purpose,develop,realisticPatient-based4dBreastPhantomIncludingTime-varyingContrastEnhancementForSimulation,Obj
stratification,isCrucialFor,developmentOfTherapies,Obj
breastCancer,is,treatableDisease,Obj
we,determinedIn,addition,Obj
it,continue,combinationTherapyForPatientsWithBreastCancerDueToHematologicalToxicities,Obj
acid,inducing,c-mycDegradation,Obj
insulinResistance,have,haveLinked,Obj
variousMethods,reduce,deadSpace,Obj
study,included,womenWithHer2-positiveBcsTreated,Obj
purpose,develop,realisticPatient-based4dDigitalBreastPhantom,Obj
contributing,supportOf,women,Obj
co-exposure,significantlyInhibitedCellProliferationIn,additiveManner,Obj
limitedInformation,isAvailableOn,alendronateRegardingAssociation,Obj
we,haveTested,peptidesDerivedAsVaccineDeliveryModalitiesForTreatment,Obj
therapy,remains,backbone,Obj
limitedInformation,isAvailableOn,commonOralAgent,Obj
recurrences,are,ER-driven,Obj
lincrna-rorExpression,isIn,tissues,Obj
breastCancer,isSecond-leadingCauseOf,centralSystemMetastasesAmongSevereMalignancies,Obj
preciseStratification,isThereforeCrucialFor,developmentOfStandardizedTherapies,Obj
predictiveRole,prognosticSignificanceOf,plasmaEsr1MutationsInMbcPatientsWithExposureToAiTherapy,Obj
3dStaticPhantom,segmentingBreastCtImageFrom,healthyPatient,Obj
erαPolyubiquitinationInhibition,may,thusMayFactor,Obj
percentCytotoxicity,increaseSteadilyWith,increasingOpaeConcentration,Obj
patients,wereDividedInto,twoGroupsIncluding196Patients,Obj
basal/humanGrowthFactorReceptor2-positiveBreastCancer,is,resistant,Obj
Display,is,alsoIncreasinglyConsidered,Obj
patients,havePrognosisWith,higherProbability,Obj
breastCancer,causeOf,deathInWomenWorldwide,Obj
History,isAssociatedWith,lowerLikelihoodOfBoneMetastasesInWomenWithBreastCancer,Obj
irAntagonist,showed,distinctAntagonism,Obj
aim,identify,evaluationMethods,Obj
expression,wasAssociatedWith,highRecurrenceRiskBeyond5Years,Obj
subtype,isWith,poorClinicalOutcome,Obj
differentPatterns,can,finallyCanSimulatedForTumorModels,Obj
productivePrognosisDiscussions,be,canDeliveredEffectivelyByPractice-basedClinicalTeamWithinPatientEducationAppointment,Obj
woman'sHeadache,wasFound,resultFromAdenocarcinomaMetastasis,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHumanEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancer,Obj
we,evaluate,prognosticValue,Obj
measurements,thusLeadTo,rateOfComplicationsInImplant-basedImmediateBreastReconstruction,Obj
acceleratedPartialBreastIrradiation,using,interstitialMulticatheterBrachytherapy,Obj
Prognosis,isGenerallyVeryPoor,disease,Obj
partialBreastIrradiation,using,fractionatedBrachytherapy,Obj
adjuvantBreastIrradiation,using,high-dose-rateBrachytherapy,Obj
measurements,thusLeadTo,lowRateInImplant-basedBreastReconstruction,Obj
we,haveRecentlyTested,peptidesDerivedAsVaccineDeliveryModalitiesForTreatmentOfTuboBreastCancerXenograftTumorsOfBalb/cMice,Obj
preoperativeMeasurements,leadTo,lowRateOfComplications,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfEpidermalGrowthFactorReceptorAdvancedBreastCancerInCombination,Obj
preoperativeMeasurements,thusLeadTo,rateOfComplicationsInBreastReconstruction,Obj
cxcl1-basedTherapy,mightBecome,novelStrategyForBreastCancerMetastasisPrevention,Obj
tumorModels,alsoPresentEnhancement,expected,Obj
differentSubtypes,isIn,metastaticOfDisease,Obj
patients,will,willRandomized,Obj
Selection,followed,flowchart,Obj
patients,received,breastIrradiation,Obj
parameters,arePrognosticFor,recurrence,Obj
predictiveBiomarkers,are,needed,Obj
agents,remainsFor,strategy,Obj
acceleratedBreastIrradiation,using,interstitialHigh-dose-rateBrachytherapy,Obj
sustainedResponse,suspiciousLesionWith,tamoxifen,Obj
multipleTam-secretedCytokines,associatingWith,poorOutcomes,Obj
80,received,95EbrtBoost,Obj
information,isAvailableOn,mostCommonOralAgentForTreatmentOfOsteoporosis,Obj
HR,remainedAfter,adjustmentForTumorStage,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancer,Obj
historicalCohortStudy,was,conducted,Obj
we,haveRecentlyTested,fewPeptidesDerivedFromHer2/neuProto-oncogeneAsVaccineDeliveryModalitiesForTreatmentOfTuboBreastCancerXenograftTumors,Obj
hypofractionatedVmat-sib,toleratedIn,terms,Obj
limitedInformation,isAvailableOn,agentForTreatment,Obj
3Patients,received,level0Doses,Obj
purpose,develop,realistic4dDigitalBreastPhantomIncludingTime-varyingContrastEnhancementForSimulationOfBreastCtPerfusionImaging,Obj
phantom,can,canUsedForOptimization,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfGrowthFactorReceptorBreastCancer,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHormoneReceptor-positiveGrowthFactorReceptorAdvancedBreastCancerInCombination,Obj
predictiveRole,significanceOf,plasmaEsr1MutationsInMbcPatientsWithPriorExposure,Obj
Palbociclib,isInhibitorOf,kinasesApproved,Obj
Overexpression,wasAssociatedWith,prognosisEspecially,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination,Obj
expression,regulates,severalAspectsOfPhenotype,Obj
largeNoncodingRna-regulator,affects,tamoxifenResistance,Obj
predictiveBiomarkers,optimize,clinicalOutcomeOfHr-positiveBreastCancerPatients,Obj
We,summarized,knowledgeOfRecurrenceBiology,Obj
time,was,63Months,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHormoneReceptor-positiveEpidermalGrowthFactorReceptor2-negativeBreastCancer,Obj
acceleratedPartialBreastIrradiation,using,high-dose-rateBrachytherapy,Obj
objective,investigate,antioxidantScavengingAgainstHumanCellLines,Obj
purpose,develop,4dDigitalBreastPhantomIncludingContrastEnhancementForSimulation,Obj
acTreatment,inhibited,EMT,Obj
oncolyticVirusTherapy,isInterestingStrategyFor,cancerTreatment,Obj
breastCancer,isCauseOf,nervousSystemMetastasesAmongSevereMalignancies,Obj
measurements,leadTo,rateOfComplicationsInImmediateBreastReconstruction,Obj
it,continue,combinationTherapyForPatientsDueToHematologicalToxicities,Obj
we,performed,analysis,Obj
it,was,difficult,Obj
We,previouslySuggested,that,Obj
dysfunctions,wereDueTo,506Percecnt,Obj
acTreatment,consistentlyInhibitedEmtAt,time,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHumanGrowthFactorReceptorBreastCancerInCombination,Obj
intergenicNoncodingRna-regulator,affects,tamoxifenResistanceOfBcCells,Obj
orthosiphonPallidusExtract,showed,potentActivity,Obj
intervention,mightReduce,lateRecurrencesInPatientsWithTumors,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfReceptor-positiveHumanEpidermalGrowthFactorReceptor2-negativeBreastCancerInCombination,Obj
salpingo-oophorectomy,mayImpactBecauseOf,symptomsAssociatedWithEarlySurgicalMenopause,Obj
threeBasal/her2,recapitulating,characteristics,Obj
AC,decrease,wnt/β-cateninTranslocation,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanEpidermalGrowthFactorReceptor2-negativeBreastCancerInCombination,Obj
breastCancer,is,disease,Obj
brcaStatus,is,onlyValidatedBiomarker,Obj
femalePatients,diagnosedWith,breastCancer,Obj
purpose,develop,4dDigitalBreastPhantomIncludingTime-varyingContrastEnhancementForSimulation,Obj
Overexpression,wasAssociatedWith,unfavorablePrognosis,Obj
therapeuticTargets,howeverAreStillRequiredFor,furtherInvestigation,Obj
we,haveRecentlyTested,fewPeptidesDerivedAsVaccineDeliveryModalitiesForTreatmentOfTuboBreastCancerXenograftTumors,Obj
preciseStratification,isThereforeCrucialFor,developmentOfPotentTherapies,Obj
model,showed,tumorGrowthReduction,Obj
preciseStratification,isCrucialFor,developmentOfPotentStandardizedTherapies,Obj
679Percecnt,isIn,groupAb,Obj
biomarkers,optimize,clinicalOutcomeOfBreastCancerPatients,Obj
intraoperativeFindings,showed,90PercecntAccuracyForMriEvaluation,Obj
TNBC,is,heterogenic,Obj
studyPopulation,included,post-menopausalWomenWithBreastCancer,Obj
irMrnaExpressionLevels,wereDownregulatedIn,continuedPresenceOfS961,Obj
3dPhantom,segmentingTissueFrom,patientIntoSkin,Obj
PROs,were,measured,Obj
we,investigated,combinatorialAnti-proliferativeEffects,Obj
breastCancerPatients,undergoing,mastectomy,Obj
circumstances,influence,function,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfEpidermalGrowthFactorReceptorBreastCancerInCombination,Obj
skinToxicity,was,atEndG1In511PercecntOfPatients,Obj
HR,remainedAfter,adjustment,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanGrowthFactorReceptorAdvancedBreastCancer,Obj
examinations,areConsideredBy,915PercecntOfResponders,Obj
study,included,514Women,Obj
salpingo-oophorectomy,mayImpactOn,qualityOfLife,Obj
mtorInhibitorEverolimus,significantlyImproves,progressionSurvival,Obj
femalePatients,diagnosedWith,advancedBreastCancer,Obj
inMolecularMarkers,isIn,tissueBiopsies,Obj
breastCancer,isSecond-leadingCauseOf,systemMetastasesAmongSevereMalignancies,Obj
chemotherapy,is,adjuvantTreatment,Obj
we,haveRecentlyTested,peptidesDerivedAsVaccineDeliveryModalities,Obj
itsSignaling,isIn,breastCancers,Obj
study,investigate,pivotalRoleOnIrSignalling,Obj
it,can,evenCanTreatedWithHormonalReplacementTherapies,Obj
purpose,develop,realisticPatient-based4dBreastPhantomIncludingContrastEnhancementForSimulation,Obj
History,isAssociatedWith,likelihoodOfBoneMetastasesInPostmenopausalWomenWithEarlyBreastCancer,Obj
breastCancer,is,frequentlyOccurringCancer,Obj
Meta-analysis,calculate,HRs,Obj
we,discovered,treatmentWithAc,Obj
personalGoal-setting,is,whereMajorComponentOfStudy,Obj
it,continue,combinationTherapyForPatientsWithAdvancedRecurrentBreastCancerDueToToxicities,Obj
erαPolyubiquitinationInhibition,may,thusMayFactorInProgressionOfBreastCancer,Obj
measurements,leadTo,rateOfComplicationsInImplant-basedBreastReconstruction,Obj
adjuvantPartialBreastIrradiation,using,interstitialFractionatedMulticatheterHigh-dose-rateBrachytherapy,Obj
combinedTreatment,blocked,cellCycle,Obj
it,can,canTreated,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHumanEpidermalGrowthFactorReceptorAdvancedBreastCancer,Obj
AC,demonstratedBy,upregulationOfE-cadherinExpression,Obj
purpose,develop,realisticPatient-based4dDigitalBreastPhantomIncludingTime-varyingContrastEnhancement,Obj
Analysis,hasLedTo,developmentOfNewGeneration,Obj
tamoxifenResistance,largeIntergenicRna-regulatorOf,lincRNA-ROR,Obj
possibility,holds,promiseInFutureOfCancerImmunotherapy,Obj
time-enhancementCurves,defining,perfusionParametersForTissue,Obj
Palbociclib,is,inhibitor,Obj
we,haveTested,peptides,Obj
productivePrognosisDiscussions,be,canDeliveredEffectivelyByTeamWithinSemi-structuredPatientEducationAppointment,Obj
exponential,dependsOn,perfusionParametersAssociatedWithTissueVoxel,Obj
cxcl1Silencing,resultsIn,significantReductionInBreastCancerGrowth,Obj
lincrna-rorExpression,using,transcriptionQuantitativePolymeraseChainReaction,Obj
measurements,canEnhance,prediction,Obj
viruses,areUnder,laboratory,Obj
viruses,areUnder,presentlyLaboratory,Obj
tamoxifenResistance,rna-regulatorOf,lincRNA-ROR,Obj
childhood,isWith,recombinantGh,Obj
Prognosis,isPoorFor,marrowMetastasis,Obj
triple-negativeBreastCancer,isSubtypeWith,poorClinicalOutcome,Obj
cdk4/6InhibitorPalbociclib,has,hasApproved,Obj
cdk4/6InhibitorPalbociclib,has,hasApprovedForTreatment,Obj
History,isAssociatedWith,lowerLikelihoodOfBoneMetastasesInWomenWithEarlyBreastCancer,Obj
information,isAvailableOn,commonOralAgent,Obj
kyotoEncyclopedia,using,Database,Obj
patients,receivedVmat-sibTechniqueTo,wholeBreast,Obj
therapies,oftenDelay,termSurvivalDataAreLacking,Obj
preoperativeMeasurements,thusLeadTo,lowRateOfComplications,Obj
we,summarize,currentKnowledgeOnCircrnas,Obj
targets,existingIn,loopTams,Obj
activities,antioxidantFree-radicalScavengingAgainst,breast-cancerCellLines,Obj
we,haveTested,fewPeptidesDerivedFromHer2/neuProto-oncogene,Obj
noncytotoxicConcentrations,reversed,fibroblastic-to-epithelialPhenotype,Obj
4dPhantom,hasDimensionsAs,example,Obj
cxcl1Silencing,resultsIn,significantReduction,Obj
seromaFormation,isAssociatedWith,delayedWoundHealing,Obj
patients,receivedVmat-sibTechniqueFor,totalDose,Obj
4D,hasDimensionsAs,example,Obj
estrogenReceptorPositivePatients,areMoreCommonOf,cases,Obj
therapeuticTargets,areStillRequiredFor,furtherInvestigation,Obj
primaryOutcome,is,number,Obj
we,summarize,theirPotentialClinicalImplicationsOnBreastCancer,Obj
adjuvantBreastIrradiation,using,interstitialBrachytherapy,Obj
pi3k/akt/mtorPathway,isKnown,importantGrowthPathwayInHrBreastCancer,Obj
massiveCircrnas,have,withDevelopmentOfSequencingHaveDiscoveredInTumorousTissues,Obj
kinases,beenIdentifiedAs,keyDrivers,Obj
therapy,mightBecome,strategy,Obj
AC,decreasedLungMetastasis,demonstratedByUpregulationOfE-cadherinExpressionInBiopsiedLungTissue,Obj
threeRepresentations,using,threeMetrics,Obj
association,isWith,boneMetastases,Obj
3dPhantom,segmentingVasculatureFrom,patientIntoSkin,Obj
photograph,wasTakenFor,patient,Obj
enrichmentAnalysis,was,applied,Obj
plasmaEsr1MutationAssessment,have,prognosticSignificance,Obj
btBoost,wasProposedIn,otherCases,Obj
multigeneAssays,are,prognostic,Obj
long-termIntervention,mightReduce,lateRecurrencesInPatientsWithTumors,Obj
woman'sHeadache,wasFound,resultFromAdenocarcinomaMetastasisInBoneMarrowFromSite,Obj
concentrations,reversed,changes,Obj
64-year-oldWoman'sHeadache,resultFrom,diffuseAdenocarcinomaMetastasisInBoneMarrow,Obj
severalParameters,arePrognosticFor,lateRecurrence,Obj
cellProliferation,co-exposureWith,them,Obj
bcTissues,presented,higherExpressionOfLincrna-ror,Obj
we,Using,combinedImmunofluorescence,Obj
qpcrScreening,furtherValidatedSox4As,responsiveGene,Obj
examinations,areConsidered,useful,Obj
Display,is,considered,Obj
skinToxicity,wasG1In,511Percecnt,Obj
orthosiphonPallidus,has,antimicrobial,Obj
we,willDiscuss,managementChallengesInTreatmentOfAdvancedHr,Obj
largeRna-regulator,affects,tamoxifenResistance,Obj
bisphosphonateTreatment,could,couldSufficient,Obj
AC,decrease,wnt/β-cateninNuclearTranslocation,Obj
adjuvantAcceleratedBreastIrradiation,using,multicatheterBrachytherapy,Obj
S961,inhibited,cellularProliferationInBreastTumourCells,Obj
upregulatedExpression,isIn,breastCancerPathogenesis,Obj
selectiveEstrogenReceptorDegraders,haveLedInAdditionTo,anti-estrogenTherapy,Obj
work,shows,impactInDiagnosticsForTreatmentSelectionInHer2CancerPatients,Obj
preoperativeMeasurements,leadTo,lowRateOfComplicationsInImplant-basedImmediateBreastReconstruction,Obj
hypofractionatedVmat-sib,was,safe,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveHumanEpidermalGrowthFactorReceptorAdvancedBreastCancer,Obj
prognosisDiscussions,be,canDeliveredEffectivelyByPractice-basedTeamWithinPatientEducationAppointment,Obj
Patients,starting,april2015,Obj
function,wasChangedIn,womenWithBreastCancer,Obj
aim,examine,evidenceOnPersonalGoal-setting,Obj
acceleratedBreastIrradiation,using,interstitialMulticatheterHigh-dose-rateBrachytherapy,Obj
cytokines,have,haveIdentified,Obj
we,explored,clinicalImpactOfHeterogeneity,Obj
purpose,develop,realistic4dBreastPhantomIncludingContrastEnhancementForSimulationOfBreastCtPerfusionImaging,Obj
preoperativeMeasurements,leadTo,rateOfComplicationsInBreastReconstruction,Obj
purpose,develop,realistic4dDigitalBreastPhantom,Obj
study,included,womenWithHer2-positiveBcsTreatedWithTrastuzumabFrom2008To2017,Obj
orthosiphonPallidus,antioxidantAgainst,humanBreast-cancerCellLines,Obj
3dStaticPhantom,segmentingAdiposeTissueFrom,patientIntoSkin,Obj
S961,blocked,expression,Obj
co-treatment,couldInhibitMoreEffectively,cellProliferation,Obj
orthosiphonPallidus,has,excellentAntioxidantAgainstHumanCellLines,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanGrowthFactorReceptor2-negativeAdvancedBreastCancer,Obj
triple-negativeBreastCancer,isSubtypeWith,clinicalOutcome,Obj
onePhotograph,beforeAndAnotherWasTakenFor,patient,Obj
phantom,can,canUsedDuringDevelopmentOfContrast-enhancedDedicatedBreastCtImagingForOptimizationOfImageAcquisition,Obj
TNBC,has,6Subtypes,Obj
limitedInformation,isAvailableOn,commonAgentForTreatmentOfPost-menopausalOsteoporosis,Obj
6Subtypes,isWith,distinctMolecularSignatures,Obj
cellCycle,combinedTreatmentOf,tamoxifen,Obj
we,haveRecentlyTested,peptidesDerivedFromHer2/neuProto-oncogeneAsVaccineDeliveryModalitiesForTreatment,Obj
Prognosis,is,poor,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHumanEpidermalGrowthFactorReceptor2-negativeBreastCancerInCombination,Obj
purpose,develop,realisticPatient-based4dBreastPhantom,Obj
newModalities,isIn,cancerImmuneTherapeutics,Obj
aim,examine,existingEvidenceOnPersonalGoal-setting,Obj
targetingBreastCscs,isNewParadigmFor,cancerPrevention,Obj
RNA-regulator,affects,tamoxifenResistance,Obj
evidence,suggests,that,Obj
skinToxicity,wasG1At,end,Obj
preciseStratification,isCrucialFor,developmentOfStandardizedTherapies,Obj
primarySexualDysfunctions,wereDueTo,506Percecnt,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHormoneReceptor-positiveEpidermalGrowthFactorReceptorAdvancedBreastCancerInCombination,Obj
activity-guidedFractionation,preparationsOver,silicaGel,Obj
use,wasAssociatedWith,hazardRatioForBoneMetastasis,Obj
proliferation,isIn,hormoneReceptor,Obj
clinicalMeasurements,thusLeadTo,rateInImplant-basedImmediateBreastReconstruction,Obj
work,shows,impactOfHeterogeneityInDiagnosticsForTreatmentSelectionInHer2CancerPatients,Obj
arterialSources,supplying,breast,Obj
endocrineTherapy,improving,survival,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfEpidermalGrowthFactorReceptorAdvancedBreastCancerInCombination,Obj
examinations,areConsidered,usefulForEarlyDiagnosis,Obj
estrogenReceptorPositivePatients,areCommonOf,cases,Obj
patients,isIn,ebrtGroup,Obj
adjuvantAcceleratedPartialBreastIrradiation,using,interstitialMulticatheterBrachytherapy,Obj
progression-freeSurvival,was,64Months,Obj
We,performed,searchOfDataInFdaWebsiteInAscoProceedings,Obj
irSignalling,isIn,MCF-7,Obj
pi3k/akt/mtorPathway,be,growthPathwayInHrPositiveBreastCancer,Obj
salpingo-oophorectomy,mayImpact,canTreated,Obj
it,continue,combinationTherapy,Obj
objective,evaluate,timeToTreatmentFailureInCombinationWithLetrozoleAsSecond-line,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHumanGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination,Obj
curves,areCalculatedBy,convolutionBetweenArterialInputFunction,Obj
cxcl1Expression,isSignificantlyCorrelatedWith,breastCancerLymphNodeMetastasis,Obj
ourData,confirmed,resultsOfStudiesPublishedOnAssociation,Obj
breastLesionModel,beAddedTo,phantom,Obj
periodicExaminations,areConsidered,usefulForEarlyDiagnosisOfCancer,Obj
endocrineTherapy,improving,survivalOfLife,Obj
objective,investigate,activitiesOfOPallidus,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveGrowthFactorReceptor2-negativeBreastCancerInCombination,Obj
examinations,areConsideredBy,915Percecnt,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentInCombinationWithFulvestrant,Obj
TDO2,may,mayPotentialTherapeuticTarget,Obj
EgKI-1,isHighlyExpressedBy,oncosphereOfCanineTapewormEchinococcusGranulosus,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfReceptor-positiveEpidermalGrowthFactorReceptorBreastCancer,Obj
purpose,develop,4dBreastPhantomIncludingContrastEnhancement,Obj
therapeuticTargets,areStillRequiredFor,investigation,Obj
evaluation,startedWith,skinFlapMeasurement,Obj
patients,havePrognosisWith,higherProbabilityOfRelapse,Obj
bisphosphonateTreatment,reducing,risk,Obj
probability,evaluate,possibleInfluence,Obj
ongoingResearch,is,anticipated,Obj
biomarkers,are,needed,Obj
Selection,followed,in-houseFlowchart,Obj
qpcrScreening,furtherValidatedSox4As,highestGene,Obj
intergenicNoncodingRna-regulator,affects,tamoxifenResistance,Obj
circRNAs,have,withDevelopmentOfSequencingHaveDiscoveredInTumorousTissues,Obj
pik3caMutations,earlyDynamicsOfBe,potentialPredictiveBiomarkerForCdk4/6Inhibitors,Obj
fulvestrant,isIn,postmenopausalWomenWithDiseaseProgressionFollowingEndocrineTherapy,Obj
phantom,can,canUsedDuringDevelopmentOfDynamicContrast-enhancedDedicatedBreastCtImagingForOptimizationOfImageAcquisition,Obj
plasmaEsr1MutationCarriers,had,worsePfs,Obj
orthosiphonPallidusExtract,showed,activityInModels,Obj
we,evaluate,valueOfHubGenes,Obj
naringenin,inhibit,cellGrowth,Obj
VMAT-SIB,toleratedIn,termsOfAcute,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentInCombinationWithFulvestrantInPostmenopausalWomenWithDiseaseProgression,Obj
productivePrognosisDiscussions,be,canDeliveredEffectivelyByClinicalTeamWithinPatientEducationAppointment,Obj
selectionTools,are,sparse,Obj
adjuvantAcceleratedBreastIrradiation,using,interstitialFractionatedMulticatheterHigh-dose-rateBrachytherapy,Obj
breastCancerCells,predominantlyExpressed,ir-aIsoform,Obj
RNA-regulator,affects,tamoxifenResistanceOfBcCells,Obj
photographs,were,analyzed,Obj
acceleratedBreastIrradiation,using,interstitialFractionatedBrachytherapy,Obj
geneSet,rankedAccordingTo,theirAssociation,Obj
differentPatterns,can,canAlsoSimulated,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveEpidermalGrowthFactorReceptor2-negativeBreastCancer,Obj
adjuvantAcceleratedBreastIrradiation,using,interstitialFractionatedHigh-dose-rateBrachytherapy,Obj
changes,isIn,breastCosmesis,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHormoneReceptor-positiveGrowthFactorReceptorAdvancedBreastCancer,Obj
treatmentSelection,isIn,her2CancerPatients,Obj
Prognosis,isPoorFor,marrowMetastasisFromSolidTumors,Obj
mtrValues,were,evaluated,Obj
latestAdvancements,displaySystemsAs,newModalitiesInCancerTherapeutics,Obj
multipleTam-secretedCytokines,associatingWith,outcomes,Obj
salpingo-oophorectomy,mayImpactBecauseOf,symptomsAssociatedWithMenopause,Obj
adjuvantPartialBreastIrradiation,using,interstitialBrachytherapy,Obj
research,evaluating,potentialBiomarkersOfResistance,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHumanGrowthFactorReceptor2-negativeBreastCancer,Obj
irMrnaExpressionLevels,wereSignificantlyDownregulatedIn,presenceOfS961,Obj
CXCL1,canPromote,transition,Obj
cyclin-dependentKinases,beenIdentifiedAs,keyDriversOfProliferationInHormoneReceptor,Obj
aim,examine,evidenceOnGoal-setting,Obj
woman'sHeadache,wasFound,resultFromDiffuseAdenocarcinomaMetastasisInBoneMarrow,Obj
we,provide,update,Obj
mtrValues,wereEvaluatedAs,measureOfCestEffect,Obj
64-year-oldWoman'sHeadache,resultFrom,adenocarcinomaMetastasisFromUnknownSite,Obj
predictiveRole,prognosticSignificanceOf,plasmaEsr1MutationsInMbcPatientsWithPriorExposure,Obj
curves,defining,perfusionParametersForTissue,Obj
findings,indicate,utilizationForBreastCancerTherapy,Obj
breastIrradiation,using,interstitialFractionatedMulticatheterBrachytherapy,Obj
breastCancer,leadingCauseAmong,womenWorldwide,Obj
S961,blockedExpressionIn,evenPresence,Obj
clinicalMeasurements,thusLeadTo,lowRateOfComplicationsInBreastReconstruction,Obj
purpose,develop,realistic4dBreastPhantomIncludingContrastEnhancementForSimulation,Obj
CSCs,is,new,Obj
TNBC,has,6SubtypesWithMolecularSignaturesWithDifferentPrognoses,Obj
brcaMutationalStatus,is,biomarker,Obj
AC,substantiallySuppressedBreastCancerMetastasisTo,lungs,Obj
recurrenceRisk,Extending,5YearsOfTamoxifenTherapy,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination,Obj
primaryOutcome,is,numberOfSeromaAspirationsConsist,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfEpidermalGrowthFactorReceptorBreastCancerInCombination,Obj
goal-setting,isMajorComponentOf,study,Obj
treatment,suppressing,transcription,Obj
threeVisualRepresentations,using,threeDifferentMetricsOfMortality,Obj
geo2rTool,screenOut,expressedGenes,Obj
work,shows,impactInMolecularDiagnostics,Obj
anticancerActivities,excellentAntioxidantAgainst,cellLines,Obj
Knockdown,alsoInduced,inactivationOfEpidermalGrowthFactorReceptorSignalingPathway,Obj
Knockdown,induced,inactivation,Obj
orthosiphonPallidus,antioxidantAgainst,cellLines,Obj
latestAdvancements,displaySystemsAs,newModalities,Obj
inModel,showed,significantTumorGrowthReductionInMice,Obj
Analysis,hasLedTo,developmentOfGenerationOfTherapiesForBreastCancer,Obj
we,selected,MCF-7,Obj
therapeuticTargets,are,howeverStillRequired,Obj
it,mainlyOwingTo,degreeOfConcernAboutCancerRisk,Obj
possibility,holds,promiseInFuture,Obj
insulinResistance,have,haveLinkedToPathogenesis,Obj
clinicalMeasurements,leadTo,lowRateOfComplications,Obj
cells,had,near-tetraploidKaryotypeWithAberrations,Obj
mucin1,facilitates,motilityPotentialOfBreastCancerCells,Obj
orthosiphonPallidus,has,anticancerActivities,Obj
estrogenReceptorDegraders,haveLedInAdditionTo,anti-estrogenTherapyWithEstrogenReceptorModulators,Obj
64-year-oldWoman'sHeadache,resultFrom,diffuseAdenocarcinomaMetastasisInBoneMarrowFromUnknownSite,Obj
cxcl1-basedTherapy,mightBecome,strategyForBreastCancerMetastasisPrevention,Obj
information,isAvailableOn,oralAgentForTreatment,Obj
adjuvantAcceleratedBreastIrradiation,using,fractionatedHigh-dose-rateBrachytherapy,Obj
retrospectiveStudy,included,womenWithBcsTreatedFrom2008To2017,Obj
we,analyzed,threeMicroarrayDatasetsDerived,Obj
intraoperativeFindings,showed,71PercecntForPinchTest,Obj
it,owingTo,lowerDegreeOfConcernAboutOvarianCancerRisk,Obj
We,predicting,lateRecurrenceFromTreatmentExtension,Obj
3dStaticPhantom,is,firstCreated,Obj
isolatedCompound,Using,13c2-dimensionalNuclearResonance,Obj
purpose,develop,4dBreastPhantomIncludingContrastEnhancementForSimulationOfDedicatedBreastCtPerfusionImaging,Obj
therapeuticTargets,howeverAreRequiredFor,investigation,Obj
TNBC,has,6SubtypesWithDistinctMolecularSignaturesWithDifferentPrognoses,Obj
severalClinicopathologicalParameters,are,prognosticForRecurrence,Obj
clinicalMeasurements,thusLeadTo,lowRate,Obj
agents,remainsFor,sequencing,Obj
tamoxifenResistance,rna-regulatorOf,reprogramming,Obj
basal/humanEpidermalGrowthFactorReceptor2-positiveBreastCancer,isResistantTo,monoclonalAntibody,Obj
findings,showed,accuracyForMriEvaluation,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveHumanGrowthFactorReceptor2-negativeBreastCancerInCombination,Obj
typical4d,hasDimensionsAs,example,Obj
it,continue,combinationTherapyForPatientsWithRecurrentBreastCancer,Obj
3dStaticPhantom,segmenting,breastCtImage,Obj
purpose,develop,patient-based4dDigitalBreastPhantomIncludingTime-varyingContrastEnhancementForSimulationOfBreastCtPerfusionImaging,Obj
breastIrradiation,using,interstitialBrachytherapy,Obj
deadliestCancers,isIn,world,Obj
higherExpression,was,associated,Obj
orthosiphonPallidusExtract,showed,activityInIn-vitroModels,Obj
orthosiphonPallidus,excellentAntioxidantAgainst,humanCellLines,Obj
S961,alsoInhibited,cellularProliferation,Obj
had,near-tetraploidOrAneuploidKaryotypeWith,aberrations,Obj
plasmaEsr1MutationAssessment,guiding,furtherEndocrineTherapyChoice,Obj
3dStaticPhantom,segmentingTissueFrom,healthyPatient,Obj
anticancerActivities,antioxidantScavengingAgainst,breast-cancerCellLines,Obj
dfsRate,was,616PercecntInGroupAb,Obj
cellProliferation,co-treatmentOf,tamoxifen,Obj
retrospectiveStudy,included,womenWithBcsTreatedWithTrastuzumabFrom2008To2017,Obj
iClinicalStudy,isIn,japanesePatientsWithMetastaticBreastCancer,Obj
noncytotoxicConcentrations,reversed,morphologicalChanges,Obj
multicenterControlledTrial,isIn,femaleBreastCancerPatientsUndergoing,Obj
bp-treatedWomen,were,significantlyOlder,Obj
breastCancer,is,subtypeOfBreastCancerWithClinicalOutcome,Obj
largeNoncodingRna-regulator,regulating,pi3k/akt/mtorSignalingPathway,Obj
circRNAs,have,withDevelopmentHaveDiscovered,Obj
cosmeticOutcomes,review,associationOfChemotherapy,Obj
primaryObjective,evaluate,timeToTreatmentFailureInCombinationWithLetrozoleAsSecond-line,Obj
adjuvantBreastIrradiation,using,fractionatedBrachytherapy,Obj
recurrenceRisk,Extending,5YearsOfTamoxifenTherapyWith5Years,Obj
we,haveTestedPeptidesIn,ourLaboratory,Obj
we,usingImmunofluorescenceOn,tissueSectionsFollowedByValidatedComputationalApproach,Obj
circumstances,influence,sexualFunctionOfWomen,Obj
correspondingTime-enhancementCurves,defining,perfusionParametersForTissue,Obj
orthosiphonPallidusExtract,showed,potentActivityInModels,Obj
characteristics,evaluate,perfusion,Obj
doses,were,escalatedTo14Mg/m2ForGem,Obj
objective,investigate,antioxidantScavenging,Obj
supportiveCare,allowing,lessToxicity,Obj
functionalAnnotation,pathwaysOf,DEGs,Obj
it,continue,combinationTherapyForPatientsDueToToxicities,Obj
parameters,are,prognostic,Obj
immediateVerbalMemoryIndex,wasHigherIn,study2,Obj
measurements,thusLeadTo,lowRateInImmediateBreastReconstruction,Obj
it,continue,combinationTherapyForPatients,Obj
tdo2Function,isIn,esccCellLines,Obj
impact,isIn,molecularDiagnostics,Obj
electronBoost,was,performed,Obj
optimalPatientSelection,is,crucial,Obj
purpose,develop,realistic4dDigitalBreastPhantomIncludingContrastEnhancement,Obj
suspiciousPrimaryLesion,achieved,response,Obj
S961,blockedExpressionIn,presenceOfInsulin,Obj
we,explored,potentialMechanismsInvolvedInMitochondrialDysfunction,Obj
therapy,strategyFor,breastCancerMetastasisPrevention,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHumanGrowthFactorReceptorBreastCancerInCombination,Obj
mrnaExpression,wasMeasuredIn,breastCarcinomaCells,Obj
acceleratedPartialBreastIrradiation,using,interstitialFractionatedBrachytherapy,Obj
woman'sHeadache,resultFrom,adenocarcinomaMetastasisFromUnknownSite,Obj
exclusionCriteria,comprehend,implications,Obj
Prognosis,isPoor,treatableDisease,Obj
sustainedResponse,suspiciousLesionIn,breast.Treatment,Obj
skinToxicity,wasG1At,endOfRtTreatment,Obj
adjuvantAcceleratedPartialBreastIrradiation,using,multicatheterBrachytherapy,Obj
we,investigate,tolerabilityWithEri,Obj
conclusionsPalbociclib,is,effectiveTreatmentOption,Obj
we,investigate,tolerability,Obj
nature,be,epidermal,Obj
role,prognosticSignificanceOf,plasmaEsr1MutationsInMbcPatientsWithExposureToAiTherapy,Obj
annotation,pathwaysOf,DEGs,Obj
it,owingTo,degreeOfConcernAboutOvarianCancerRisk,Obj
Women,on,sexualFunction,Obj
cellAuthenticationTesting,confirmed,humanOrigin,Obj
phantom,can,canUsedDuringDevelopmentOfDynamicBreastCtImagingForOptimization,Obj
breastCancer,is,subtype,Obj
breastCancer,remains,leadingCauseOfDeathInWomen,Obj
intraoperativeFindings,showed,90PercecntAccuracyForMriPreoperativeEvaluation,Obj
invasionAbility,epithelial-mesenchymalTransitionIn,mouse,Obj
EgKI-1,inhibitsGrowthIn,dose-dependentManner,Obj
Women,has,personalGoals,Obj
stratification,isCrucialFor,developmentOfPotentStandardizedTherapies,Obj
tam-secretedCytokines,associatingWith,poorOutcomes,Obj
information,isAvailableOn,commonOralAgentForTreatmentOfOsteoporosis,Obj
tdo2Overexpression,wasCorrelatedWith,outcome,Obj
AO,wasScoredBy,bcctcoreSoftware,Obj
patients,received,vmat-sibTechnique,Obj
compound,reduces,aldehydeDehydrogenase,Obj
phantom,can,canUsedDuringDevelopmentOfDynamicDedicatedBreastCtImaging,Obj
patients,have,veryPoorPrognosis,Obj
threeNovelBasal/her2,recapitulating,characteristics,Obj
3dPhantom,segmentingTissueFrom,healthyPatientIntoSkin,Obj
study,included,womenWithHer2-positiveBcs,Obj
2MutationCarriers,follow,intensiveClinicalSurveillancePrograms,Obj
basal/humanEpidermalGrowthFactorReceptor2-positiveBreastCancer,is,resistant,Obj
preoperativeMeasurements,thusLeadTo,lowRateInImplant-basedBreastReconstruction,Obj
data,remainsFor,idealStrategy,Obj
findings,indicate,utilizationOf3-o-p-coumaroyltormenticAcidForBreastCancerTherapy,Obj
breastCancer,is,occurringCancer,Obj
cells,wereExposedTo,singleTamoxifen,Obj
co-treatment,induced,cellApoptosis,Obj
EgKI-1,giving,rise,Obj
findings,indicate,novelUtilizationOfAcidForBreastCancerTherapy,Obj
preoperativeMeasurements,thusLeadTo,rateOfComplicationsInImplant-basedBreastReconstruction,Obj
events,areResponsibleFor,increase,Obj
aqueousOrthosiphonPallidusExtract,showed,potentActivityInIn-vitroModels,Obj
use,wasAssociatedWith,hazardRatio,Obj
patients,found,t-patAppointment,Obj
AC,suppressedBreastCancerMetastasisTo,lungs,Obj
breastCancerCells,showed,extensiveGrowth,Obj
woman'sHeadache,resultFrom,adenocarcinomaMetastasisFromUnknownPrimarySite,Obj
study,investigate,pivotalRoleOfIrAntagonistS961OnIrSignalling,Obj
study,included,womenWithBcs,Obj
recommendations,impact,aspectsOfTheirLife,Obj
breastIrradiation,using,multicatheterHigh-dose-rateBrachytherapy,Obj
furtherPros,wereMeasuredWith,eortcQlq-c30,Obj
women,wereSignificantlyOlderThan,ones,Obj
furtherEndocrineTherapyChoice,isIn,erPatients,Obj
tnbcPatients,responseComparedTo,otherBreastCancerSubtypes,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHormoneReceptor-positiveGrowthFactorReceptorBreastCancerInCombination,Obj
tenHubGenes,isWith,highDegreeOfConnectivity,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveEpidermalGrowthFactorReceptorAdvancedBreastCancer,Obj
investigated,combinatorialEffectsOn,erCancer,Obj
woman'sHeadache,wasFound,resultFromAdenocarcinomaMetastasisInBoneMarrowFromPrimarySite,Obj
phantom,can,canUsedDuringDevelopmentForOptimization,Obj
erαPolyubiquitinationInhibition,may,mayFactor,Obj
study,investigate,roleOfIrAntagonistS961OnIrSignalling,Obj
phantom,can,canUsedDuringDevelopmentOfDynamicContrast-enhancedDedicatedBreastCtImagingForOptimization,Obj
adjuvantBreastIrradiation,using,interstitialFractionatedBrachytherapy,Obj
modality,couldProvide,functionalInformation,Obj
diseaseNature,be,estrogenReceptor-positive/humanGrowthFactorReceptor2-negativeBreastCancer,Obj
Agents,mightOf,mightEffect,Obj
breastCancerCells,expressed,ir-aIsoform,Obj
G1,isIn,135PercecntOfPatients,Obj
phantom,can,canUsedDuringDevelopmentOfDedicatedBreastCtImagingForOptimization,Obj
lincrna-rorExpression,using,transcriptionPolymeraseChainReaction,Obj
studyPopulation,included,women,Obj
co-treatment,alsoInduced,cellApoptosis,Obj
noncodingRna-regulator,affects,tamoxifenResistance,Obj
aldehydeDehydrogenase,expressing,expressionOfSelf-renewal-relatedGenes,Obj
effect,disappeared,5YearsOfEndocrineTherapyReduced,Obj
we,explored,potentialMechanisms,Obj
2MutationCarriers,areOffered,breast,Obj
dynamics,be,potentialPredictiveBiomarker,Obj
Results,have,haveInconsistent,Obj
cellProliferation,were,thenDetectedBy3,Obj
role,significanceOf,plasmaEsr1MutationsInMbcPatients,Obj
patientSelection,isCrucialGiven,effectsOfTherapy,Obj
cellMigration,combinedTreatmentOf,tamoxifen,Obj
retrospectiveStudy,included,womenWithBcs,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentInCombinationWithFulvestrantInPostmenopausalWomen,Obj
purpose,develop,realisticPatient-based4dBreastPhantomIncludingContrastEnhancement,Obj
estrogenReceptorPatients,areMoreCommonOf,cases,Obj
study,was,aimed,Obj
Display,is,increasinglyConsidered,Obj
Comparison,showed,significantDifferencesBetweenViableTumor,Obj
biomarkers,optimize,clinicalOutcome,Obj
purpose,develop,4dDigitalBreastPhantomIncludingContrastEnhancementForSimulationOfBreastCtPerfusionImaging,Obj
use,was,inMultivariableCox'sHazardsSurvivalModelAssociatedWithHazardRatioOf004ForBoneMetastasis,Obj
AC,decreasedLungMetastasis,demonstrated,Obj
severalAspects,expressionOf,IRs,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHormoneReceptor-positiveGrowthFactorReceptorBreastCancer,Obj
inhibition,be,key,Obj
itsPotentialPracticalApplications,merit,furtherInvestigation,Obj
expression,regulates,severalAspects,Obj
findings,indicate,novelUtilizationOfAcid,Obj
aim,examine,evidenceOnPersonalGoal-settingAmongWomen,Obj
CXCL1,canPromote,invasionAbility,Obj
chemotherapyInjection,isIn,inTumorModel,Obj
we,usingImmunofluorescenceOn,tissueSectionsFollowedByApproach,Obj
tdo2Function,wereEvaluatedBy,RNAi,Obj
acTreatment,downregulating,markerProteins,Obj
therapy,is,interesting,Obj
recapitulating,characteristicsOf,ofParentTumor,Obj
objective,investigate,scavenging,Obj
Knockdown,induced,inactivationOfGrowthFactorReceptorSignalingPathway,Obj
t-patParticipants,holdBeliefsAfter,appointment,Obj
aromataseInhibitors,haveLedIn,firstLineSettings,Obj
higherExpression,wasAssociatedWith,recurrenceRiskBeyond5YearsAfterDiagnosis,Obj
effect,incorporatingGoal-settingInto,support,Obj
HR,remained,similar,Obj
productivePrognosisDiscussions,be,canDeliveredByClinicalTeamWithinPatientEducationAppointment,Obj
we,hereExplored,significance,Obj
clinicalMeasurements,leadTo,lowRateOfComplicationsInImplant-basedBreastReconstruction,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHumanEpidermalGrowthFactorReceptor2-negativeBreastCancer,Obj
adjuvantPartialBreastIrradiation,using,interstitialMulticatheterHigh-dose-rateBrachytherapy,Obj
AO,was,unfavourable,Obj
work,shows,impactInMolecularDiagnosticsForTreatmentSelection,Obj
CXCL1,canPromote,transitionInMouse,Obj
we,discovered,treatment,Obj
changes,concentrationsOf,20-60Μg/ml,Obj
work,shows,impactInDiagnosticsForTreatmentSelection,Obj
modality,couldProvide,functionalInformationOfBreast,Obj
repeatedPreparations,using,aroniaExtracts,Obj
it,continue,combinationTherapyDueToHematologicalToxicities,Obj
objective,investigate,free-radicalScavengingAgainstBreast-cancerCellLines,Obj
advancements,displaySystemsAs,newModalities,Obj
prognosisDiscussions,be,canDeliveredEffectivelyByTeamWithinSemi-structuredPatientEducationAppointment,Obj
we,haveTested,peptidesDerivedAsVaccineDeliveryModalitiesForTreatmentOfTuboBreastCancerXenograftTumorsOfBalb/cMice,Obj
effects,feasibilityOf,plannedPrognosisDiscussion,Obj
patients,found,appointment,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentInCombinationWithFulvestrantInWomenWithDiseaseProgression,Obj
woman'sHeadache,wasFound,resultFromAdenocarcinomaMetastasisInBoneMarrowFromUnknownSite,Obj
bilateralSalpingo-oophorectomy,mayImpactBecauseOf,symptomsAssociatedWithEarlySurgicalMenopause,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveHumanGrowthFactorReceptorAdvancedBreastCancerInCombination,Obj
3dStaticPhantom,segmentingBreastCtImageFrom,patientIntoSkin,Obj
acceleratedPartialBreastIrradiation,using,interstitialFractionatedHigh-dose-rateBrachytherapy,Obj
clinicalMeasurements,leadTo,rateOfComplications,Obj
morphologicalChanges,concentrationsOf,μg/ml,Obj
photographs,measuring,distances,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHumanGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveHumanGrowthFactorReceptor2-negativeBreastCancer,Obj
64-year-oldWoman'sHeadache,wasFound,resultFromAdenocarcinomaMetastasisInBoneMarrowFromUnknownPrimarySite,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHumanEpidermalGrowthFactorReceptorBreastCancer,Obj
64-year-oldWoman'sHeadache,wasFound,resultFromAdenocarcinomaMetastasisInBoneMarrow,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfGrowthFactorReceptorBreastCancerInCombination,Obj
measurements,thusLeadTo,rate,Obj
higherExpression,wasAssociatedWith,highRecurrenceRisk,Obj
measurements,thusLeadTo,lowRateOfComplicationsInImplant-basedImmediateBreastReconstruction,Obj
purpose,develop,patient-based4dBreastPhantom,Obj
differentPatterns,can,canAlsoSimulatedForTumorModels,Obj
adjuvantPartialBreastIrradiation,using,interstitialFractionatedHigh-dose-rateBrachytherapy,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfReceptor-positiveGrowthFactorReceptorBreastCancerInCombination,Obj
information,isAvailableOn,commonOralAgentForTreatmentOfPost-menopausalOsteoporosis,Obj
we,explored,impactOfHeterogeneity,Obj
Display,is,consideredAsNewCancerVaccineDeliveryStrategy,Obj
It,understand,pathwaysInvolvedInPathogenesis,Obj
we,hereExplored,expressionOfTdo2,Obj
patterns,can,canAlsoSimulatedForTumorModels,Obj
compound,Using,13c2-dimensionalNuclearResonance,Obj
personalGoal-setting,is,whereComponent,Obj
breastMri,canEnhance,prediction,Obj
co-treatment,regulating,expressionOfProteins,Obj
expression,was,measured,Obj
epithelial-mesenchymalTransition,isIn,mouse,Obj
It,understand,molecularPathwaysInvolved,Obj
variousMethods,reduceSpaceAfter,mastectomy,Obj
We,generated,threeVisualRepresentations,Obj
measurements,leadTo,lowRateOfComplications,Obj
doses,wereEscalatedFor,GEM,Obj
basal/humanGrowthFactorReceptor2-positiveBreastCancer,isResistantTo,monoclonalAntibody,Obj
co-exposure,significantlyInhibited,cellProliferation,Obj
prognosisDiscussions,be,canDeliveredByPractice-basedClinicalTeamWithinPatientEducationAppointment,Obj
preoperativeMeasurements,thusLeadTo,rateOfComplicationsInImplant-basedImmediateBreastReconstruction,Obj
adjuvantAcceleratedPartialBreastIrradiation,using,interstitialFractionatedBrachytherapy,Obj
information,isAvailableOn,agent,Obj
measurements,thusLeadTo,lowRateOfComplicationsInImmediateBreastReconstruction,Obj
woman'sHeadache,wasFound,resultFromDiffuseAdenocarcinomaMetastasisFromUnknownSite,Obj
time,was,forOutcome63Months,Obj
productivePrognosisDiscussions,be,canDeliveredEffectivelyByPractice-basedTeam,Obj
problems,included,excitement,Obj
clinicalMeasurements,leadTo,rateInImplant-basedBreastReconstruction,Obj
RNA-regulator,regulating,pi3k/akt/mtorSignalingPathway,Obj
cosmeticOutcome,wasExcellentIn,635Percecnt,Obj
onePhotograph,wasTakenFor,patient,Obj
objective,evaluate,timeToTreatmentFailureInCombination,Obj
viruses,areUnder,laboratoryAsTherapeutics,Obj
chemokine,secretedBy,TAMs,Obj
We,generated,threeVisualRepresentationsOfSeer-basedBreastCancerPatientCohorts,Obj
findings,indicate,novelUtilizationOf3-o-p-coumaroyltormenticAcidForBreastCancerTherapy,Obj
tamoxifenResistance,largeIntergenicRna-regulatorOf,reprogramming,Obj
4dArray,isProduced,continuousTime-enhancementCurves,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfGrowthFactorReceptorBreastCancer,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHumanEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancer,Obj
80,received,btBoost,Obj
clinicalMeasurements,thusLeadTo,lowRateInImplant-basedBreastReconstruction,Obj
Analysis,hasLedTo,developmentOfGenerationOfTargetedTherapiesForBreastCancer,Obj
measurements,thusLeadTo,lowRateOfComplicationsInImplant-basedBreastReconstruction,Obj
combinedTreatment,suppressed,cellMigration,Obj
had,near-tetraploidKaryotypeWith,aberrations,Obj
woman'sHeadache,resultFrom,adenocarcinomaMetastasisInBoneMarrowFromSite,Obj
activity,isRelatedTo,endocrineTherapyResistance,Obj
estrogenReceptorAlpha,is,detected,Obj
multipleCytokines,associatingWith,clinicalOutcomes,Obj
therapy,is,effective,Obj
use,was,inMultivariableCox'sProportionalHazardsSurvivalModelAssociatedWithHazardRatio,Obj
therapeuticTargets,howeverAreStillRequiredFor,investigation,Obj
tumorModels,present,enhancement,Obj
EgKI-1,isExpressedBy,oncosphereOfCanineTapewormEchinococcusGranulosus,Obj
Interleukin-1,drives,colonization,Obj
clinicalMeasurements,thusLeadTo,rateOfComplications,Obj
stratification,isThereforeCrucialFor,developmentOfStandardizedTherapies,Obj
tumorModels,show,enhancementDynamics,Obj
findings,indicate,novelUtilizationOf3-o-p-coumaroyltormenticAcid,Obj
cancerStemCells,are,drug-resistant,Obj
3-o-p-coumaroyltormenticAcid,inducing,c-mycDegradation,Obj
3dStaticPhantom,segmenting,vasculature,Obj
information,isAvailableOn,mostCommonOralAgentForTreatment,Obj
combinedTreatment,blockedCellCycleIn,g2/mPhase,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfHormoneReceptor-positiveEpidermalGrowthFactorReceptor2-negativeBreastCancer,Obj
curves,areComputedFor,voxelInPhantom,Obj
study,investigate,pivotalRole,Obj
adjuvantBreastIrradiation,using,interstitialFractionatedMulticatheterBrachytherapy,Obj
we,haveTested,fewPeptidesDerivedAsVaccineDeliveryModalitiesForTreatmentOfTuboBreastCancerXenograftTumors,Obj
chemotherapy,is,mainTreatment,Obj
objective,evaluate,timeToTreatmentFailureInCombinationWithLetrozoleAsSecond-lineOfTherapy,Obj
Prognosis,isGenerallyPoor,treatableDisease,Obj
adjuvantAcceleratedBreastIrradiation,using,interstitialMulticatheterBrachytherapy,Obj
latestAdvancements,displaySystemsAs,modalitiesInCancerTherapeutics,Obj
overcoming,mechanismsOf,resistance,Obj
endocrineTherapy,canReduce,recurrencesOccurring,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfReceptor-positiveGrowthFactorReceptorAdvancedBreastCancer,Obj
circRNAs,have,haveDiscoveredInTissues,Obj
acuteSkinToxicities,were,recorded,Obj
3dStaticPhantom,segmentingVasculatureFrom,healthyPatientIntoSkin,Obj
predictiveBiomarkers,optimize,outcomeOfHr-positiveBreastCancerPatientsTreated,Obj
tumors,wereAssociatedWith,significantlyShorterSurvival,Obj
response,suspiciousPrimaryLesionWith,tamoxifen,Obj
compound,Using,13c2-dimensionalResonance,Obj
skinToxicity,was,G1,Obj
ourData,confirmed,resultsOfOtherStudiesPublishedOnAssociationOfHypofractionation,Obj
periodicExaminations,areConsideredBy,915PercecntOfResponders,Obj
objective,evaluate,timeToTreatmentFailureOfPalbociclibInCombination,Obj
near-tetraploidKaryotype,isWith,structuralAberrations,Obj
Knockdown,induced,inactivationOfEpidermalGrowthFactorReceptorSignalingPathway,Obj
woman'sHeadache,wasFound,resultFromDiffuseAdenocarcinomaMetastasisInBoneMarrowFromUnknownSite,Obj
geo2rTool,screenOut,differentiallyExpressedGenesBetweenTnbc,Obj
hypofractionatedVmat-sib,wellToleratedIn,termsOfAcute,Obj
Prognosis,isPoor,disease,Obj
analysis,was,conducted,Obj
we,haveRecentlyTested,peptidesDerivedAsVaccineDeliveryModalitiesForTreatmentOfTuboBreastCancerXenograftTumors,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfReceptor-positiveEpidermalGrowthFactorReceptor2-negativeBreastCancerInCombination,Obj
adjuvantAcceleratedPartialBreastIrradiation,using,brachytherapy,Obj
goal-setting,is,whereComponent,Obj
partialBreastIrradiation,using,brachytherapy,Obj
basal/humanEpidermalGrowthFactorReceptorBreastCancer,isResistantTo,antibody,Obj
methods,reduce,space,Obj
targets,howeverAreStillRequiredFor,furtherInvestigation,Obj
time-enhancementCurves,areComputedFor,voxelInPhantom,Obj
it,continue,combinationTherapyDueToToxicities,Obj
co-treatment,regulating,expression,Obj
protein-proteinInteraction,wasAnalyzedBasedOn,searchTool,Obj
productivePrognosisDiscussions,be,canDeliveredByPractice-basedClinicalTeamWithinSemi-structuredPatientEducationAppointment,Obj
analysis,using,2231MrnaProfilesOfPatientsWithEr-positive/humanEpidermalGrowthFactorReceptorBreastCancer,Obj
potentialApplications,isIn,cancerPrevention,Obj
predictiveBiomarkers,optimize,outcomeOfBreastCancerPatientsTreatedWithPalbociclib,Obj
It,was,perceived,Obj
TNBC,has,6SubtypesWithSignatures,Obj
predictiveRole,significanceOf,plasmaEsr1MutationsInMbcPatientsWithPriorExposureToAiTherapy,Obj
antrodiaCamphorata,exhibits,potential,Obj
woman'sHeadache,resultFrom,diffuseAdenocarcinomaMetastasisInBoneMarrow,Obj
phantom,can,canUsedDuringDevelopmentOfContrast-enhancedBreastCtImaging,Obj
protein-proteinInteraction,wasAnalyzedBasedOn,searchToolForRetrievalOfInteractingGenesDatabase,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfReceptor-positiveHumanEpidermalGrowthFactorReceptorBreastCancerInCombination,Obj
cells,grew,showInvasivenessInMice,Obj
phantom,can,canUsedDuringDevelopmentOfDynamicContrast-enhancedBreastCtImagingForOptimizationOfImageAcquisition,Obj
4dArray,isProduced,curvesAtDesiredSamplingRate,Obj
64-year-oldWoman'sHeadache,resultFrom,adenocarcinomaMetastasisInBoneMarrowFromPrimarySite,Obj
cellLines,were,basal/HER2,Obj
erαPolyubiquitinationInhibition,may,mayKeyFactor,Obj
seromaFormation,is,commonComplication,Obj
palbociclib,survivalOfWas,64Months,Obj
using,combinationOf,ovTherapyWithCheckpointInhibitors,Obj
3dPhantom,segmenting,vasculature,Obj
we,summarize,knowledgeOnCircrnas,Obj
S961,efficientlyBlockedExpressionIn,evenPresence,Obj
64-year-oldWoman'sHeadache,resultFrom,adenocarcinomaMetastasisFromPrimarySite,Obj
adjuvantPartialBreastIrradiation,using,interstitialFractionatedBrachytherapy,Obj
possibility,holds,greatPromise,Obj
3dStaticPhantom,segmentingBreastCtImageFrom,healthyPatientIntoSkin,Obj
massiveCircrnas,have,withDevelopmentHaveDiscoveredInTumorousTissues,Obj
adjuvantAcceleratedPartialBreastIrradiation,using,interstitialFractionatedHigh-dose-rateBrachytherapy,Obj
systems,advancementsIn,applications,Obj
data,are,scarce,Obj
adjuvantBreastIrradiation,using,fractionatedMulticatheterHigh-dose-rateBrachytherapy,Obj
Overexpression,was,associated,Obj
mainProblems,included,desire,Obj
we,explored,impact,Obj
aim,compare,seromaFormationInMethodsOfFlapFixation,Obj
tumorModels,show,differentEnhancementDynamics,Obj
had,karyotypeWith,aberrations,Obj
Analysis,hasLedTo,developmentOfNewGenerationOfTherapiesForAdvancedBreastCancer,Obj
expression,wasAssociatedWith,highRecurrenceRisk,Obj
activities,free-radicalScavengingAgainst,humanBreast-cancerCellLines,Obj
partialBreastIrradiation,using,interstitialFractionatedMulticatheterBrachytherapy,Obj
bilateralSalpingo-oophorectomy,mayImpact,canTreated,Obj
it,mainlyOwingTo,lowerDegreeOfConcernAboutOvarianCancerRisk,Obj
fifty-threePatients,meeting,eligibilityCriteria,Obj
TAMs/CXCL1,promotesBreastCancerMetastasisVia,nf-κb/sox4Activation,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentOfGrowthFactorReceptor2-negativeBreastCancer,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentInCombinationWithFulvestrantInPostmenopausalWomen,Obj
risk,yearsOf,endocrineTherapy,Obj
triple-negativeBreastCancer,isSubtypeOf,breastCancer,Obj
assays,arePrognosticFor,lateRecurrence,Obj
Analysis,hasLedTo,developmentOfGenerationOfTherapiesForAdvancedBreastCancer,Obj
EgKI-1,shows,promise,Obj
characteristics,evaluate,perfusionInTypesOfBreastLesions,Obj
tumorModels,moreoverShow,enhancementDynamics,Obj
productivePrognosisDiscussions,be,canDeliveredEffectivelyByTeamWithinPatientEducationAppointment,Obj
purpose,develop,4dBreastPhantomIncludingTime-varyingContrastEnhancementForSimulationOfDedicatedBreastCtPerfusionImaging,Obj
kinases,beenIdentifiedAs,driversOfProliferationInHormoneReceptor,Obj
femaleBreastCancerPatients,undergoing,mastectomy,Obj
geo2rTool,screenOut,genes,Obj
expression,were,repressedByTamAfterSilencingLincrna-ror,Obj
objective,investigate,scavengingAgainstHumanBreast-cancerCellLines,Obj
acceleratedBreastIrradiation,using,interstitialFractionatedHigh-dose-rateBrachytherapy,Obj
time,upregulating,epithelialMarkerProteinsLikeOccludin,Obj
cells,hadRespectively,doublingTimes,Obj
mtrValues,wereEvaluatedAs,measureOfCestEffectAt05ΜtSaturationAmplitude,Obj
905Percecnt,wouldChoose,it,Obj
interaction,wasAnalyzedBasedOn,searchToolForRetrieval,Obj
circumstances,sexualFunctionOf,women,Obj
percentCytotoxicity,increaseWith,increasingOpaeConcentrationUpTo240G/ml,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfGrowthFactorReceptorAdvancedBreastCancer,Obj
interaction,wasAnalyzedBasedOn,searchToolForRetrievalOfInteractingGenesDatabase,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHumanEpidermalGrowthFactorReceptor2-negativeAdvancedBreastCancerInCombination,Obj
women,were,older,Obj
virusTherapy,is,interestingStrategy,Obj
salpingo-oophorectomy,mayImpact,canTreatedWithHormonalReplacementTherapies,Obj
we,haveRecentlyTested,fewPeptides,Obj
Expression,has,hasLinkedWithTumorSurvivalOfBrain,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentInCombinationWithFulvestrantInPostmenopausalWomenWithDiseaseProgressionFollowingEndocrineTherapy,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHormoneReceptor-positiveGrowthFactorReceptor2-negativeBreastCancer,Obj
circumstances,influence,functionOfWomen,Obj
4dArray,finallyIsProduced,continuousCurvesAtDesiredSamplingRate,Obj
purpose,develop,realistic4dBreastPhantomIncludingTime-varyingContrastEnhancement,Obj
therapies,improve,outcomes,Obj
we,haveRecentlyTested,fewPeptidesDerivedFromHer2/neuProto-oncogeneAsVaccineDeliveryModalitiesForTreatmentOfTuboBreastCancerXenograftTumorsOfBalb/cMice,Obj
interaction,visualizedBy,cytoscapeSoftware,Obj
tdo2ProteinExpression,was,evaluated,Obj
use,was,inMultivariableCox'sProportionalHazardsSurvivalModelAssociatedWithHazardRatioForBoneMetastasis,Obj
retrospectiveStudy,included,women,Obj
adjuvantAcceleratedBreastIrradiation,using,interstitialFractionatedBrachytherapy,Obj
Prognosis,is,veryPoor,Obj
predicting,benefitFrom,endocrineTherapy,Obj
preoperativeMeasurements,thusLeadTo,rateInImplant-basedImmediateBreastReconstruction,Obj
This,was,retrospective,Obj
3dStaticPhantom,is,created,Obj
woman'sHeadache,resultFrom,diffuseAdenocarcinomaMetastasisFromUnknownPrimarySite,Obj
lateRecurrenceRisk,Extending,5Years,Obj
objective,evaluate,timeToTreatmentFailureOfPalbociclibInCombinationAsSecond-line,Obj
64-year-oldWoman'sHeadache,wasFound,resultFromAdenocarcinomaMetastasisFromUnknownPrimarySite,Obj
geneSet,rankedAccordingTo,theirAssociationWithRecurrenceRisk,Obj
biomarkers,allowing,patientSelection,Obj
anticancerActivities,antioxidantFree-radicalScavengingAgainst,cellLines,Obj
showing,expressionOf,genes,Obj
it,owingTo,degree,Obj
findings,indicate,utilizationOf3-o-p-coumaroyltormenticAcid,Obj
percentCytotoxicity,increaseSteadilyWith,increasingOpaeConcentrationUpTo240G/ml,Obj
breastIrradiation,using,fractionatedMulticatheterHigh-dose-rateBrachytherapy,Obj
methods,have,haveDescribed,Obj
examinations,areConsidered,usefulForDiagnosisOfBreast/ovarianCancer,Obj
History,isAssociatedWith,lowerLikelihood,Obj
total,reducing,powerActivities,Obj
combinedTreatment,markedlySuppressed,cellMigration,Obj
women'sPersonalGoals,mayProvideInsightIn,contextOfBreastCancer,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfReceptor-positiveEpidermalGrowthFactorReceptor2-negativeBreastCancer,Obj
basal/humanGrowthFactorReceptor2-positiveBreastCancer,isResistantTo,antibody,Obj
4dArray,isProduced,continuousTime-enhancementCurvesAtSamplingRate,Obj
aim,examine,existingEvidenceOnGoal-settingAmongWomenWithBreastCancerDiagnosis,Obj
sexualFunction,investigate,potentialRelationshipBetweenSexualDysfunction,Obj
3dStaticPhantom,segmentingTissueFrom,patientIntoSkin,Obj
curves,areCalculatedBy,convolution,Obj
We,thereforeSummarized,currentKnowledgeOfLateRecurrenceBiology,Obj
Patients,will,willAllocatedToOneOfThreeTreatmentArmsConsistingOfFlapFixation,Obj
we,explored,potentialMechanismsInvolved,Obj
highRisk,isIn,patientsTreatedWithGhAfterCranialRadiotherapy,Obj
breastCancer,isSecond-leadingCauseOf,centralNervousSystemMetastasesAmongSevereMalignancies,Obj
earlyDynamics,bePotentialBiomarkerFor,cdk4/6Inhibitors,Obj
TDO2,may,mayPotentialTherapeuticTargetInEscc,Obj
lincrna-rorExpression,using,reverseTranscriptionQuantitativePolymeraseChainReaction,Obj
it,mainlyOwingTo,lowerDegreeOfConcern,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfReceptor-positiveHumanGrowthFactorReceptor2-negativeBreastCancer,Obj
We,generated,threeVisualRepresentationsOfBreastCancerPatientCohorts,Obj
irMrnaExpressionLevels,wereSignificantlyDownregulatedIn,presence,Obj
cells,had,times,Obj
maximumResponse,occurredAfter,chemotherapyInjection,Obj
TNBC,betweenGenesIs,DEGs,Obj
personalizedTherapy,isIn,TNBC,Obj
upregulatedExpression,regulates,severalAspectsOfPhenotypeIncludingCellProliferation,Obj
Patients,will,willRandomlyAllocatedToOneOfThreeTreatmentArmsConsisting,Obj
multigeneAssays,arePrognosticFor,recurrence,Obj
inModel,isIn,balb/cNudeMice,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatment,Obj
ourScopingReview,willSearchFor,females,Obj
predictiveRole,significanceOf,plasmaEsr1Mutations,Obj
skinToxicity,wasG1In,511PercecntOfPatients,Obj
It,understand,pathways,Obj
Palbociclib,isInhibitorOf,kinasesApprovedForTreatmentOfHormoneReceptor-positiveHumanGrowthFactorReceptorBreastCancerInCombination,Obj
clinicalMeasurements,thusLeadTo,rateOfComplicationsInImplant-basedImmediateBreastReconstruction,Obj
purpose,develop,realisticPatient-based4dBreastPhantomIncludingTime-varyingContrastEnhancementForSimulationOfDedicatedBreastCtPerfusionImaging,Obj
Patients,presenting,breastCancer,Obj
AC,demonstratedBy,upregulation,Obj
plasmaEsr1Mutations,isIn,estrogenReceptor,Obj
expression,regulates,severalAspectsIncludingCellProliferation,Obj
parameters,arePrognosticFor,lateRecurrence,Obj
pi3k/akt/mtorPathway,be,importantGrowthPathwayInHrBreastCancer,Obj
conclusionsPalbociclib,is,viableEffectiveTreatmentOption,Obj
ongoingResearch,isAnticipated,continue,Obj
orthosiphonPallidus,has,antioxidantAgainstBreast-cancerCellLines,Obj
phageConstructFormulation,actsAs,vaccine,Obj
prognosisDiscussions,be,canDeliveredByPractice-basedClinicalTeamWithinSemi-structuredPatientEducationAppointment,Obj
Palbociclib,isInhibitorOf,cyclin-dependentKinasesApprovedForTreatmentInCombinationWithFulvestrantInWomenWithDiseaseProgressionFollowingEndocrineTherapy,Obj